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  Chapter I 
 
Introduction 
 
Campylobacter  jejuni is a microaerophilic, spiral shaped, motile, gram-negative, 
enteric food borne pathogen (14).  It is a fastidious, facultative intracellular bacterium 
and requires an oxygen concentration of 3-15% and CO2 of 3% (14). Biochemically,       
C. jejuni is catalase and oxidase positive and urease negative (26). It does not ferment 
carbohydrates (14). The optimal growth temperature is 42○C which is also the normal 
body temperature of poultry, its natural commensal host (17). 
 
C.  jejuni is the most common cause of bacterial food-borne enteritis in the 
industrialized countries (3). Campylobacteriosis is a zoonosis (3). Poultry and poultry 
products are reported to be the major sources of human infection. C. jejuni behaves as a 
commensal in birds and occurs in exceptionally high numbers (108-1010 cfu per gram) in 
the cecum of chickens (12). However, in humans, an infectious dose as low as 500 to 800 
organisms have been reported to cause the disease (7). The symptoms associated with 
campylobacteriosis vary from mild diarrhea to severe colic (25). Campylobacter is an 
important cause of traveler’s diarrhea (3). Generally, Campylobacter enteritis is a self 
limiting disease which rarely requires antimicrobial therapy, although one in 1000 
infections can lead to a paralytic condition, Guillain- Barré syndrome {GBS} (1, 9) . The 
annual incidence rate of Campylobacter is 13.3 per 100,000 of the US population (29), 
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and it accounts for 33.4% of laboratory confirmed cases of bacterial gastro-enteritis in the 
US (29). The high incidence rate of campylobacteriosis necessitates the development of 
new strategies to combat the disease, and which requires a better understanding of the 
host-pathogen interactions. The exact mechanism of gut colonization and disease 
pathogenesis is not well known.  However, the availability of the complete genome 
sequence of C. jejuni NCTC11168 in 2000, has led to new opportunities in the 
investigation of Campylobacter pathogenesis. Some of the Campylobacter colonization 
and virulence factors that have been characterized so far include flagella, host cell 
adherence and invasion, and toxin production (5). 
 
                Iron, in addition to having a nutritional role, is also a key environmental signal 
for controlling the bacterial pathogenesis of most human pathogens (4, 15). Recently, the 
complex response of C. jejuni to iron availability was demonstrated  (11, 18).  Although 
iron is abundant in nature, the availability of free iron is very limited in mammalian 
hosts. Oxidation creates insoluble iron complexes that are not readily available to the 
bacteria within the host. Bioavailability of iron depends on conditions such as pH and 
oxygen tension which affect the oxidation state of the iron molecule. Under aerobic 
conditions at neutral to alkaline pH, iron is in the insoluble form as Fe (III), and its 
bioavailability is limited to 10-18 M (22). In the mammalian host its bioavailability is 10-24 
M as majority of Fe(III) is tightly bound to iron-binding and transport proteins such as 
hemoglobin, transferrin,  lactoferrin and ferritin (22). These levels are far below the 
minimum requirements of 10-7 M for the bacterial growth. Therefore, microorganisms 
have evolved complex mechanisms to acquire iron and maintain its homeostasis.  
 3 
 
          The enteric pathogenic bacteria utilize several methods for high affinity iron 
acquisition. The two most commonly used methods are the direct utilization of host iron 
sources such as heme, hemoglobin, transferrin and lactoferrin  and synthesis and transport 
of siderophores (29). Siderophores are low molecular weight compounds that chelate 
Fe(III) with sufficient affinity to remove it from host compounds (24) . Only a few strains 
of C. jejuni have been shown to produce siderophores and these siderophores are 
uncharacterized (6). The C. jejuni genome lacks the genetic machinery required for the 
biosynthesis of enterobactin which is an E. coli siderophore (19). However, all the strains 
of Campylobacter tested were able to acquire iron from enterobactin. Ferric- siderophore 
complexes exceed the diffusion limit of the outer membrane of gram-negative bacteria; 
thus energy dependent transport systems are required for their efficient acquisition. There 
is no known source of energy available at the outer membrane, and the proton motive 
force (PMF) of the cytoplasmic membrane is harnessed as the energy source (20) via the 
TonB system, consisting of three proteins: TonB, ExbB, and ExbD. The TonB system 
transduces the cytoplasmic membrane proton motive force (PMF) to the active transport 
of nutrients through outer membrane receptors. E. coli and most of the other              
gram-negative bacteria contain a single TonB system (2, 20) whereas V. cholerae has two 
distinct TonBs which contribute to its ability to use a variety of iron sources to perform 
specific as well as redundant functions (16). Based on the genome sequence of C. jejuni 
NCTC 11168, there are three putative TonB systems (19). These are not closely mapped 
on the chromosome, and their exact role is not clear. We hypothesize that the presence of 
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three TonBs in C. jejuni may contribute to its ability to utilize varied iron sources under 
different environmental conditions. 
 
The complete genome sequence of C. jejuni NCTC11168 suggests the presence of 
several iron acquisition systems, some of which have been partially/completely 
identified: a complete hemin uptake system [ChuABCD] (27), an enterochelin transport 
system [CeuBCDE] (23, 27), a  ferric enterobactin uptake receptor [CfrA] (10, 18), 
ferrichrome uptake system [CfhuABD] (8), and three putative TonB/ ExbB/ ExbD 
complexes (27). Additionally, a putative ferrous iron transporter protein [FeoB] has been 
identified (21). The FeoB-mediated ferrous iron transport has been demonstrated to be 
critical for growth of E. coli (13) and  H. pylori in vivo as well as in vitro (28).  However, 
the role of these iron acquisition systems as virulence/colonization determinants in 
Campylobacter pathophysiology is not completely understood. Also, the intracellular 
growth environment with respect to the availability of specific nutrients and the nature of 
the iron sources (whether ferrous or ferric) available to the different strains of C. jejuni in 
the cytoplasm of the infected host cells within the gut is not known. Based on the above 
background information, I propose to accomplish the following objectives: 
1. Characterize FeoB mediated Fe (II) iron uptake and 
2. Characterize TonB dependent Fe(III)  iron uptake in different strains of  
     C. jejuni and examine their role in Campylobacter pathophysiology. 
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Chapter II 
 
 
Review of Literature 
 
1 Iron 
Iron plays a pivotal role in the metabolism of almost all forms of life and occupies a 
unique position in biological systems. It is an essential element for almost all living 
organisms, with the possible exception of only Lactobacillus species and Borrelia 
burgdorferi that utilize manganese and cobalt as biocatalysts in place of iron (35, 74, 
102). Iron is an important co-factor of many enzymes and is involved in a wide variety of 
biological mechanisms such as oxygen transport, electron transfer, photosynthesis, amino 
acid biosynthesis and DNA synthesis (73). 
 
1.1 Availability of Iron 
Although abundant on earth, the bioavailability of iron is very limited in most 
environments. In aerobic environments and at neutral to alkaline pH, iron occurs in the 
oxidized ferric form, Fe(III). The ferric form aggregates into insoluble, oxy-hydroxide 
polymers. This insoluble ferric iron is not readily available for bacteria unlike the Fe(II) 
form, which is soluble (98). Paradoxically, although iron is essential for bacteria, excess 
iron is toxic. Iron catalyzes the formation of harmful hydroxyl anions and radicals via the 
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Haber-Weiss and Fenton reactions. The ferrous iron can activate the Fenton reaction and 
react with hydrogen peroxide which is formed under aerobic conditions.  
 
1.2 Haber-Weiss Reactions 
The traces of ferric iron can react with H2O2   to produce Fe (II) and generate superoxide 
anion. 
Fe (III) + H2O2   Fe (II) + O2- + 2H+ 
In another reaction, the Fe (III) iron can react with superoxide anion to form ferrous iron 
and molecular O2 
Fe (III) + O2- Fe (II) + O2 
The toxicity of the O2- and H2O2 involves their conversion to OH. radical  (102). 
Therefore, in human and animal tissues, to avoid the generation of free radicals, iron is 
complexed into hemoglobin and stored intracellularly in ferritin, or is chelated by 
transferrin in serum and by lactoferrin at mucosal surfaces (35). Thus, iron homeostasis is 
strictly regulated. Consequently, there is restriction of free iron availability to support 
bacterial growth. 
 
1.3 Fenton Reaction 
Fe(II) + H2O2   Fe(III) + OH- + OH
. 
The Fenton reaction produces highly reactive hydroxyl anions and hydroxyl radicals that 
are very harmful for most of the macromolecules (102). 
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2 Iron Transport in gram-negative Bacteria 
Gram-negative bacteria have developed several mechanisms to acquire iron from various 
sources available in their respective habitats and have to compete fiercely with the 
normal microbiota within their habitat. The cell envelope of Gram-negative bacteria 
comprises the inner cytoplasmic membrane (CM), the peptidoglycan rich periplasm, and 
the outer membrane (OM). The outer membrane confers protection to the cell and 
selectively permeates uptake of nutrients. The proteins within the OM either provide 
porin channels for passive solute diffusion or mediate active transport (63). For example, 
ferrous iron is mostly soluble under anaerobic conditions and can passively diffuse 
through the porins in  the OM, whereas, ferric complexes such as transferrin, heme or 
lactoferrin are too large to be transported by porins and need to be actively transported 
(63). Broadly based upon the oxidation state of iron, iron sources can be categorized as 
ferrous and ferric.  
 
3 Fe(II) 
Fe (II) iron is the major form of iron under anaerobic and reducing conditions or at acidic 
pH. Fe (II) iron uptake is also important in the presence of oxygen since many bacteria 
can reduce extracellular ferric iron (98). The ferrous iron is highly soluble,  and a small 
molecule of less than 600 Da, may diffuse through outer membrane porins. There is no 
evidence for the involvement of any specific outer membrane receptor in this process. 
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Once inside the periplasm, the ferrous iron is transported through the cytoplasmic 
membrane via the “FeoB” protein (2).  FeoB homologs are found in genomes of Archae, 
gram-positive and gram-negative bacteria (98). The FeoB protein is highly conserved in 
many species of gram-negative bacteria. The crystal structure of FeoB has not yet been 
determined in any bacteria. The FeoB protein contains a G-Protein domain (39, 60), 
suggesting that FeoB energizes the transport of ferrous iron through the cytoplasmic 
membrane via GTP hydrolysis. Refer to Figure 1 for the schematic diagram of ferrous 
iron transport in gram-negative bacteria. 
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Figure 1:  Schematic Diagram of Ferrous Transport in gram-negative Bacteria 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
{Source:  Modified from Velayudhan et.al (2000) Molecular Microbiology 37:274-286} 
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3.1 Ferrous Iron Uptake in E. coli 
The first bacterial ferrous iron transport system to be identified was the high affinity Feo 
transport system of E. coli (49), encoded by the feoABC operon. The feoA encodes a 
small protein of 75 amino acids, while feoB encodes a membrane protein of 773 amino 
acids. The feoC was initially overlooked, but was recently reported to be present in the 
operonic frame. It encodes a protein of 78 amino acids in length, and is found only in 
members of the Enterobacteriaceae (49). Figure 2 is the schematic diagram of the feoABC 
operonic structure in E. coli. Initially it was thought that the transport of ferrous iron was 
driven by ATP hydrolysis. More recently FeoB has been  shown to be similar to 
eukaryotic and prokaryotic G-proteins (60). There are 4 of the 5 GTPase characteristic 
signature motifs in the FeoB of E. coli. Based on mutational studies, it has been proposed 
that GTPase activity is necessary for iron uptake. However, the mechanism of transport 
and the precise function of FeoB still need to be determined. Similarly, the exact role of 
FeoA and FeoC in the uptake is not known, and they might play the role of modulators by 
changing the properties of the GTPase domain of FeoB. Hence, they may speed the 
uptake process and satisfy the iron needs of the cell (60).  
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Figure 2: E. coli  feoABC Operonic structure (source Ferrous iron transport) 
 
 
 
 
 
 
 
{Source: Iron transport in bacteria (2004) Chapter 12. Ferrous iron transport Page 179} 
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3.1.1 Regulation of FeoB in E. coli 
It is evident in E. coli that ferrous iron uuptake is repressible by iron. There are 2 protein 
regulators of ferrous uptake, namely, Fur and Fnr.  
 The fur gene is the iron uptake regulator gene and its binding site, known as the Fur box, 
is present upstream of the feoB gene. Binding of the fur gene to the Fur box has been 
demonstrated in vivo. In addition, the ferrous iron uptake system is over expressed in a 
fur mutant (3). 
The Fnr activates genes required for optimal growth under anaerobic conditions. It has 
been demonstrated that regulation of feo by Fnr likely favors ferrous iron uptake under 
anaerobic conditions (3, 49). 
 
3.1.2 FeoB and Pathogenicity in E. coli 
Enteric pathogens, upon their entry into the host, have to colonize, survive and replicate 
in the GI tract, and must efficiently acquire iron under extremely low iron conditions. It 
has been shown that feoB mutants in E. coli were less efficient in their ability to colonize 
the intestine as compared to the wild type strain (91). E. coli has been shown to possess 
ribA and ribB genes which are involved in riboflavin biosynthesis, and the riboflavin thus 
synthesized, is involved in ferric reduction activity (46). CorA, a magnesium transporter, 
has been shown to transport ferrous iron in the absence of magnesium (38). It has been 
demonstrated that E. coli feoB mutants take up less ferrous iron than the wild type in the 
presence of 1 mM magnesium (38).  Thus, CorA appears to be a non-specific ferrous 
transporter in E. coli. 
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3.2 Ferrous iron transport of Helicobacter pylori 
H. pylori is a microaerophilic, gram-negative bacterium, and a major cause of gastritis 
and adenocarcinoma of the stomach (7, 8, 50-53). An Fe (II) transporter ‘FeoB’ exists in 
H. pylori (1). It is 29% identical to the E. coli FeoB protein. There is no evidence of 
FeoA homolog in H. pylori (1).  Iron transport in feoB mutant was 10 fold lower than that 
in the wild type strain, and complementation of the mutant fully restored its high affinity 
ferrous transport (101). A feoB mutant was more sensitive to other metal toxicities such 
as zinc, nickel and manganese than the wild type strain (101). The increased sensitivity of 
the feoB mutant to other metals is likely due to increased expression of other transport 
systems, leading to an increase in the accumulation of potentially toxic metals. Also, the 
feoB mutant was unable to colonize the gastric mucosa of mice, indicating its importance 
in establishing colonization in the low pH, low O2 environment of the stomach (101). 
Similar to E. coli, it has been demonstrated that the magnesium transporter CorA 
catalyzes low affinity ferrous iron uptake in H. pylori (101). The H. pylori genome also 
possesses an iron regulated ribBA gene which encodes the riboflavin biosynthesis protein 
(24, 105). The riboflavin synthesized under iron restricted conditions was shown to be 
excreted in the culture medium where it acts as a reductant. Disruption of ribBA in         
H. pylori eliminated ferric reduction activity (24, 105). 
 
3.3 FeoB dependent Fe (II) uptake in Salmonella species 
In S. typhimurium, Fe (II) iron is transported by a high affinity transport system encoded 
by the FeoABC system (96). In addition to the transporter, S. typhimurium possesses a 
magnesium transport system encoded by CorA protein which might also contribute to the 
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non-specific transport of iron into the cell, as well as the non-specific transport of other 
essential rare metals like cobalt, manganese and nickel, which are required in trace 
amounts by the cell (38). Interestingly, S. typhimurium feoB mutant was shown to be out 
competed by the wild type strain during mixed colonization in the mouse model (96). 
However, the disruption of FeoB did not attenuate the feoB mutant for oral or intra 
peritoneal infection in mice (96). In fact, the feoB gene was shown to contribute to the 
bacterial growth at intra-intestinal sites, while the tonB gene (another iron transport 
system) was found to be required for the subsequent colonization of Peyers patches of 
mesenteric lymph nodes. Consequently, different iron transport systems might be 
required at different stages of mice infection (9, 47, 80, 96). 
 
3.4 Ferrous iron transport in Shigella species 
3.4.1 Shigella flexneri  
S. flexneri is a facultative intracellular bacterium that causes dysentery in humans (78, 
103). It possesses several iron acquisition systems comprised of siderophore mediated 
ferric transporters, high affinity ferrous transporter “FeoB”, and the SitA transport 
system, which transports ferrous iron and manganese (83, 104) . The sit genes are in an 
operonic frame sitABCD, and are located in a pathogenicity island. Expression of SitA is 
induced in the eukaryotic intracellular environment, which is suggestive of its role in the 
survival or growth of Shigella within the eukaryotic cells (83, 104). The FeoB system 
also contributes towards Shigella’s intracellular survival or growth in the eukaryotic cells 
(83, 104). 
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3.4.2 Shigella dysenteriae 
S. dysenteriae is a facultative intracellular human pathogen and causes bacillary 
dysentery (78). Its virulence is dependent on its ability to invade colonic epithelial cell, 
escape from phagosomes, multiply intracellularly, and spread to adjacent cells (78). It is 
likely that FeoB transporter contributes towards its virulence machinery since a TonB 
independent iron transport system was shown to exist in S. dysenteriae (78). 
 
3.5 Ferrous iron transport in Campylobacter jejuni 
The importance of iron acquisition and metabolism for the successful colonization of the 
host has been demonstrated for many pathogens (77). C. jejuni’s lifestyle in the rabbit gut 
was recently studied and iron acquisition genes were identified to be important for gut 
colonization (88). The genome sequence of C. jejuni NCTC11168 reveals the presence of 
a FeoB homolog (Cj1398), which is approximately 1.8 Kb in size and encodes a 70 KDa 
cytoplasmic membrane protein (70). C. jejuni FeoB shares 50 % and 29 % amino acid 
identity with H. pylori and E. coli FeoB respectively. Cj1398 appears to be in an operonic 
structure with Cj1397 (Figure 3) (70, 98). However, this has not yet been experimentally 
demonstrated. Cj1397 encodes a putative protein of 74 amino acids and bears 16% 
identity to the E. coli FeoA (98). However, its role in iron transport is not yet known.  
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Figure 3:  Cj 1397 (feoA homolog) - Cj 1398 (feoB homolog) Operon 
 
 
 
 
 
 
 
The promoter region of Cj1398 contains a putative “Fur” box (98). Therefore, the 
expression of FeoB is likely Fur regulated. The putative Fur binding site upstream of 
C. jejuni FeoB is shown in Figure 4.  
      
 Figure 4:  C. jejuni FeoB Putative Fur Box 
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{Source: AHM van Vliet et al. FEMS Microbiology Reviews 26 (2002) Page 182} 
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The fur mutant in C. jejuni was shown to be significantly affected in colonization of the 
chicken gut (68).  Raphael et al characterized the C. jejuni feoB genes from the strains 
M129, F38011, and RM1221 (76).  They reported that FeoB did not play a role in ferrous 
iron transport in C. jejuni. They did not observe any significant difference in invasion and 
intracellular survivability of the feoB mutant and the wild type. Also, they found the corA 
gene to be not involved in ferrous iron transport, whereas corA has been demonstrated to 
be involved in low affinity ferrous iron transport in H. pylori, E. coli and Salmonella (39, 
101). Raphael et al. reported FeoB to be not iron regulated since the feoB transcripts were 
observed under iron rich and iron starved conditions. Their findings are in contrast to the 
recent in vitro reports which demonstrated the iron acquisition systems to be repressed 
under iron rich condition and de-repressed under iron starved condition (44, 68). 
Interestingly, the C. jejuni feoB gene was found to be up-regulated in vivo (89). The 
contradictory evidence pertaining to the involvement of FeoB in ferrous iron uptake can 
be attributed to the different strains used in characterization and the growth conditions 
prior to performing the assays. Till date, there has been no in vivo characterization of the 
feoB mutant of C. jejuni  in any animal models of colonization.  
 
4 Fe (III) 
 
In an aerobic neutral pH environment, the concentration of free ferric iron is only about 
10-18 M since most of the iron occurs in the insoluble Fe(OH)3 form (77). Therefore, the 
concentration of free ferric iron available for biological processes is far below the 
minimum requirement of the cell (102). Consequently, pathogens have evolved specific 
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mechanisms for the acquisition of iron form their hosts. The principal host sources of iron 
which may be accessed by specific bacterial pathogens are outlined in Figure 5. 
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Figure 5: Potential Iron sources for Bacterial Pathogens 
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Iron acquisition in gram-negative bacteria has revolved around 2 strategies. These are as 
follows: 
1) Direct contact of the bacterium with the source of iron (usually transferrin or 
individual iron proteins such as heme). Once the contact is established, there is direct 
removal of iron, and uptake occurs (35, 77, 102). 
2) An alternative strategy adopted by many gram-negative bacteria is to synthesize a 
high-affinity ferric iron chelator or to utilize the chelators produced by other bacteria 
to efficiently steal and capture the iron from the host iron-binding proteins. Such 
compounds are known as siderophores (35, 77, 102). 
 
4.1 Iron Sources from Host Proteins 
4.1.1 Transferrin (Tf) and Lactoferrin (Lf) 
These are monomeric glycoproteins of ~ 80 KDa and bind two ferric ions per molecule. 
The affinity constant for Fe (III) ion is ~ 1023 M-1 and that for Fe (II) ion is only ~ 103 M-1 
(19, 20). Tf serves two purposes: Iron transport and protection against iron toxicity. Lf 
confers protective function as an iron chelator. X-ray crystal structures of both of these 
sources have been reported (48, 56). Many bacterial pathogens have been documented to 
use these iron sources (15, 92, 106).   
 
4.1.2 Ferritins  
These are iron storage proteins consisting of 24 sub-units assembled into a hollow sphere 
with a diameter of 120 Å and are filled with several hundred thousand of Fe(III) ions. 
However, there is a lack of evidence of the use of ferritins as an iron source by bacteria 
(17).  
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4.1.3 Heme 
 Heme is an iron protoporphyrin IX molecule. It is a prosthetic group of many enzymes. 
Although it is scarcely found free, it is used as an iron source by many bacterial species. 
Heme is required in nM range while iron requirement ranges in µM concentrations for 
bacteria (102). 
 
4.1.4 Hemoglobin (Hb)  
It is a tetramer of two α and two β chains and each subunit binds a heme molecule. Hb is 
present in red blood cells and functions as an oxygen transporter. Many pathogens as well 
as non pathogenic bacterial species have heme-hemoglobin uptake systems such as 
Vibrio cholerae, Shigella dysenteriae, Yersinia pestis, Haemophilus influenzae, and 
others (77, 102).  
 
4.1.5  Hemopexin 
 This is a 60 KDa glycoprotein. Although several bacteria have been shown to bind 
and/or to use heme-hemopexin, it has not been demonstrated whether a direct utilization 
exists (77, 102). 
 
4.2 Siderophores 
 These are low molecular weight iron chelating compounds that are secreted into the 
environment (64, 66). The first siderophore to be identified and characterized was 
ferrichrome, a reddish brown iron binding compound produced by the fungus Ustilago 
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(55). The chelating power of the siderophores for iron is very strong, such that it can 
remove iron attached to molecules like Tf and Lf, but not from heme proteins. The 
dissociation constant (Ks) ranges from 1022 M to 1050 M (102). The number of different 
siderophores produced by bacteria, yeast and fungi is more than 500 (102).  However, not 
all siderophore producing microbes are pathogenic. Siderophore biosynthesis is 
invariably derepressed when cells are grown under iron limiting conditions (65, 66).  
 
4.3 Classification of Siderophores 
The 3 major classes of siderophores based on chemical structure and metal binding 
functionality are: catecholates, hydroxamates and hydroxycarboxylates (102).  
Figure 6 shows the principal ferric iron chelating groups found in siderophores. There are 
two common features among all the structurally diverse siderophores: 
i) Presence of hard donor atoms (usually oxygen, occasionally nitrogen or sulfur)  
ii) Formation of thermodynamically stable, high spin ferric species. 
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Figure 6: Principal Functional Groups found in Siderophores 
 
 
 
 
 
 
{Source: Raymond and Dertz (2004) Chapter1 Pages 1- 17, Iron transport in bacteria, 
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4.3.1 Catecholate Siderophores 
4.3.1.1 Enterobactin   
This is the best characterized catecholate. It has a trilactone backbone and possesses a 
three-fold symmetry. It is composed of three 2, 3-dihydroxybenzoic acid groups, each 
appended to an L-serine group (77). The E. coli enterobactin gene cluster contains 6 
genes (entA to entF) involved in its biosynthesis and 7 genes involved in its utilization. 
These 7 genes encode for a ferric-enterobactin transporter system (fepA to fepG) and an 
esterase gene, which hydrolyses the molecule at its three ester linkages releasing iron in 
the cytoplasm (36, 37). The Enterobactin has the highest stability constant for iron among 
all the known siderophores (77). The enterobactin breakdown products and the 
enterobactin precursor (DHB) can also serve as secondary siderophores to meet the iron 
requirements of the cell (36, 37, 102).  
 
4.3.1.2   Salmochelins 
These are catecholate-siderophores consisting of 2 or 3 dihydroxybenzoic acid moieties 
linked by glucose residues. The proteins involved in the synthesis and transport of 
salmochelins are encoded in the iro locus. With the exception of S. bongori, all 
Salmonella strains synthesize salmochelins and have the iro genes. The iro locus is also 
present in Shigella dysenteriae type I and some pathogenic E. coli strains (5, 41). 
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4.3.2  Hydroxamate Siderophores 
 These are produced by gram-positive and gram-negative bacteria and fungi.  Typically 
there are two or three hydroxamate groups per molecule. They are observed with either 
linear or cyclic conformations. The ferrichrome and aerobactin are the most common 
hydroxamates (102). 
 
4.3.2.1 Ferrichrome 
 This is a cyclic hexapeptide with 3 contiguous glycine residues and 3 molecules of N-
acyl-N-hydroxyornithine. It is used as an iron source by fungi, gram-positive and 
negative bacteria. Of  gram-negative bacteria, E. coli, Salmonella species and V. cholerae 
have well characterized ferrichrome transport (77).  
 
4.3.2.2 Aerobactin  
Enteric pathogens like E. coli, Shigella, Yersinia, Klebsiella and Salmonella are known to 
produce aerobactin (77, 102). The aerobactin backbone is comprised of two molecules of 
lysine, two acetyl groups derived from acetyl CoA and one molecule of citrate, which is 
the central linker. The iucABCD operon is responsible for the biosynthesis of aerobactin 
in E. coli. The iutA encodes an outer membrane receptor ~ 77 KDa. There is evidence 
that bacteria which produces or utilizes both aerobactin and enterobactin, such as E. coli, 
utilize these siderophores under different conditions (13). The enterobactin is used to 
acquire iron from Tf, whereas aerobactin is utilized to obtain iron preferentially from 
ferritin within macrophages (13). 
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4.3.3  Hydroxycarboxylates 
 This class of ferric siderophores is a five membered heterocyclic compound that arises 
by cyclization of cysteine, serine or threonine side chains during siderophore elongation 
on NRPS assembly lines. NRPS is non ribosomal peptide synthetase. It has specialized 
domains that link amino acids via thio ester intermediates. The domains required for 
peptide bond formation are adenylation, peptidyl carrier protein and condensation 
domains, which are physically tethered to each other in repeats. Examples of 
hydroxycarboxylates include anguibactin, pyochelin, yersiniabactin and vibriobactin 
(102). 
 
4.4 Synthesis and Excretion of Siderophores  
 Genes that encode for siderophore biosynthesis are iron regulated. They are generally 
found to be in a cluster with genes involved in siderophore uptake. Siderophores are 
usually assembled by non ribosomal cytoplasmic peptide synthetase (102) 
Once the siderophore is synthesized and utilized, it needs to be eventually excreted. The 
mechanism of excretion is not clearly understood. Currently, data is only limited to a 
single report wherein the gene, EntS, involved in the excretion of enterobactin, was 
determined to be located within the enterobactin biosynthesis gene cluster.  EntS encodes 
a membrane protein and is directly involved in enterobactin export via a proton-motive 
force dependent efflux pump (30). 
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4.5 Ferric-Siderophore uptake 
Ferric-siderophores and heme molecules are too big to diffuse through the restricted 
diameter of porins (35, 63). In addition, these compounds must be efficiently captured at 
the cell surface by outer membrane receptors. These receptors are highly specialized and 
specific and effectively concentrate the ligand (heme, ferric-siderophores) at the cell 
surface. In the case of heme, only the prosthetic group is transported across the OM. The 
mechanism for stripping of the prosthetic group on the extracellular surface of the OM 
and the exchange of holo-and apo-proteins is not well known (102). The subsequent 
translocation of these molecules into the periplasm is an active process which works 
against the concentration gradient and is energized by the proton motive force provided 
by the functional TonB complex (57, 58) Please refer to Figure 7 for the schematic 
representation of TonB dependent ferric iron transport in gram-negative bacteria.  
 
5 Outer Membrane Receptors (OMR) 
Until recently, three OMRs have been crystallized, namely, FhuA, FepA and FecA (14, 
18, 26, 28, 59, 107). All these receptors belong to E. coli. FepA is the receptor for 
enterobactin. FhuA is the receptor for ferrichrome and FecA is the receptor for ferric 
dicitrate. These OMRs share some common characteristics. They have a low level of 
primary sequence homology in their N termini, and their transport function depends on 
the TonB complex. The OMRs have 5 conserved residues, together known as the TonB 
box at their N-termini  (10, 23). 
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Figure 7:  Schematic representation of TonB dependent ferric iron transport in   
gram-negative bacteria. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
{Source: Modified from Annual Reviews of Microbiology, 2004.58:611-647} 
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The receptor structures have a “plug and a beta barrel” organization (77). N termini of the 
OMR that constitute the plug is folded inside the beta barrel and anchored to the OM. 
The beta barrel consists of 22 beta strands. The structure is stabilized by the formation of 
hydrogen bonds and salt bridges between the plug and inner surface of the beta barrel. 
The plug has a “floor” which mainly consists of beta strands. The substrate sits at the top 
of the plug. Substrate binding triggers conformational changes in the apices of the plug, 
which triggers movement in the periplasmic side and allows the functioning of the TonB 
complex(27).  
 
6 TonB 
 ‘Ton’ stands for T-one and dates back to the 1940’s classical experiment wherein it was 
demonstrated that tonB mutations confer resistance to T1 Bacteriophage. Hence, the 
mnemonic “ton” for T-1 (12).  The TonB complex consists of three proteins TonB, ExbB 
and ExbD (16). This complex interacts at the cytoplasmic membrane (CM) and 
transduces the energy of the proton motive force generated at the CM to the OMR for 
allowing substrate internalization into the periplasmic space. The substrate internalized 
includes iron, its chelates, heme and also vitamin B12 (16). Although it is evident that the 
CM protein TonB is required for this process, the exact mechanism for transduction of 
energy is still incompletely understood (102). Transport over the CM is subsequently 
mediated by ABC transporter. TonB activity has been related to OM transport of Fe (III), 
Fe (III)-siderophore complex, heme and vitamin B12 (11). The TonB system is considered 
as a target for antibiotics since it plays a role in the specific permeability of gram-
negative cell envelope (33). It is evident that upon substrate binding by the receptor, the 
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TonB protein binds to the membrane receptor, TonB interacts preferentially and directly 
with ligand loaded receptors (75).  Also, it has recently been recognized that certain 
TonB dependent transporters contain an additional domain at the N terminus (107). This 
interacts with cytoplasmic membrane regulatory protein and a cytoplasmic sigma factor 
to induce transcription of iron transport genes. Based on biophysical and crystallographic 
evidence, these TonB dependent iron transporters bind to both, iron free and iron loaded 
ligands, however, it is only the ferric loaded ligand that is transported into the periplasm 
(81, 86, 107). 
 
6.1 Conservation of TonBs  
The TonB membrane domain is likely to be conserved over a range of gram-negative 
bacteria. It has been shown that E. coli tonB mutant was complemented with tonB gene 
from Salmonella or from Serratia , but not from Pseudomonas putida or V. chloerae 
tonB1 gene (6, 31, 67, 87, 96). Interestingly, V. cholerae tonB2 could complement in an 
E. coli tonB mutation (87). This differential ability to function in E. coli suggest that the 
targets to which the complex delivers energy in E. coli differs from the target of the        
V. cholerae tonB1 (87). 
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6.2 Single TonB systems  
6.2.1 TonB complex in E. coli 
 E. coli has a single TonB complex, which consists of 239 amino acids and is ~ 26 KDa 
in size, the bulk of which occupies the periplasmic space, where it associates with both 
CM and OM components (10). A tonB mutant in E. coli strain CFT073 failed to use heme 
as an iron source or to utilize enterobactin and aerobactin, suggesting that heme and 
siderophore mediated iron transports are TonB dependent (95). Further, the tonB mutant 
of uro-pathogenic E. coli strain was found to be significantly reduced in virulence in a 
mouse model of urinary tract infection (95). In addition, the tonB mutant failed to 
compete with the wild type for colonization and to infect the kidneys in a mouse model 
(95).  
 
6.2.2 TonB Complex in Salmonella species 
 Most of the iron transport studies have been conducted with S. enterica serovar 
Typhimurium and S. enterica serovar Typhi. No single siderophore is found to be 
essential for Salmonella virulence. However, TonB dependent transport is required (54, 
96). A     S. enterica serovar Typhimurium tonB mutant was found to be attenuated for 
virulence by intragastric route (96). However, the mutant was as virulent by intra 
peritoneal route as the wild type strain. Interestingly, a S. enterica serovar Typhi feoB 
mutant exhibited greater virulence defect than the S. enterica serovar Typhimurium tonB 
mutant (96).  The S. enterica serovar Typhi tonB mutant was also shown to be attenuated 
in mice infected intraperitoneally and was defective for growth in HeLa and human 
monocytes (34, 96).  
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6.2.3 TonB complex in Shigella species 
TonB independent iron acquisition is important for the growth of Shigella flexneri in the 
intracellular environment (82, 83).  Iron was found to be available to intracellular bacteria, 
even in the absence of TonB dependent iron transport. The failure of the TonB mutant to 
grow well in an iron replete intracellular environment suggests that TonB plays a role, in 
addition to heme and siderophore mediated iron acquisition in vivo, and this function is 
required for intracellular growth and intercellular spread (78). The FeoB of           
Shigella dysenteriae is likely responsible for the acquisition of iron inside the cell (78). 
 
6.2.4 TonB Complex in Yersinia pestis 
Y. pestis possesses a TonB dependent outer membrane receptor for heme transport and 
for yersiniabactin mediated iron transport (71, 84). In Y. enterocolitica, virulence has 
been shown to be  closely associated with siderophore production (42). 
 
6.3 Multiple TonB Systems  
6.3.1 Vibrio cholerae  
The first identification of multiple TonB genes within the same genome was reported in 
V. cholerae (43, 67). It is a gram-negative human pathogen known to cause cholera and 
watery diarrhea. V. cholerae has two sets of TonBs which confer specific as well as 
redundant functions (87). The genetic organization of TonBs in V. cholerae is shown in 
Figure 8. 
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Figure 8:  Genetic organization of TonB systems in Vibrio cholerae 
 
 
 
 
 
 
 
{Source: Iron Transport in Bacteria (2004) Chapter 16. Vibrio Page 253}
Unknown tolR exbB2    exbD2    tonB2 Unknown ( tpr) 
Chromosome 1 
Chromosome 2 
 tonB1        exbB1     exbD1    hutB        hutC       hutD 
 39 
 ferrichrome. However, TonB1 is specifically required for the uptake of schizokinen 
siderophore while TonB2 is essential for enterobactin uptake (62). A double mutant 
lacking both tonBs showed a decreased ability to colonize the intestine of suckling mice, 
thus demonstrating the importance of the TonB systems for growth in the host (67, 87). 
The difference in siderophore transport suggests that the two TonB proteins specifically 
recognize distinct OM transporters. Sequence analysis has shown that TonB1 is bigger 
than TonB2 by 38 amino acids. This difference enables TonB1 to expand the periplasmic 
space under conditions of high osmolarity, while the TonB2 is unable to span the 
increased distance between the CM and OMR at high osmolarity conditions (61). This 
shows that TonBs have a differential role under different environmental conditions. In 
Vibrio anguillarum, there are two functional TonB systems, TonB1 and TonB2 (93). 
Each of the TonBs is transcribed in an operon with the cognate ExbB and ExbD in 
response to iron limitation. However, only TonB2 has been found to be essential for the 
transport of ferric anguibactin and virulence (93). 
 
6.3.2 Pseudomonas aeruginosa TonBs 
 There exists multiple TonBs, TonB1, TonB2 and PA0695, in Pseudomonas aeruginosa, 
a gram-negative, opportunistic pathogen (108, 110). The tonB1 gene has been shown to 
be essential for siderophore mediated iron acquisition (109). Two additional tonB genes 
{tonB2 and PA0695, (http:/www.pseudomonas.com)} have been identified in this 
organism, although neither of the two play a significant role in iron uptake. There is also 
a report about the existence of a fourth tonB-like gene in P. aeruginosa, tonB3, whose 
product is required for twitching motility (45). 
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6.3.3 Actinobacillus pleuropneumoniae TonBs 
A. pleurpneumoniae causes porcine pleuropneumonia, a highly infectious disease of 
swine (4). There are 2 TonBs: TonB1 and TonB2 in A. pleuropneumoniae, and both are 
upregulated upon iron restriction. TonB2, but not TonB1 was found to be essential for 
growth in vitro when the sole source of iron was hemin, porcine hemoglobin or 
ferrichrome (4). TonB2 appeared to play a more important role in virulence than TonB1 
in an acute porcine infection model (4). 
 
6.3.4 TonBs in Campylobacter jejuni 
The complete genome sequence of C. jejuni NCTC 11168 revealed the presence of three 
TonB ExbB ExbD complexes (70). The TonB1 protein is 248 amino acids in length and 
is the largest of the three TonBs in C. jejuni. The TonB2 and TonB3 proteins are 227 
amino acids each in length and have 41% identity between them. The identity between 
TonB1 and TonB3 is only 19% and that between TonB1 and TonB2 is 23%. None of  the 
three TonBs are closely situated on the chromosome and their exact role is not yet 
known.  E. coli TonB is 22%, 26% and 28% identical to C. jejuni TonB1, TonB2 and 
TonB3 respectively.  
Two of these complexes, ExbB1-ExbD1-TonB1 and ExbB2-ExbD2-TonB2 were recently 
shown to be up-regulated under iron limited conditions whereas, the ExbB3-ExbD3 
wasup-regulated under iron- rich conditions (68). In another recent study, all three 
TonBs, and ExbB1, ExbB2 , ExbD1 and ExbD2 genes were found to be up-regulated 
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under iron restricted condition and their relative  transcript abundance was ~ three to ten 
fold increased (44). 
 
7 Ferric Iron acquisition in C. jejuni 
The C. jejuni NCTC 11168 genome sequence analysis has revealed the absence of  genes 
encoding siderophore biosynthesis proteins (70).  However, in one study, a few strains 
have been demonstrated to produce siderophores, and these have been not characterized 
(29). Bioassays and growth promotion assays with different iron sources have indicated 
that C. jejuni is able to utilize a limited number of iron sources (29). The genome 
sequence analysis has suggested the presence of several iron uptake systems (70).          
C. jejuni is able to utilize heme compounds like hemin, hemoglobin, enterobactin (29).   
Ferrichrome uptake system has been identified in some strains of C. jejuni; however, the 
genome of the sequenced strain lacks a ferrichrome uptake system questioning those 
results (32, 70). C. jejuni is unable to utilize aerobactin, desferiferrioxamine, ferritin, 
lactoferrin and transferrin (29, 72). C. jejuni expresses several ferric iron uptake systems 
as shown in the Figure 9, some of which are partially or completely characterized.  These 
uptake systems have been described in the context of their substrate specificities such as 
siderophore uptake, heme uptake and unknown substrate specificity(98). 
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Figure 9: Schematic Model of Iron Uptake Systems in C. jejuni 
 
 
Systems marked with an asterisk (*) are not present in all C. jejuni strains. 
 
{Source: Modified from schematic model of iron transport systems of C. jejuni A.H.M 
van Vliet et al., F.E.M.S. Microbiology Reviews 26 (2002) Page 176} 
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7.1   Enterobactin/Enterochelin uptake 
            The ceu system (Cj1352 - Cj1355) has been identified to encode the ceuBCDE 
operon and is specific for enterobactin uptake (69, 70, 79). CeuE is a lipoprotein and is 
homologous to siderophore specific periplasmic binding proteins in other gram-negative 
bacteria. CeuB and CeuC are cytoplasmic permeases and the CeuD is likely an ATPase 
energizing the transport. The CeuE is annotated as a periplasmic binding protein and 
putative eneterobactin transporter (98). By growth promotion studies, Palyada et al, have 
shown that the ceuE mutant was slightly impaired, although not fully incompetent in its 
ability to utilize iron from ferric enterobactin-complex (68). However, the ceuE mutant 
was found to be significantly affected in the cecal colonization of chicks (68). 
           The CfrA protein has been identified as a specific outer membrane receptor for 
enterobactin uptake in C. jejuni NCTC 11168 (68). The cfrA mutant was shown to be 
significantly affected in the chicken cecal colonization studies (68). As cfrA is not present 
in all the C. jejuni strains, there maybe other unknown outer membrane receptors for 
enterobactin uptake in C. jejuni (98).   
           In another recently reported study, Holmes et al demonstrated that ceuE and cfrA 
transcripts were increased in abundance by 16 fold and 57 fold respectively, under iron 
limited conditions, thus highlighting the importance of ferric enterobactin utilization in  
C. jejuni (44). 
 
7.2    Ferrichrome uptake 
The C. jejuni NCTC 11168 genome sequence lacks the presence of a ferrichrome uptake 
system (70), while a CFhu ABCD operon encoding for ferrichrome uptake was identified 
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in 6 out of 11 C. jejuni strains (32). Experimental evidence for ferrichrome uptake is still 
missing. Nevertheless, an 80 KDa CFhuA protein was identified in C. jejuni M129 isolate 
(32).Therefore, ferrichrome uptake system is not present in all the C. jejuni strains and 
there are no reports about its role in pathogenesis. 
 
7.3    Heme uptake 
The C. jejuni NCTC11168 genome sequence reveals the presence of a heme uptake 
system ChuABCD  (70).  ChuA is highly homologous to the OM siderophore receptors 
of other bacteria. ChuBCD encode the ABC transporter system (100) . Based on 
bioassays and mutagenesis studies, there is functional evidence for the role of ChuABCD 
in C. jejuni heme uptake  (72). In addition, it has been observed that there was an 87-fold 
increase in the transcript abundance of ChuA, when C. jejuni was grown under iron 
limited conditions (44). It must be noted that chuABCD was only slightly expressed        
in vivo, suggesting that it may not be the main source of iron in the gut (89).  
 
7.4 cFbpA 
The Campylobacter ferric binding protein (cFbpA) is a periplasmic protein. Recently, its 
crystal structure was reported (94). The cFbpA iron binding site lacks a synergistic anion, 
which is responsible for the high affinity for free ferrous iron rather than for free ferric 
iron(94). The role of cFbpA in Campylobacter pathogenesis is not yet established, 
although recently it has been shown that there was increase in transcript abundance of 
cFbpA under iron limited conditions (44, 68). 
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7.5 Cj1658-p19 
C. jejuni genome encodes Cj1658-p19 genes which are putative membrane proteins and 
are potentially involved in iron transport (70). There was an increase in their expression 
under iron limiting conditions by 37.6 fold and 110 fold for Cj1658 and p19 respectively, 
while the protein expression level of p19 increased by 11.8 fold (44, 68). They were 
upregulated in vivo when C. jejuni lifestyle was studied in the rabbit gut (89). Further 
functional characterization for studying their role in pathogenesis has not yet been done. 
 
8   Iron and Fur Regulation in C. jejuni 
8.1 Iron Regulon 
The iron regulon of C. jejuni has been recently characterized in two independent studies 
(44, 68). Using DNA microarrays, Palyada et al. identified the C. jejuni genes that had 
transcript abundance affected by the availability of iron. They identified 647 genes to be 
affected as an immediate response after the addition of iron, and only 208 genes were 
differentially expressed during the steady state experiments where the transcriptome 
profile was compared  under iron rich and iron limiting conditions(44, 68).  
    Another study (44), Holmes et al found an increase in transcript abundance of 117 
genes and a decrease in transcript  levels of 30 genes in response to iron limitation  (44, 
68).  Genes induced under iron limited conditions encoded for cell surface protein, iron 
binding and transport systems such as ChuA, cfrA and p19.  These genes were also found 
to be iron regulated in earlier studies (100).  
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 8.2 Fur Regulon 
Fur (iron uptake regulator gene) is a global regulator of gene expression in gram-negative 
bacteria in response to intracellular iron concentration (21), and was identified three 
decades ago (40). It is a 17 KDa protein (44, 100). Classically, Fur is a transcriptional 
repressor using Fe(II) as a co-repressor. Homologs of Fur have been found in many 
gram-negative bacteria such as Vibrio, Salmonella, Pseudomonas, Helicobacter, 
Brucella, Yersinia, Legionella, Neisseria, Haemophilus and others (22).  
In C. jejuni, the fur gene is located in an operon that includes two downstream 
housekeeping genes lysS and glyA, leading to a multi-cistronic mRNA (99).  The            
C. jejuni Fur protein bears 40% identity with the Fur protein of E. coli and is mostly 
identical at the C-terminal (85). Fur regulated gene have been identified by a Fur titration 
assay (FURTA) in E. coli and Salmonella (90, 97) However, FURTA was unsuccessful in 
identifying genes in C. jejuni and  H. pylori (25). EMSA (Electrophoretic Mobility Shift 
Assay) was tried recently in C. jejuni to compare the fur mutant with the wild type Fur 
protein (44). Also, the mutation of the fur gene of C. jejuni significantly affected the 
chicken colonization, indicating that it might play an important role in virulence (68). 
           The fur gene has been demonstrated to repress the transcription of at least seven 
iron regulated proteins, some of which include CeuE, p19, ChuA, ChuD and CfrA (100). 
Palyada et al recently identified the Fur regulon in C. jejuni by transcriptome profiling of 
the fur mutant and the wild type strain. They identified 53 genes to be Fur regulated. The 
flagellum biogenesis machinery (FlaD, FlgE2, FlgG2, FlgH and FlgI), iron acquisition 
genes (cfrA, p19, ceuB, ceuC, 1658, tonB, exbB, exbD) and the oxidative stress defense 
response gene (trxB) were repressed upon addition of iron. They observed six genes to be 
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up-regulated, including fdxA in the presence of iron (68). The Fur regulon was also 
characterized by Holmes et al (44) in another recent study. Their findings were similar to 
those demonstrated by Palyada et al, and they further confirmed the repression of Fur 
regulated genes in the presence of iron. Under iron limited conditions, the Fur regulated 
iron acquisition genes and oxidative stress defense response genes were up-regulated 
(44).  
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Abstract 
Fe (II) uptake via the cytoplasmic membrane protein FeoB has been well characterized in 
many bacterial enteric pathogens and has been shown to significantly contribute towards 
iron acquisition and the establishment of infection. The genome sequence of 
Campylobacter jejuni reveals the presence of a Fe (II) transporter, FeoB. 55Fe2+ uptake 
via FeoB was abolished by the membrane protonophore carboxyl cyanide-m-chlorphenyl 
hydrazone (CCCP), indicating proton dependency for ferrous iron transport. Using an 
allelic exchange strategy, we constructed mutants of feoB gene in three strains of           
C. jejuni, C. jejuni NCTC 11168 and two clinical isolates, C. jejuni ATCC 43431 (TGH 
9011) and C. jejuni 81-176. The feoB mutant had a significantly lower cellular iron 
accumulation than the wild type strain and was significantly affected in the 55Fe2+ uptake. 
Microarray experiments identified 110 genes to be differentially expressed between the 
feoB mutant and wild-type C. jejuni NCTC 11168. Interestingly, it revealed the 
upregulation of the oxidative stress defense gene katA and the gene encoding the non-
heme iron protein Cj0012c in the feoB mutant strain. Furthermore, the feoB mutant was 
found to be significantly affected in its ability to survive within porcine (IPEC-1) and 
human (INT-407) intestinal cell lines. A significant extracellular ferric reductase activity 
was identified from both the wild type strain C. jejuni NCTC 11168 and the feoB mutant. 
Finally, the feoB mutants were extensively assessed in vivo for their ability to colonize 
the gastrointestinal tract of chicks, colostrum-deprived neonatal piglets and rabbits. 
Interestingly, the feoB mutants were significantly affected in the gut colonization of all 
the animal models screened by competitive and non-competitive colonization assays. 
This is the first study documenting the use of neonatal piglets in screening mutants of    
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C. jejuni and use of IPEC-1 porcine epithelial cells to assess the intracellular survival of 
C. jejuni wild type and feoB mutants.  Overall, this work indicates that FeoB significantly 
contributes towards iron acquisition and in the colonization of C. jejuni within the animal 
host.     
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Introduction 
Campylobacter jejuni is the most common cause of human enteritis worldwide. 
Contamination of poultry products with gut contents during slaughter is a major source of 
C. jejuni infection. The signs and symptoms associated with campylobacteriosis vary 
from mild non-inflammatory diarrhea to severe dysentery       (6, 13, 29). The complete 
genome sequence of C. jejuni NCTC 11168 was released in 2000 (18). It has been an 
important tool for the post-genomic investigations in understanding the physiology of C. 
jejuni and deciphering the molecular mechanisms of its pathogenesis. Potential virulence 
factors include chemotaxis, motility, adhesion, invasion, intracellular survival, toxin 
production and iron acquisition (13, 29, 32, 33). The importance of iron acquisition for 
the successful colonization of the host has been demonstrated for many pathogens (23). 
The significance of iron acquisition and regulation in C. jejuni has been recently reported 
and is based on the global gene expression studies in response to iron (10, 17).  Also, the 
role of iron in C. jejuni colonization in vivo using the chick colonization model has been 
previously reported (17). Furthermore, the intestinal lifestyle of C. jejuni in the rabbit gut 
has been recently studied, and it suggests an important role for iron acquisition genes 
during colonization (26). 
 
Analysis of the C. jejuni NCTC 11168 genome reveals the presence of a feoB homolog 
(Cj1398) which is about 1.8 Kb in size and encodes a 70 KDa cytoplasmic membrane 
protein (18). C. jejuni FeoB shares 50% and 29% amino acid identity with Helicobacter 
pylori and Escherichia coli, respectively. Cj1398 appears to be in an operonic structure 
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with Cj1397. Cj1397 encodes a putative protein of 74 amino acids and bears 16% identity 
to the E. coli FeoA protein. However, its role in iron transport is not yet known (29). 
The FeoB protein is highly conserved in many species of gram-negative bacteria (8). The 
FeoB protein contains a G-protein domain suggesting that FeoB energizes the transport of 
ferrous iron through the cytoplasmic membrane via GTP hydrolysis (8, 15). The feoAB 
operon of E. coli is the first well characterized Fe (II) iron transport system (12). Fe (II) 
iron transport through the membrane protein FeoB has been shown to be required for 
infectivity and host tissue colonization by E. coli, V. cholerae and other enteric 
pathogens (12, 30). In contrast to all other characterized FeoB transporter systems in 
bacteria, the FeoB protein from C. jejuni has been recently proposed to be not essential 
for Fe(II) iron uptake (22). 
 
In the present study, we re-investigated the role of FeoB in iron acquisition in C. jejuni 
and tested its requirement for the colonization/infectivity of C. jejuni in animal hosts. To 
achieve this purpose, we constructed C. jejuni feoB mutants in the wild type strain         
C. jejuni NCTC 11168 and two clinical isolates, C. jejuni 81-176 and C. jejuni ATCC 
43431 (TGH 9011) by allelic exchange, and characterized them in vitro and in vivo.   
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Materials and Methods  
Bacterial strains, media and growth conditions 
The bacterial strains used in this study are listed in Table 1. E. coli DH5α was routinely 
cultured aerobically at 37˚C in Luria-Bertani (LB) broth or on LB agar plates. Plasmid 
containing strains were grown in a medium supplemented with kanamycin at 30 µg/ml.  
C. jejuni NCTC 11168 was acquired from the National Collection of Type Cultures, 
whereas C. jejuni 81-176 and C. jejuni ATCC 43431 (TGH 9011) were acquired from Dr 
Pickett and the American Type Culture Collection, respectively. These strains were 
routinely grown at 37˚C in a MACS-VA500 microaerophilic work station (Don Whitley, 
West Yorkshire, England) under 83% N2, 4% H2, 8% O2 and 5% CO2 on Mueller Hinton 
(MH) agar plates, MH broth medium or minimum essential medium (MEMα, 
Invitrogen).  Kanamycin was added as required at a concentration of 30 µg/ml. Prior to 
performing any in vitro cell culture studies or in vivo animal experiments, the C. jejuni 
strains were checked for motility on 0.4% MH agar plates. 
 
Cell Culture 
Human INT-407 embryonic intestinal cells were obtained from the American Type 
Culture Collection and routinely maintained in minimum essential medium (MEMα,  
Invitrogen), supplemented with 10% fetal bovine serum (Invitrogen). Porcine IPEC-1 
small intestinal epithelial cells were obtained from Dr Zhang (Animal Science 
Department, OSU) and were routinely maintained on Dulbecco’s minimum essential 
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medium (DMEM, Invitrogen), supplemented with 5% fetal bovine serum (Invitrogen), 
insulin (5 µg/ml), transferrin (5 µg/ml), selenium (5 ng/ml) (ITS, Invitrogen), and 
epidermal growth factor (5 ng/ml), (EGF, Invitrogen). Cells were grown in an incubator 
at 37˚C under 5% CO2. 
 
Bacterial binding, invasion and intracellular survival assays 
These assays were performed as described previously (21). In brief, the binding assay 
was performed by co-incubation of C. jejuni cells grown to mid-log-phase in biphasic 
MH media with 24 hour grown, semi-confluent INT-407 cells, or 48 hour grown IPEC-1 
cells (about 105 cells per well) at a multiplicity of infection (MOI) of 10:1 (10 bacteria 
per eukaryotic cell). After three hours of incubation at 37˚C in the presence of 5 % CO2, 
the cell growth medium was removed, and the monolayer was washed thrice with Hanks 
balanced salt solution (HBBS). Thereafter, the infected cells were lysed with 0.1 % 
Triton X-100 at room temperature for 30 minutes. Serial dilutions of the cell lysates were 
plated on MH agar plates to enumerate the number of bacteria bound to and internalized 
within the eukaryotic cells.  
 
A similar procedure was followed for the invasion assay, with the exception of a further 
incubation of the infected cells for an additional hour in fresh medium with 250 µg of 
gentamicin per ml, to kill the extracellular bacteria. Thereafter, the cells were washed 
thrice with Hanks balanced salt solution, and lysed using 0.1 % Triton X-100 for 30 
minutes at room temperature. Serial dilutions of cell lysates were plated on MH agar 
plates in order to enumerate the number of bacteria invaded within the eukaryotic cells. 
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The binding efficiency was obtained by subtracting the number of invaded bacteria from 
the total number of bacteria recovered from cells not subjected to gentamicin treatment, 
whereas the invasion efficiency was expressed as the percentage of inoculum recovered 
after gentamicin treatment. The results shown for the binding and invasion assays 
represent the means of three independent experiments ± standard error. 
 
The intracellular survival (ICS) assay was performed with semi-confluent INT-407 and 
IPEC-1 intestinal epithelial cells, similar to the invasion assay as described above. After 
incubation with gentamicin for the killing of extracellular bacteria, the cells were washed 
thrice using HBSS and were cultured for an additional 24, 48 and 72 hours in fresh 
medium without antibiotics. The medium was changed every 24 hours. After the desired 
incubation time points, the monolayer were washed three times with HBSS, and then 
lysed with 0.1 % Triton X-100 at room temperature for 30 minutes. The number of viable 
intracellular bacteria was determined by plating the serially diluted cell lysate 
suspensions on MH agar plates. The experiment was repeated thrice, and the results 
shown are the mean ± standard error. 
 
Construction of C. jejuni NCTC microarray 
The microarray was constructed as previously described (25, 26) using DNA fragments 
covering approximately 98% of all of the open reading frames (ORFs) from C. jejuni 
NCTC 11168.  
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Total RNA extraction 
The iron restricted wild type or mutant feoB cells were grown in 100 ml of MEM α under 
microaerophilic conditions. At the mid-log-phase, (OD600 ≈ 0.2), 15 ml of the samples 
were removed and immediately mixed with 1.5 ml cold RNA degradation stop solution 
(10% phenol in ethanol). The cells were pelleted by centrifugation at 4˚C for 10 minutes 
at 8000 X g and then resuspended in lysozyme-TE buffer [50 mM Tris-Cl (pH 8), 1 mM 
EDTA, 0.5 mg/ml lysozyme]. Total RNA was extracted using a hot phenol-chloroform 
procedure, as previously described (17). Total RNA was suspended in RNase-free water 
and subjected to two successive DNase-1 (Invitrogen) treatments to remove any 
contaminating chromosomal DNA. Finally, RNA was further purified using the RNeasy 
kit from Qiagen. The absence of genomic DNA was ensured by PCR using several of the 
primers designed for the microarray construction. The RNA integrity was confirmed by 
agarose gel electrophoresis, followed by quantification with RiboGreen RNA 
quantification reagent (Molecular probes). This RNA was then stored at -80˚C until 
further use. 
 
Labeling of probes and hybridization on slides 
The total RNA from each growth condition was converted to cDNA with Superscript II 
enzyme (Invitrogen), in the presence of aminoallyl-dUTP at 42˚C as previously 
described. The protocol for the reverse transcription reaction was as follows: 16 µg of 
total RNA was mixed with 10 µg of random hexamers in a 34.35 µl reaction mixture, 
containing 2 µl of 0.1 M dithiothreitol and 8 µl of 5 X Superscript II reverse transcriptase 
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buffer. The reaction mixture was made up to a final volume of 40 µl after a 5 minute 
incubation at 65˚C, by the addition of 0.5 mM dGTP, 0.5 mM ATP, 0.5 mM CTP,      
0.34 mM amino allyl-dUTP, 0.16 mM dTTP and 2 µl of Superscript II (200 units/µl) and 
incubated at 42˚C for 120 minutes. Then the reverse transcription was stopped and the 
RNA was hydrolyzed by the addition of 2 µl of 10 N NaOH and 4 µl of 50 mM EDTA, 
and incubation at 65 ˚C for 20 minutes. This reaction was neutralized by adding 4 µl of   
5 M acetic acid.  Separation of aminoallyl-labeled cDNA from unincorporated 
aminoallyl-labeled-dUTP and free amines was achieved by the addition of 450 µl of 
water, followed by spinning through a Microcon YM-30 filter (Millipore) at 8000 X g for 
8 minutes. This step was repeated thrice.  Following the last wash, the aminoallyl-labeled 
probes were subjected to vacuum in a Speed Vac to condense the volume to less than 9 
µl, after which, a final volume of 10 µl was attained by the addition of 1 µl of 1 M 
sodium carbonate (pH 9.0) and water. The aminoallyl-labeled cDNA thus obtained was 
linked to monoreactive fluors (Amersham), by the addition of 10 µl dimethyl sulfoxide 
containing one-sixth of one reaction vial of FluoroLink indodicarbocyanine or 
indocarbocyanine dye, and was incubated for 45 minutes in the dark, at room 
temperature. Quenching of this reaction was achieved by the addition of 4.5 µl of 4 M 
hydroxylamine, followed by incubation at room temperature for 15 minutes, in the dark. 
The fluorescent indodicarbocyanine- and indocarbocyanine-labeled cDNAs were 
combined and purified using Qiaquick PCR spin columns (Qiagen, Valencia, Calif.). The 
fluor-labeled cDNA mixture was vacuum dried with a Speed Vac prior to resuspension in 
15.14 µl of water. To this resuspension was added 9 µl of 20 X SSC (1 X SSC is 0.15 M 
NaCl + 0.015 M sodium citrate pH 7.0), 9 µl of formamide, 0.36 µl of 10 % SDS and 2.5 
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µl of salmon sperm DNA (10 mg/ml). The microarray slides were prehybridized at 42 ˚C 
for 45 minutes in a prehybridization buffer containing 25 % formamide, 5 X SSC buffer, 
1 % bovine serum albumin and 0.1 % SDS. Prior to hybridization, the slides were rinsed 
with water and dried by spinning. Denaturation of the probe was achieved by boiling for 
two minutes, followed by cooling to 42˚C.  The probe was applied to the microarray slide 
under a coverslip (Grace Bio-labs) and placed in a humidified chamber (ArrayIt), 
followed by overnight incubation at 42˚C. Post hybridization, the slides were washed for 
5 minutes in 2 X SSC, 0.1 % SDS at 42˚C, 10 minutes in 0.1 X SSC-0.1 % SDS at room 
temperature, and then four times in 0.1 X SSC for one minute at room temperature. The 
slides were subsequently rinsed with distilled water and dried by centrifugation.  
 
Data collection and analysis 
The microarray slides were scanned at 10 µm resolution using a Scan Array 5000 
confocal scanner (Perkin Elmer) and analyzed with GenePix Pro 4.0 software (Axon 
Instruments, Foster City, Calif.). Spots were excluded from further analysis if either of 
the following two criteria were met: 1) the mean intensities of fluorescence were less than 
3 times the standard deviation of the local background in both channels                   
1 (indodicarbocyanine) and 2 (indocarbocyanine);  2) the spots were contained in regions 
of slide hybridizations or anomalies.  
 
Normalization of the fluorescent intensities in each wavelength was achieved by applying 
a locally weighted linear regression (Lowess) using the MIDAS software (available from 
TIGR, http://www.tigr.org/software/). After normalization, the ratio of channels 2 to 1 
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was transformed to log2, following which, the data were statistically analyzed using a 
Student t test. The experiment was repeated three times (3 biological replicates). Three 
measurements per gene were obtained per experiment and thus, there were nine 
measurements for every gene. 
 
Construction of the C. jejuni feoB mutants by allelic exchange 
C. jejuni NCTC 11168 chromosomal DNA was extracted using the Wizard genomic 
DNA purification kit (Promega). The feoB gene was PCR amplified with the primers  
feo-1 (5’CGCTGGCCAAAGTCATTGATTTGCCAGGAAC3’) and feo-2 
(5’CGCTGGCCAGCCACTGCACTTGGTATAGG3’) (both containing a MluNI 
restriction site). These primers annealed within the feoB gene and amplified a fragment of 
1617 bp. The resultant fragment was digested with MluNI  and  ligated to the MluNI- 
restricted pCAP vector to obtain pAS43 ( pCAP-feoB). Then, the feoB gene was 
disrupted by cloning in its unique ClaI site a ClaI-restricted kanamycin resistant cassette 
obtained from pILL600, yielding pAS223 (pCAP::feoB::Km). The orientation of the Kmr 
cassette was determined to be in the same direction as the feoB gene by PCR and 
restriction digestion. This final construct pAS223 was used to transform C. jejuni 
NCTC11168 using previously established protocols (36). The feoB mutants were selected 
on MH agar plates containing 30 µg of kanamycin per ml, and the homologous 
recombination event was confirmed by PCR using a combination of primers that 
amplified the Kmr and feoB genes. The primers and plasmids used for the mutant 
construction are listed in Table 2. The same plasmid pAS223 was used to construct the 
feoB mutants in the non-sequenced C. jejuni 81-176 and C. jejuni TGH 9011. 
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Cj1397-Cj1398 operon mapping 
Total RNA was purified as described above, from mid-log-phase C. jejuni grown in 
MEMα medium. First strand cDNA synthesis and subsequent PCR were performed using 
the Qiagen one step RT-PCR kit following the manufacturer’s recommendations. 100 ng 
of total RNA was used for each reaction. The primers used in the RT-PCR reaction are 
listed in Table 2. In order to confirm the absence of contaminating genomic DNA, PCR 
reactions (without previous reverse transcription) were performed using the same RNA 
templates, as a negative control. The RT-PCR products were electrophoresed in 0.9% 
agarose gel. 100 bp and 1 Kb standard ladder (Bayou-BioLabs) were run simultaneously, 
as can be seen in Figure 12.  
 
55Fe2+ uptake assays  
The 55Fe2+ uptake assays were performed with the feoB mutant and C. jejuni wild-type 
cells grown to mid-log-phase in MH, MH-desferriferrioxamine (20 µM) and iron limited 
MEMα media. The cells were pelleted and washed in 10 mM Tris buffer (pH 7.4). Then, 
the cells were resuspended in the uptake buffer to an OD600=0.6 (equivalent to 109 
bacteria/ml) and kept on ice. The uptake buffer was composed of 5 g/L Na2HPO4, 5 g/L 
KH2PO4, 1.18 g/L NH4Cl, 0.089 g/L Na2SO4, 0.042 g/L MgCl2.6H2O and 10 g/L 
casamino acids. Then, the resuspended cells were allowed to equilibrate at 37˚C for       
10 minutes before initiating the assay, by adding 55Fe2+ iron source in the reduced form. 
The 55Fe2+  iron source was prepared by diluting the stock 55FeCl3, using 1 M sodium 
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ascorbate as follows: 1µl of 3.7 mM stock 55FeCl3 was diluted with 60 µl of 1M sodium 
ascorbate and 940 µl of the uptake buffer to maintain the radiolabeled iron in the reduced 
Fe(II) state. 100 µl of the diluted Fe(II) iron source was added to 10 ml of the 
resuspended cells, providing a final concentration of 0.036 µM, and the ferrous iron 
uptake was initiated. Samples (1 ml) were taken every 2 minutes and the cells were 
pelleted by centrifugation at 13000 rpm for 2 minutes. The pelleted cells were washed 
twice using 0.1 M citric acid buffer and finally resuspended in 500 µl of cold water. This 
suspension was placed in 5 ml of scintillation cocktail (Scintiverse, Fisher) and counted 
in Beckman LS5000 TD scintillation counter. Activity as counts per minute (CPM) were 
corrected for background. For proton dependency studies, cells were treated with 33 µM 
of proton ionophore carbonyl-cyanide-m-chlorphenyl hydrazone (CCCP) prior to the 
addition of the labeled ferrous iron with another batch of cells.  
 
Subcellular fractionation 
For confirmation of the actual ferrous iron uptake from the periplasm to the inner 
cytoplasm of the feoB mutant and wild-type cells, subcellular fractionation was 
performed by osmotic lysis using the periplastic lysing kit (Epicenter). Mid-log-phase 
grown cells were pelleted and washed in 10 mM Tris buffer (pH 7.4). Then the cells were 
resuspended in the uptake buffer to an OD600=0.6 (equivalent to 109 bacteria/ml) and kept 
on ice. The uptake buffer was composed of 5 g/L Na2HPO4, 5 g/L KH2PO4, 1.18 g/L 
NH4Cl, 0.089 g/L Na2SO4, 0.042 g/L MgCl2.6H2O and 10 g/L casamino acids. The 
resuspended cells were allowed to equilibrate at 37˚C for 10 minutes before initiating the 
assay by 55Fe2+ iron source (prepared as described earlier) was added to a final 
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concentration of 0.036 µM and samples (1 ml) were taken every 2 minutes. The cells 
were pelleted by centrifugation at 13000 rpm for 2 minutes. Then the cells were washed 
twice using 0.1 M citric acid and lysed by resuspending in 50 µl of periplastic lysing 
buffer and incubating at room temperature for 5 minutes. Then 50 µl of cold water was 
added to the lysed cells, mixed by inversion and incubated on ice for        5 minutes. The 
lysed cells were centrifuged for 5 minutes and the aqueous layer (periplastic fraction) was 
aspirated.  The pellet was washed twice using 0.1 M citric acid and resuspended in 500 µl 
of cold water constituting the spheroplastic (cytoplasmic) fraction. Both the fractions 
were placed in 5 ml scintillation cocktail and counted as described previously.  
 
 
55Fe2+ accumulation and growth assays  
The accumulation of 55Fe2+ iron and the growth kinetics were compared between the feoB 
mutant and the wild-type strains by growing them separately in MEMα medium in the 
presence and absence of radiolabeled Fe(II) iron source, provided at a final concentration 
of 0.036 µM. The radiolabeled Fe (II) iron source was prepared as described earlier. 
Then, 250 µl of the diluted Fe (II) source was added to 25 ml of starting culture.  Sodium 
pyruvate (20 mM) was added as a carbon source to all the cultures. The gowth kinetics of 
the feoB mutants and the wild-type strains were monitored at 0, 8, 12 and 24 hours after 
the addition of the ferrous iron source (0.036 µM) by measuring the OD600 per ml at the 
above time points. In addition to monitoring the accumulation of ferrous iron in whole 
cells, the actual ferrous iron accumulation in the periplamisc and spheroplastic fractions 
were determined as described previously, by collecting samples (1 ml) at 0, 8, 12 and 24 
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hours. The data was statistically analyzed for all the 55Fe2+ uptake assays and growth 
assays using the Student t test at a 5% level of significance. 
 
In vivo colonization studies 
 
Chick colonization assays 
Two types of chick colonization assays were conducted: Non-competitive and 
competitive colonization.  
 
Non-Competitive Chick colonization 
One day old specific pathogen free chicks were obtained from Tyson farms, Arkansas. 
On arrival, cloacal swabs of the chicks were taken to ensure that they were 
Campylobacter free. Housing of chicks was maintained at 25˚C, and was provided with a 
brooder which maintained a temperature in the range of 33-35˚C. Chicks were given ad 
libitum commercial chicken starter diet and water. For challenge, C. jejuni wild-type and 
feoB mutant strains were grown in an MH biphasic medium in a microaerophilic 
chamber. The bacteria were harvested at mid-log-phase and resuspended in PBS buffer. 
Each chick was inoculated with 0.25 ml of a bacterial suspension which contained 
approximately 104 to 105 viable bacteria. An uninoculated group of birds was the 
negative control. Five birds per group were inoculated separately with the wild-type or 
mutant. Four days post challenge, the colonization potential was determined as per 
standard procedures described previously (17). After euthanasia, the ceca were collected, 
and the contents were homogenized and checked for viable counts by plating on plates of 
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Campylobacter agar base (Oxoid CM935) along with the Campylobacter selective 
Karmali antimicrobial supplements (Oxoid SR167E). Plates were incubated at 37˚C for 
72 hours and the bacterial recovery titer was determined and expressed as CFU per gram 
of ceca. Non parametric Mann-Whitney rank sum test was used for statistical analysis at 
a 5% level of significance.  
 
Competitive chick colonization 
Five chicks were used per group for the competitive colonization studies. Each chick was 
inoculated with 0.5 ml of bacterial suspension containing a 1:1 mixture of wild-type and 
feoB mutant strains. The mixed inoculum contained approximately 105 viable bacteria 
each, of the wild-type and of the mutant, and was confirmed by plating serial dilutions of 
the mixed culture on MH agar with and without kanamycin (30 µg/ml). At 4 days post 
inoculation, the ceca were collected as described above. The cecal contents were 
homogenized, serially diluted in PBS buffer and were then plated onto Campylobacter 
agar base (Oxoid CM935), enhanced with the Campylobacter selective Karmali 
supplement (Oxoid SR167E) and on Karmali agar plate containing kanamycin              
(30 µg/ml). The plates were then incubated at 37˚C for 72 hours in a microaerophilic 
chamber before the colonies were counted. The mutant titer was obtained from the CFU 
recovered on Karmali agar plates containing kanamycin, and the wild type bacterial titer 
was calculated by subtracting the number of mutants from the total number of bacteria 
recovered on Karmali agar plates without kanamycin. Finally, the in vivo competitive 
index was calculated for each bird, which is the ratio of output mutant to wild-type 
bacteria recovered divided by the ratio of input mutant to wild type bacteria inoculated. A 
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single sample Student t test was used to statistically analyze the data at a 5 % level of 
significance.  
 
Rabbit Ileal Loop (RIL) competitive colonization 
The in vivo competitive index of the feoB mutant and the wild-type NCTC 11168 in the 
RIL model was determined as previously described (26). Rectal swabs were taken from 
the rabbits upon arrival to verify that they were Campylobacter free. Ileal loops were 
prepared according to the published protocols (5, 26). Briefly, two New Zealand White 
rabbits (<2 Kg, female) were anaesthetized, a laprotomy was performed, and two 20 cm 
sections of ileum with intact mesentric blood supply were ligated per animal. The four 
ileal loops (from 2 rabbits) were injected (each) with a 1 ml PBS suspension of a 1:1 
mixed culture containing approximately 106 CFU/ml, each, of C. jejuni NCTC 11168 
wild-type and feoB mutant strains. The 1:1 mixed inocula of the mutant and wild-type 
strains were confirmed by plating serial dilutions of this mixed culture on MH agar with 
and without kanamycin (30 µg/ml). The loops of 2 additional rabbits were inoculated 
with sterile PBS buffer and served as uninfected controls. After inoculating the intestinal 
loops, they were replaced in their appropriate position in the abdominal cavity, the 
abdominal wall and skin were closed as per standard procedures, and the rabbits were 
allowed to recover from anaesthesia. Forty-eight hours post inoculation, the rabbits were 
anaesthetized again, the intestinal loops were excised intact, and the animals were then 
euthanised. The contents of the loop as well as the mucous layer were collected and 
homogenized in 10 ml of PBS buffer. Serial dilutions of bacteria recovered from each 
rabbits’ loop were plated on Karmali agar plates [Campylobacter agar base (Oxoid 
 85 
CM935)] supplemented with the Campylobacter selective Karmali supplements (Oxoid 
SR167E) and Karmali agar plates containing kanamycin (30 µg/ml). Plates were 
incubated at 37˚C for 72 hours in a microaerophilic chamber before the colonies were 
counted. The titer of the mutant was obtained from CFU recovered on Karmali agar 
plates containing kanamycin, and the titer of the wild type was calculated by subtracting 
the number of mutants to the total number of bacteria recovered on Karmali agar plates 
without antibiotic. Finally, the in vivo competition index for each loop was calculated as 
described above for the competitive chick colonization studies. A Student t test was used 
to statistically analyze the data from the in vivo competition assays. 
 
Piglet Colonization studies 
Colostrum-deprived new born piglets were obtained from the Oklahoma State University 
swine farm, Stillwater,Oklahoma. The piglets, once farrowed, were cleaned with sterile 
towels and Betadine, and transported to the Laboratory Animal Research facility, OSU, 
Stillwater,Oklahoma. The experimental and uninoculated control piglets were kept in 
separate pens. The piglets were checked upon arrival with rectal swabs to verify that they 
were Campylobacter free. Each piglet was fed about 80-100 ml protein-rich, free of 
antibody and antibiotics reconstituted commercial replacer milk ration (Sav-A-Calf, 
Wisconsin) four times daily.   
They were starved for about 2 hours prior to challenge with the mixed inocula. C. jejuni 
wild-type NCTC 11168 and feoB mutant strains were grown in biphasic MH medium to 
the mid-log-phase, centrifuged and resuspended in Similac commercial milk to an OD600 
of approximately 2.0 (corresponding to ≈ 5 X 1010 CFU/ml). Five ml (each) of the mutant 
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and wild-type strains were mixed at a 1:1 ratio. Two or three piglets (each) were fed the 
above mixed inocula orally. The mixed inocula were confirmed by plating serial dilutions 
on MH agar with and without kanamycin (30 µg/ml). Control piglets were fed milk 
without any bacteria.  
 
All the piglets were observed daily for clinical signs such as fecal consistency, diarrhea 
and general health. The presence of blood in the feces was detected using EZ detection 
kit (Biomerica, USA). At 72 hours post inoculation, the piglets were first anesthetized 
with 0.25 ml/kg of ketamine (100 mg/ml) and 0.125 ml/kg of xylazine (20 mg/ml) 
(intramuscular), following which, they were euthanised with 0.25 ml/kg of    
Beuthenesia-D (intracardiac).  Intestinal segments duodenum, jejunum, ileum, cecum and 
colon were recovered following necropsy. Gross lesions were examined in the piglets 
inoculated with the wild type strain alone. The contents and the mucous layer were 
collected from the intestinal segments and homogenized in 5 ml of PBS buffer. Serial 
dilutions of bacteria recovered from each organ were plated on Campylobacter selective 
media with and without antibiotics as described previously in the chick competitive 
colonization assay. The plates were then incubated at 37˚C for 72 hours in a 
microaerophilic chamber before the colonies were counted.  The mutants and wild-type 
titer was determined and the competitive index was computed and statistically analyzed 
as described earlier in the chick competitive colonization assay. 
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In vitro Competition assay 
A 1:1 mixture of mid-log-phase wild-type and mutant strains of C. jejuni from overnight 
cultures was taken in fresh MH medium and was used for the inoculation of three 
replicates of biphasic MH cultures. The measurement of OD600 over time was used to 
monitor the bacterial growth. Determination of the titer of each strain by plating on MH 
agar and MH agar containing kanamycin (30 µg/ml) was done in the early stationary 
phase and in the inoculum. The in vitro competitive index, which is the ratio of mutant to 
wild-type strain, was calculated for three independent growth experiments. The data was 
analyzed using the Student t test. 
 
Ferric Reduction Assay 
The ability of C. jejuni NCTC 11168 wild-type strain and feoB mutant to reduce a ferric 
iron source was assessed using bathophenantrolin-disulfonate (BPDS, Sigma) as a 
chromogenic ferrous iron chelator as described by others (35). C. jejuni NCTC 11168 and 
feoB mutant strains were cultured overnight in 50 ml of iron chelated MH + DFO         
(20 µM) medium. Uninoculated medium which was incubated under similar conditions 
served as a reference. BPDS was added to the overnight inoculated and uninoculated 
media, to achieve a final concentration of 1 mM. FeCl3, which served as a ferric iron 
source, was added, so as to reach a final concentration of 50 µM, following which, the 
media and cells were incubated at 37˚C for 1 hour. Aliquots of 1 ml were taken, and 
centrifugation was done to remove the cells. Subsequently, at 535 nm, the optical 
densities of the Fe(II)-BPDS complexes in the supernatant was measured. Quantification 
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of the Fe(III)-reduction activity was expressed as nanomoles of Fe(II)-BPDS complexes 
formed per hour per 109 cells.  A molar extinction coefficient of 22,140 at 535 nm was 
used for the determination of the amount of Fe(II)-BPDS complex formed in the assay. 
The experiment was performed in triplicates. 
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Results and Discussion 
 
Construction of C. jejuni feoB mutants 
In order to determine the role of the feoB gene in iron acquisition and colonization of the 
host gastrointestinal tract, we mutated the feoB gene in C. jejuni NCTC 11168 by allelic 
exchange strategy. Since C. jejuni NCTC 11168 is poorly invasive (21), we also mutated 
the feoB gene in two other highly invasive clinical isolates, C.jejuni ATCC 43931 (TGH 
9011) and C.jejuni 81-176 (20, 21). The correct construction of the mutants was 
confirmed by PCR (Figure 1). 
 
The feoB mutant had no growth defect in vitro 
In order to determine whether the C. jejuni feoB mutant was affected in its ability to grow 
in vitro, we compared the growth rate of the feoB mutant and the wild-type C. jejuni 
NCTC 11168 strains grown in MH biphasic medium (Figure 2) and iron limited MEMα 
medium (Figure 3). The MH biphasic growth kinetics experiments represent the 
phenotype of the C. jejuni strains in iron containing medium, whereas the growth 
experiments in MEMα medium represent the growth pattern in iron limited conditions. 
There was no significant difference observed between the feoB mutant and the wild-type 
C. jejuni NCTC 11168 strains at a 5% level of significance in any of the growth 
experiments. Similar growth patterns were observed with C. jejuni 81-176 and               
C. jejuni TGH 9011 wild-type and feoB mutant strains (data not shown). These data 
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suggest that the feoB mutant had no growth defect in vitro. Similar findings were 
observed in another gram-negative pathogen Helicobacter pylori (30). There was no 
significant difference between the wild-type and the feoB mutant strains of H. pylori 
when grown in brain heart infusion (BHI) supplemented with 5% fetal bovine serum 
(FBS). Also, the gowth rates of the wild-type and feoB mutant strains were similar when 
grown in iron depleted BHI FBS. It has been shown that the feoB mutant of Shigella 
flexneri grew less well than the wild-type, indicative of a slight in vitro growth defect 
(24) , whereas, the feoB mutant of Salmonella typhimurium was unaffected in the  in vitro 
growth as compared to the wild-type strain (28). It has been documented in E. coli that 
the feoB mutant was not affected in growth rate compared to the wild-type strain (27). 
 
55Fe2+   uptake assays 
Transport of ferrous iron in C. jejuni is proton dependent 
It has been demonstrated in E. coli and H. pylori that the active transport of iron against 
its concentration gradient requires energy (8). The protonophore CCCP has been shown 
to dissipate the proton motive force across the inner membrane and abolish the iron 
transport in H. pylori (30). Recently, it has been demonstrated that the membrane protein 
FeoB contains an intramolecular G protein, which is essential for Fe (II) uptake in 
bacteria (15). It has not been documented in C. jejuni whether the ferrous iron transport 
across the inner membrane is proton dependent, and in order to determine the proton 
dependency for ferrous iron uptake, we used the proton ionophore cyanide-m-
chlorphenyl hydrazone (CCCP). Radiolabeled Fe (II) uptake (0.036 µM) was monitored 
after treatment of cells with 33 µM CCCP. As shown in Figure 4, the CCCP treated C. 
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jejuni cells were completely inhibited in iron transport, whereas the untreated cells were 
able to transport Fe(II) iron. This result suggests that the transport of the non-FeoB 
mediated ferrous iron in C. jejuni is proton dependent.  
 
FeoB was involved in ferrous iron transport 
 The C. jejuni FeoB system has not been extensively studied. Till date, there is only a 
single report on C. jejuni FeoB characterization and its role in ferrous iron transport by 
Raphael et al (22). They reported that in contrast to other bacterial FeoB systems,          
C. jejuni FeoB does not play a role in ferrous iron transport as analyzed by 55Fe2+ uptake 
assays. They found no significant difference in the wild-type strain and feoB mutant in 
iron transport with non-sequenced C. jejuni isolates, C. jejuni M129 and C. jejuni 
F38011. Although they used iron depleted uptake buffer for the ferrous iron uptake 
experiments, the cells used in their assay were not iron starved, as they were grown in 
MH, which is an iron containing medium. They also reported that the feoB and the wild 
type C. jejuni F38011 strains were identical with respect to invasion of INT-407 intestinal 
epithelial cells and survival within J774A.1 macrophages, and therefore concluded that 
FeoB was non-functional in C. jejuni.  
           In order to determine whether the FeoB phenotype differs with respect to the       
C. jejuni isolates used in the study and the culture conditions in which the cells were 
grown prior to performing the uptake assays, we re-investigated the role of FeoB in 
ferrous iron transport in the sequenced strain, C. jejuni NCTC 11168.  
We assessed the ferrous iron uptake of the wild-type and feoB mutant strains with cells 
grown in MH medium and in MH containing the iron chelator desferriferrioxamine      
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(20 µM) to the mid-log-phase. The objective of using cells grown in iron limited and iron 
rich media was to test whether the iron in the growth medium influenced the kinetics of 
ferrous iron uptake. The uptake assay was performed as described in the materials and 
methods section.  As seen in Figure 4, there was no significant difference in the uptake of 
ferrous iron between the wild-type and mutant strains grown in MH medium. These 
findings are similar to the findings reported by Raphael et al (22). It has been shown that 
the expression of iron acquisition systems in cells grown under iron limited conditions 
was notably up-regulated compared to cells grown in iron rich conditions (10, 17). 
Therefore, monitoring the ferrous iron uptake rates of the feoB mutant and the wild type 
strains grown in the presence and absence of iron would ensure proper expression of iron 
acquisition systems. We determined the ferrous iron transport with cells grown in the 
presence and absence of iron prior to initiating the ferrous iron uptake assays. 
Interestingly, the ferrous iron uptake performed with cells grown in iron restricted 
desferriferrioxamine treated MH medium exhibited a significant difference (p<0.009) 
between the feoB mutant and the wild-type strains (Figure 5), with a decreased ferrous 
iron uptake in the feoB mutant.  
 
Subcellular fractionation reveals cytoplasmic membrane transport 
The uptake of ferrous iron requires only a cytoplasmic membrane transporter (29).  
Neither the specialized outer membrane receptors, nor energy is required for the entry of 
ferrous iron into the periplasm (31).  
In order to determine whether the transport of Fe (II) iron from the periplasm to the 
cytoplasmic space is FeoB mediated in C. jejuni, we assessed the cellular fractions 
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(periplasmic and spheroplastic), for the accumulation of 55Fe following osmotic lysis of 
the cells. The fractionation of whole cells into the periplasmic and spheroplastic fractions 
was confirmed by scanning electron micrograph (data not shown). C. jejuni wild-type 
strain and the feoB mutant were grown overnight in desferriferrioxamine (20 µM) treated 
MH medium to mid-log-phase and then assessed for iron transport. As shown in Figure 5, 
the feoB mutant had significantly lesser cytoplasmic 55Fe(II) levels than the wild-type, 
indicating the feoB mutant to be defective in ferrous iron transport. On the other hand, the 
wild-type strain was demonstrated to have functional FeoB system since there was 
significantly higher 55Fe(II) levels in the spheroplast (cytoplasmic fraction), suggestive of 
ferrous iron uptake from the periplasm to the inner cytoplasmic membrane. This 
subcellular fractionation data (Figure 5) is similar to the data from non-fractionated 
ferrous iron uptake experiments and therefore corroborates FeoB to be functional in the 
wild-type strain. However, these findings (Figure 5) are not in agreement with the ferrous 
iron transport studies reported by Raphael et al. This difference is therefore likely due to 
different growth conditions and different C. jejuni isolates used in the two studies. 
 
The feoB mutant accumulates less iron when grown under iron-replete 
conditions  
In order to analyze if the reduced iron uptake rates affected the iron accumulation in the 
feoB mutant, we determined the accumulation of 55Fe2+ iron of the wild-type NCTC 
11168 and the feoB mutant strains by performing 55Fe2+ accumulation assays as described 
in the materials and methods section. The wild-type and feoB mutant strains were grown 
separately in MEMα medium with 55Fe2+ iron at a final concentration of 0.036 µM. One 
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ml aliquots were collected at regular intervals and the iron accumulation was monitored 
as a function of the optical density at 600 nm (Figure 6A). In addition, uptake was 
determined following cell fractionation (Figure 6 B), similar to the previous experiment. 
As shown in Figure 6, the wild-type strain contains more radiolabeled iron than the feoB 
mutant at the mid-log and at early stationary phases. Statistical analysis by Student t  test 
of the mid-log-phase samples shows that there is a trend for the NCTC and the feoB 
mutant strain to be different with respect to iron accumulation over time (p=0.08). At 
early stationary phase, there is a significant difference at a 5 % level of significance.  The 
fractionated counts at mid-log-phase further corroborated the fact that the accumulation 
of 55Fe2+ iron in the spheroplastic fraction of the wild type was higher than that of the 
feoB mutant, indicative of FeoB mediated iron uptake. In the feoB mutant, there was      
81 % lower 55Fe2+ iron accumulation in the spheroplastic fraction of the mutant compared 
to the wild type (p=0.03). Therefore, this significant decrease in iron accumulation in the 
feoB mutant cells can be attributed to the disruption of the FeoB inner membrane protein. 
Velayudhan et al. have shown similar results with the feoB mutant in H. pylori. By 
atomic absorption spectrophotometry, they demonstrated approximately 4-fold lower 
cellular iron levels in the mutant compared with the wild-type strain.  
 
Role of FeoB in C. jejuni intracellular survival within eukaryotic cells 
Although the importance of iron as an essential nutrient for C. jejuni metabolism has 
been previously shown (10, 17, 26, 29),  however, the role of iron in intracellular survival 
of C. jejuni within eukaryotic cells is not known. Studies related to intracellular survival 
of C. jejuni within eukaryotic cells have been done to assess the role of catalase and 
 95 
superoxide dismutase (4, 19). The intracellular iron requirements of C. jejuni within the 
host and its available sources are not exactly known. It has been conjectured that 
following internalization, C. jejuni should be able to survive and replicate intracellularly 
(4, 19). In order to determine if FeoB plays a role in intracellular iron acquisition for       
C. jejuni, we compared the survival of the feoB mutant and the wild-type C. jejuni 81-176 
within cultured epithelial cells. 
 
Intracellular survival assay was performed as described in materials and methods section. 
The INT-407 and IPEC-1 cells were infected with C. jejuni 81-176 and the feoB mutant 
at a MOI of 10:1 (number of bacteria per eukaryotic cell) and survival kinetics were 
analyzed over a 72 hour period (Figure 7A, 7B). The wild-type strain and the feoB mutant 
showed a decline in intracellular survival until 48 hours. There was no significant 
difference in the survivability of the wild type as compared to the mutants (p>0.4). 
Interestingly, between 48 hours to 72 hour period, the wild-type strain exhibited an 
increase in the recovery of intracellular bacteria, indicating its ability to persist and even 
multiply within INT-407 and IPEC-1 cells, whereas the number of feoB mutant continued 
to decline. The feoB mutant was approximately 5 fold and 8 fold more sensitive than the 
wild type strain in its ability to survive within IPEC-1 and INT-407 cells (p<0.0001) 
respectively, at a 5% level of significance. These results suggest that FeoB likely 
contributes towards C. jejuni intraepithelial survival and replication. It is likely that 
within 24-48 hours post infection, the majority of the cellular nutrient reserves may have 
been depleted, thus producing an acute shortage of iron for the bacterial metabolism. 
These findings suggest that under extremely limited iron conditions, only high affinity 
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iron transporters such as FeoB enable the iron starved bacteria to persist and multiply 
within the infected eukaryotic cells.  
 
In addition to the intracellular survival assays, we also tested the binding and invasion 
efficiencies of the feoB mutant and the wild-type strains as a control to determine if FeoB 
played any role in the binding and invasion of C. jejuni to the host epithelial cells.  
FeoB is not involved in binding and invasion of epithelial cells 
It has been demonstrated that adhesion and invasion of the host mucosal surface are 
essential steps in the pathogenesis of Campylobacter gastroenteritis (11, 14, 34). 
However, poorly invasive C. jejuni strains have also been reported to heavily colonize the 
chicken ceca and the rabbit ileal loop (17, 26). This highlights the pathogenesis of          
C. jejuni infection to be a complex process. 
 
In order to determine if FeoB plays a role in adhesion and invasion, we assessed the 
binding and invasion efficiency of feoB mutants and the wild-type using INT-407 human 
epithelial cells and IPEC-1 porcine epithelial cells. INT-407 cells have been commonly 
reported in adhesion and invasion studies of C. jejuni (21). IPEC-1 is an epithelial cell 
line derived from neonatal piglets. This is the first report where IPEC-1 cells have been 
used to study the C. jejuni virulence and colonization determinants. The objective of 
using IPEC-1 cells along with INT-407 cells was to correlate the findings from these in 
vitro experiments with the in vivo characterization of feoB mutants in neonatal piglets.  
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Adhesion and invasion assays were performed as described in materials and methods 
section. INT-407 and IPEC-1 cells were infected with C. jejuni wild-type and feoB 
mutants, with a multiplicity of infection (MOI) of 10:1 (number of bacteria per 
eukaryotic cell). Table 3 summarizes the findings of adhesion and invasion assays with 
INT-407 cells by comparing the wild-type C. jejuni strain and the feoB mutants. As 
previously shown, C. jejuni NCTC 11168 was found to poorly adhere and invade the 
INT-407 cells, whereas, C. jejuni TGH 9011 and C. jejuni 81-176 had higher percent 
binding and percent invasion efficiencies (21). Figure 7 A and B also shows binding and 
invasion efficiencies of the feoB mutant and the wild type C. jejuni 81-176 strain along 
with the intracellular survival. The feoB mutants and the wild-type C. jejuni strains had 
no significant differences (p>0.2) in binding and invasion efficiencies at a 5% level of 
significance. 
 
Table 4 summarizes the binding and invasion assays with IPEC-1 cells comparing the 
wild-type strains and the feoB mutants of C. jejuni TGH 9011 and C. jejuni 81-176. There 
was no significant difference in the binding and invasion efficiencies of the feoB mutant 
and wild-type (p>0.34) at a 5% level of significance. The binding and invasion 
efficiencies of C. jejuni TGH 9011 and C. jejuni 81-176 with IPEC-1 cells were 
comparable to the corresponding efficiencies with INT-407 cells. This indicates that 
binding and invasion of C. jejuni isolates are independent of the cell lines used in the in 
vitro studies.  
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Experimental design and analysis of feoB microarray. 
It has been shown that the genes involved in iron metabolism are expressed under iron 
limited conditions (1, 10, 17). In order to investigate the global changes in the gene 
expression profile elicited in response to iron limitation of the feoB mutant and the         
C. jejuni NCTC 11168 wild-type strains, we studied their transcriptome profiles when 
grown to mid-log-phase under iron-limited conditions in MEMα medium. The MEMα 
has been previously used to grow C. jejuni for microarray studies associated with iron 
metabolism (17). In this experiment, total RNA was purified from mid-log-phase grown 
wild-type strain and feoB mutant under iron-limited conditions. The RNA was reverse 
transcribed and fluorescently labeled as previously described (17, 25). Finally, the 
relative abundance of gene transcripts was compared for the wild type strain and feoB 
mutant using a C. jejuni NCTC 11168 microarray. The experiment was repeated three 
times (three biological replicates) and each experiment had three observations. So there 
were nine observations per gene. The data was normalized, merged and reported as the 
log2 ratio of the transcript abundance of C. jejuni feoB mutant (Cy5) grown in iron-
starved conditions to that of the wild type strain (Cy3). 
 
The statistical significance of the differential abundance of transcripts was analyzed by a 
Student t test. Genes were considered to be differentially expressed if the ‘P’ value was 
less than 0.01 and a minimum of two-fold change in the transcript abundance was found.  
Overall, 110 genes were differentially expressed between the feoB mutant and the     
wild-type strain. Table 5 summarizes the trend of these differentially expressed genes. 
Only 10 genes were found to be 2 to 4 fold up-regulated (p<0.06) (Table 6). The gene 
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involved in oxidative stress defense katA was 2-fold up-regulated. Expression of 
Cj0012c, which encodes a non-heme iron protein was 4-fold up-regulated. Components 
of cytochrome b6 (petA, petB) and a putative periplasmic protein were also up-regulated 
in the feoB mutant.  Surprisingly, our experiments did not identify many iron acquisition 
genes that were reported in earlier studies to be up-regulated in iron-limited conditions. 
Also, our experiments revealed down-regulation of genes belonging to the flagellar 
biogenesis. These findings are in contrast to the findings reported in the microarray 
studies of   C. jejuni’s response to iron limitation (17). This differential expression profile 
of the flagellar biogenesis genes in the feoB mutant with respect to iron starvation is 
unclear and requires further investigation. This highlights the complex nature of iron 
transport systems in C. jejuni.  
 
The observed up-regulation of katA and other genes which are not involved in iron 
acquisition suggest that this could be a secondary regulatory response of C. jejuni, 
signaling iron restricted state of the feoB mutant. The katA gene and other oxidative stress 
defense genes such as ahpC and PerR have also been identified to be up-regulated under 
iron limited conditions in vitro (10, 17).  Previous reports have shown that C. jejuni katA 
mutant was affected in its survival ability within the macrophages (4). Some of the 
hypothetical proteins and putative periplasmic proteins were up-regulated in the feoB 
mutant strain. It might be possible that the transcription of these genes was altered due to 
physiological and metabolic changes that take place in iron starved conditions.  
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Extensive screening of C. jejuni feoB mutants for colonization and 
pathogenicity testing in three animal models 
 
Although the development of several animal models mimicking the C. jejuni 
pathogenesis have been cited in the literature, reports of their utilization in assessing the 
disease or colonization potential factors are very limited (16). Here we report the 
colonization potential of C. jejuni feoB mutants from three isolates based on competitive 
and non-competitive gut colonization testing in three diverse animal models; chicks, 
colostrum-deprived neonatal piglets and rabbits. 
  
The chick model is a well characterized colonization model and has been used to screen 
the colonization potentials of C. jejuni mutant strains (7, 17). C. jejuni colonizes the 
intestine of chicks as commensals (9). As there are no clinical signs observed in chicks 
challenged with C. jejuni, the chicks serve solely as a colonization model.  
 
The digestive tract of neonatal piglets is similar to the human gastrointestinal tract         
(2, 16). Use of colostrum-deprived new born piglets as an in vivo model for human 
Campylobacterioisis has been documented by Babakhani et al (2). They observed 
diarrhea in experimentally infected piglets characterized by the presence of mucous and 
blood, as seen typically in human Campylobacterioisis. Therefore, we chose to use this 
model to screen the C. jejuni feoB mutant by competitive colonization assay. However, 
till date, there are no reports documenting the use of colostrum-deprived neonatal piglets 
in the screening of C. jejuni mutants.  
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The RIL model has also been shown to be a suitable model for human 
Campylobacteriosis as characteristic histopathological lesions were observed in the gut of 
experimentally infected rabbits (5). Signs of intestinal distention due to increased 
accumulation of fluid and gas was previously reported in RIL studies (26). We have 
recently reported the rabbit ileal loop model for screening of C. jejuni mutants by 
competitive colonization (26).  
 
The feoB mutant is significantly affected in colonization of chicken ceca 
Colonization potential of the feoB mutants of C. jejuni NCTC 11168, C. jejuni TGH 9011 
and C. jejuni 81-176 were assessed by non-competitive and competitive colonization in 
chicks. 
 
Non-competitive cecal colonization 
The colonization potential of feoB mutants and wild-type C. jejuni strains were 
determined by orally challenging 5 birds per group separately with approximately 104 to 
105 viable bacteria. Five uninoculated birds served as negative control. Four days post 
inoculation, chicks were euthanized and ceca were recovered. Bacterial recovery was 
calculated for every bird per gram of ceca. The minimal limit of detection for this assay 
was 100 cfu/g ceca. As shown in Figure 8, all the three feoB mutants were significantly 
attenuated in their ability to colonize the chick ceca. These results indicate the importance 
of feoB in cecal colonization by C. jejuni. This in vivo phenotype of C. jejuni feoB mutant 
is similar to the feo mutant phenotype of enteric pathogens E. coli and  
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Salmonella enterica which were reported to be defective in the intestinal colonization of 
mice (27, 28). 
 
The competitive chick colonization assays 
The feoB mutants of C. jejuni NCTC 11168 and C. jejuni TGH 9011 were also tested for 
their colonization potential in vivo by competitive colonization in chicks. Each feoB 
mutant and the corresponding wild-type strain was independently mixed in a 1:1 ratio and 
orally challenged to 5 birds. Mixed inocula contained approximately 105 viable bacteria 
of each type and the inoculum titer was confirmed by plating the serially diluted 
inoculum on MH plates with and without kanamycin (30µg/ml). Four days post 
inoculation, the birds were euthanized and the cecal contents were collected, diluted 
serially and plated on Campylobacter selective medium with and without kanamycin 
(30µg/ml) to enumerate the number of feoB mutant and wild-type strain. Then, the 
competitive index (C.I.) was calculated as the ratio of the output mutant to the wild-type 
strain recovered divided by the ratio of input mutant to the wild-type bacteria inoculated 
per bird. Interestingly, as shown in figure 9, both the feoB mutants were significantly 
affected in their colonization abilities (p<0.0001), based on a single sample Student t test 
at a 5 % level of significance. The outcome of in vivo chicken competitive colonization 
assays was similar to the outcome of in vivo chicken non-competitive assays. Therefore, 
feoB mutant was significantly affected in its colonization potential. 
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The C. jejuni infected colostrum-deprived neonatal piglets produce symptoms 
associated with the disease  
We successfully established the neonatal piglet model by demonstrating substantial 
colonization levels with each of the three C. jejuni isolates, C. jejuni NCTC 11168, TGH 
9011 and 81-176. Approximately 104 cfu per gram of intestine were recovered when 
these piglets were orally challenged with approximately 1010 cfu. All the isolates equally 
colonized the intestine of piglets (data not shown). The challenged piglets developed 
diarrhea within 24 to 48 hours. The feces were semi-solid to watery in consistency, and 
were characterized by the presence of blood and mucus in the piglets challenged with C. 
jejuni TGH 9011 and C. jejuni 81-176 isolates. No blood was observed in the feces of 
piglets challenged with C. jejuni NCTC 11168 isolate.  The non-infected control piglets 
did not have any diarrhea. These findings were consistent with the findings of Babakhani 
et al (2). Histopathological analyses revealed no or very mild gross lesions consisting of 
hyperemia and patches of petechial hemorrhages. Therefore, in contrast to the study from 
Babakhani et al, no severe pathological lesions were observed. This difference seen in 
pathogenesis could be a result of host specificity, inoculum or differences in the C. jejuni 
isolates used in the two studies. 
 
The feoB mutant of all the C. jejuni isolates tested were significantly 
attenuated in competitive colonization of intestine of piglets 
The feoB mutants from all the three strains, C. jejuni NCTC 11168, C. jejuni TGH 9011 
and C. jejuni 81-176 were tested with their corresponding wild-type strain in 3, 3 and 2 
piglets respectively for in vivo competitive colonization. Housing and management of the 
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colostrums-deprived neonatal piglets used in this study has been described in the 
materials and methods section. 
 
C. jejuni wild-type and feoB mutant strains were grown in biphasic MH medium to mid-
log-phase, centrifuged and resuspended in 5 ml Similac milk (commercial formula) each 
for every piglet. Approximately 5 X 1010 cfu viable bacteria per ml was the strength of 
each inoculum. Both the inocula were mixed and 10 ml of this mixed inocula was fed 
orally to each piglet. The mixed inocula was confirmed by plating serial dilutions on MH 
agar plates with and without kanamycin. Seventy-two hours post challenge, the 
duodenum, jejunum, ileum, cecum and colon portions of the intestinal segments were 
recovered. The gut contents along with the mucus were collected, resuspended in PBS 
buffer and serial dilutions of recovered bacterial suspensions were plated for enumeration 
on selective media for each organ as described in the chick competitive colonization 
assay. The mutant and the wild-type titer were determined and the competitive index 
(C.I) calculated for each organ. One-sample Student t test statistical analysis was 
performed at a 5% level of significance. The competitive indices for all the intestinal 
segments were calculated as the ratio of the output mutant and wild-type strain recovered 
divided by the ratio of the input mutant and wild-type strain inoculated. For all the 
organs, the p value was <0.0001, indicating that the feoB mutant of C. jejuni NCTC 
11168 strain was significantly affected in colonizing the gastrointestinal tract of piglets 
(Figure 10A). Similarly, the colonization potentials of the feoB mutants of C. jejuni TGH 
9011 (Figure 10B) and C. jejuni 81-176 (Figure 10C) strains were also significantly 
affected. 
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The feoB mutant of C. jejuni TGH 9011 was recovered from only one organ (cecum) of 
one piglet of the three piglets assessed for competitive colonization in the gut. In case of 
all of the other organs from the three piglets, the recovery of mutant bacteria was below 
the detection limit of our assay (100 cfu/gm) (Figure 10B). From these data, it is clear 
that C. jejuni FeoB plays a significant role in the colonization of the gastrointestinal tract 
of piglets.  
 
The feoB mutant was compromised in competitive colonization of the in vivo 
rabbit ileal loop (RIL)  
We determined the competitive colonization ability of feoB mutant and wild-type           
C. jejuni NCTC 11168 strain in the RIL model. Surgical procedures have been explained 
in materials and methods section.  Four loops were inoculated with a mixed inocula 
containing approximately 1:1 ratio of wild-type strain and the mutant. Mixed inocula 
contained approximately 106 bacteria each of the wild-type and the feoB mutant strain 
and were confirmed by plating the serial dilutions on MH plates with and without 
kanamycin (30 µg/ml). Two ileal loops inoculated with sterile PBS buffer served as 
uninfected control. Upon 48 hours post infection, the loop contents were recovered and 
plated to enumerate the wild-type and mutant bacterial titer similar to the bacterial titer 
determination described in the in vivo competitive chick colonization assay.  
 
The data was statistically analyzed using a Student t test and the feoB mutant was found 
to be significantly affected in its colonization ability (p=0.0176) at a 5% level of 
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significance (figure 11). The overall recovery of the feoB mutant in the RIL assay was 
more than the feoB mutant recovered in the chick and piglet in vivo competition assay. 
This difference in mutant colonization levels could be attributed to the increased dose of 
inoculum administered in the RIL model. Also, with the RIL model, the ileal loop is 
physically ligated and might favor the survival of mutants unable to efficiently colonize 
the gut as compared to the two other models, where there is no physical ligation and they 
are subjected to removal through peristalsis and mechanical flushing.  
 
The feoB mutant is not affected in the in vitro competition growth assay 
In order to determine whether the in vivo colonization defect of the feoB mutant was a 
specific characteristic feature of in vivo growth, we performed the in vitro competition 
growth assay. A 1:1 mixture of feoB mutant and the wild-type C. jejuni NCTC 11168 
strain was mixed into fresh MH medium. The mixed inocula was plated on MH and MH 
containing kanamycin (30 µg/ml) to confirm the 1:1 ratio of the mutant and the wild-type 
strains. The cultures were grown under microaerophilic conditions at 37˚C until early 
stationary phase. The titer of the wild type and feoB mutant was then determined by 
plating on MH and MH containing kanamycin (30 µg/ml). The in vitro competition index 
(C.I) was determined by calculating the ratio of the mutant to the wild-type strain  
(Figure 11). The feoB mutant was found to be not significantly affected in its ability to 
grow in competition with the wild type strain (p>0.648) at 5 % levels of significance as 
determined by the Student t test. Consequently, the decreased ability of the feoB mutant 
to colonize the gut of all the animal models tested is an in vivo specific defect.  
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Cj1397 and Cj1398 (feoB) genes are co-transcribed 
Cj1397 gene encodes a putative protein of 74 amino acids and bears 16% identity to the 
E. coli FeoA. Its role in iron transport is not yet known. Cj1398 (FeoB) appeared to be in  
an operonic structure with Cj1397 (13, 18). However, this genetic organization has not 
been experimentally demonstrated. By RT-PCR, we demonstrated that Cj1397 and 
Cj1398 are in an operonic structure. The RT-PCR reactions were performed using a 
combination of primers that annealed within the genes Cj1395, Cj1397 and Cj1398. Each 
reaction gave a product of the expected size, as shown in Figure 12. Cj1395, located 
upstream of Cj1397, was in the same orientation as Cj1397. Cj1395 was individually 
transcribed, however it was not co-transcribed with Cj1397. Cj1397 and Cj1398 genes 
were found to be co-transcribed. Cj1399c, located downstream of Cj1398, is in opposite 
orientation to that of Cj1398 and was therefore not checked. Therefore, these results 
confirmed that only Cj1397 and Cj1398 genes are co-transcribed.  
 
C. jejuni possesses ferric iron reduction ability 
Ferric reduction ability has been demonstrated in H. pylori (30, 35). In order to test 
whether the ferric iron reduction ability is present in C. jejuni, we performed ferric 
reduction assays as described in the materials and methods section. Using a specific 
chromogenic Fe(II) iron chelator, bathophenantrolin-disulfonate (BPDS) at 1 mM, we 
observed a ferric reduction activity of 16.68 ± 0.8 nM of BPDS-Fe2+ complex produced 
by 109 cells per minute by the wild type C. jejuni NCTC 11168 strain. There was no 
reduction of ferric iron observed in the cell-free controls. This data demonstrated that the 
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wild type strain C. jejuni NCTC 11168 possessed a ferric reduction ability, which 
suggests the presence of an unknown reductant or extracellular ferric reductase in          
C. jejuni. It is likely that the ferric iron source maybe reduced to ferrous iron before being 
transported through the inner cytoplasmic membrane in C. jejuni. A similar role of 
NAD(P)H:flavin oxido reductase in Fe(III) reduction was proposed by Coves et al (3). 
Worst et al have demonstrated in H. pylori that the ribBA locus, which encodes genes for 
riboflavin synthesis also causes ferric reduction and plays a role in iron acquisition (35). 
 
The feoB mutant and the wild-type C. jejuni NCTC 11168 strain exhibit 
comparable ferric iron reduction activity 
In order to compare the ferric iron reduction ability of the C. jejuni wild-type strain and 
the feoB mutant strain, we performed the ferric iron reduction assay as described earlier. 
A Fe3+ reduction activity of 16.68 ± 0.8 nmol and 16.27 ± 0.423 nmol of BPDS-Fe2+ 
complex were produced by 109 cells per minute by the wild-type strain and feoB mutant 
strain respectively. Therefore, the ferric reduction ability was not affected in the feoB 
mutant at a 5% level of significance as compared to the wild-type strain. 
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Concluding remarks 
The role of FeoB in C. jejuni was assessed for iron acquisition and colonization of animal 
hosts. The feoB gene was knocked out by insertional mutagenesis in three C. jejuni 
isolates.  In vitro characterization of these feoB mutants by intracellular survival assays 
(within porcine and human intestinal epithelial cells), FeoB microarray analysis, iron 
transport and accumulation experiments demonstrated that the FeoB protein is required 
for ferrous iron transport and that ferrous iron is an important intracellular iron source for 
Campylobacter. In vitro experimental findings were strongly supported by in vivo animal 
colonization experiments. This was the first study which documented the screening of  
C. jejuni mutants for their colonization potentials in the colostrum-deprived neonatal 
piglets along with the chicken ceca and rabbit ileal loop colonization. Consistently, the 
animal experiments revealed that the feoB mutant was attenuated in the in vivo 
colonization in all the animal models tested. Consequently, this study clearly indicates 
that FeoB mediated ferrous iron transport is essential for successful gut colonization by 
C. jejuni. 
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Table 1: Bacterial strains and plasmids 
Strain or Plasmid Relevant characteristicsa Source or reference 
E. coli DH5α endA1 hsdR17(rK-m K-)supE44 thi-1 Invitrogen 
C. jejuni   
AS 144 C. jejuni NCTC 11168 NCTC 
AS 53 C. jejuni ATCC 43431 (TGH 9011) ATCC 
AS 275 C. jejuni 81-176 Pickett 
AS 217 AS 144 ∆ feoB::Kmr This study 
AS 236 AS 53 ∆ feoB::Kmr This study 
AS 237 AS 275 ∆feoB::Kmr This study 
Plasmids 
  
pILL 600 Kmr resistance gene Labigne 
pCAP Cloning and suicidal vector, Ampr Roche 
pAS 43 pCAP carrying feoB This study 
pAS 223 pCAP carrying ∆feoB:: Kmr This study 
a
  Kmr, kanamycin resistance gene; Ampr , ampicillin resistant  
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Table 2: Primers used in this study 
Primer DNA sequence from 5’ to 3’ (restriction site) a 
feo-1 CGCTGGCCAAAGTCATTGATTTGCCAGGAAC 
(MluNI) 
feo-2 CGCTGGCCAGCCACTGCACTTGGTATAGG (MluNI) 
Cj1395-F CGATTGCGATCCTTTAGAAGCAAA 
Cj1395-R CGAGTGGTTTAAATTTTCTAGATTGATGA 
Cj1397-F CGACGCTCACAAAGAACTCAAAAA 
Cj1397-R CGAGCTTCATCAGATCTTAGGATAACACA 
Cj1398-F CGATCAGCCTAATGTAGGCAAAAGTC 
Cj1398-R CGATGCGTTCTAAATTGGTAGCATC 
a
 The restriction sites used for cloning are underlined and correspondingly shown in 
parenthesis 
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Table 3: Binding and Invasion assays using the INT-407 cell line 
NCTC TGH 81-176  
Wild 
Type 
∆feoB Wild 
Type 
∆feoB Wild 
Type 
∆feoB 
% 
Bindinga 
0.0043 ± 
0.001 
0.003 ± 
0.0007 
1.39 ± 
0.18 
1.49 ± 
0.19 
1.71 ± 
0.11 
1.49 ± 
0.13 
% 
Invasionb 
0.00036 
± 
0.000087 
0.00035 
± 
0.000087 
0.37 ± 
0.064 
0.38 ± 
0.053 
0.67 ± 
0.08 
0.63 ± 
0.06 
a obtained by subtracting the number of invaded bacteria from the total number of 
bacteria recovered without gentamicin treatment 
b 
 percentage of inoculum recovered after gentamicin treatment 
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Table 4: Binding and Invasion assays using the IPEC-1 cell line 
NCTC TGH 81-176  
Wild 
Type 
∆feoB Wild 
Type 
∆feoB Wild 
Type 
∆feoB 
% Bindinga NDc NDc 1.43 ± 
0.1 
1.57 ± 
0.13 
1.43 ± 
0.13 
1.37 ± 
0.12 
% 
Invasionb 
NDc NDc 0.3 ± 
0.033 
0.28 ± 
0.046 
0.62 ± 
0.08 
0.49 ± 
0.09 
a obtained by subtracting the number of invaded bacteria from the total number of 
bacteria recovered wihtout gentamicin treatment 
b 
 percentage of inoculum recovered after gentamicin treatment 
c  Not Determined 
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Table 5: Summary of genes differentially expressed 
 
Number of genes Fold change Genes of interest 
a) Up-regulated in ∆feoB   
20 1.5-4.0 ExbB2, hrcA, hspR, ceuE and all the 
genes listed in Table 6. 
23 1.2-1.5 ExbB2 
b) Down-regulated in ∆feoB   
25 2.5 and above Flagellar biosynthesis genes: FlgD, FlgE, 
FlgE2, FlgL, FlgB 
15 1.2-2.0 ExbB3, Cj020, Cj0203 
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Table 6: feoB microarray analysis  
Genes up-regulated in 
∆feoB 
Fold 
change 
P value Function 
katA 2.0 0.00643 Oxidative stress defense 
petA 2.6 0.00418 Cytochrome b6 component  
petB 2.0 0.00114 Cytochrome b6 component 
Cj1169c 2.0 9.25E-4 Putative periplasmic protein 
Cj0012c 3.85 5.94E-4 Non-heme iron protein 
Cj0262c 2.0 1.4E-5 Putative signal transduction protein 
ppi 2.0 9.75E-4 Peptidyl-prolyl-cis-trans isomerase 
rpsP 2.0 0.00376 30S ribosomal protein 
aat 2.0 0.00542 Putative leucyl/phenylalanyl t-RNA protein 
transferase 
Cj1710c 3.4 1.8E-4 Hypotheical unknown protein 
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Figure 1:    Mutagenesis strategy of the feoB gene in C.jejuni NCTC 11168 and mutant 
verification. A) An feoB mutant was constructed by the insertion of a Kmr cassette into a 
unique ClaI site within the feoB gene. The distance from the translational start codon of 
the gene to the Kmr cassette insertion site is indicated. B) 0.9% agarose gel of PCR 
product obtained with the wild type C.jejuni NCTC 11168 (lane 2), the feoB mutant  
(lane 3) and standard 1Kb DNA ladder (lane 1).  
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Figure 2: Comparitive growth of C. jejuni NCTC 11168 wild-type and feoB mutant in 
MH biphasic growth medium. C. jejuni starter cultures were grown overnight in MH 
biphasic medium and were then inoculated into fresh MH biphasic flasks. The data 
represents the mean of three independent experiments ± standard error. 
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Figure 2: 
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Figure 3: Growth of C. jejuni NCTC 11168 wild-type and feoB mutant in MEMα 
(supplemented with 20 mM sodium pyruvate as an additional carbon source) in the 
presence or absence of 55Fe2+ [0.036 µM final concentration]. Strains were pre-cultured 
overnight in MH biphasic medium, harvested, washed and resuspended in MEMα before 
inoculating into fresh MEMα with and without radiolabeled iron. The data is from two 
independent experiments and represents the mean ± standard error. Since radiolabeled 
iron was reduced to ferrous iron using sodium ascorbate, sodium ascorbate was also 
added in equimolar concentration to MEMα culture, grown without an iron source.  
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Figure 4: 55Fe (II) uptake of C. jejuni NCTC 11168 and feoB mutant with cells grown in 
MH medium. 0.036 µM was the final concentration of radiolabeled Fe (II) used in the 
assays. Proton dependent and energy dependency for uptake was demonstrated by 
addition of   33 µM CCCP and by performing uptake at 0ºC. The experiment was 
repeated twice, and the data represents the mean ± standard error. 
 
 129 
Figure 4: 
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Figure 5: Whole cell 55Fe(II) uptake assay for C. jejuni wild-type strain and feoB mutant. 
A) Cells were grown overnight to mid-log-phase in iron chelated medium (MH+DFO) 
[20 µM concentration] and uptake of radiolabeled ferrous iron was assessed 15 minutes 
after the addition of iron (0.036 µM) for the whole cells. The data represents the means of 
two independent experiments ± standard error.  B) Cells were grown overnight upto mid-
log-phase in iron chelated medium (MH+DFO) [20 µM concentration] and uptake of 
radiolabeled ferrous iron was assessed 15 minutes after the addition of iron (0.036 µM) 
for the sub cellular fractions obtained by osmotic lysis post uptake. The data represents 
the means of two independent experiments ± standard error. * indicates significant 
difference at a 5% level of significance 
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Figure 6: Whole cell 55Fe(II) accumulation in  C. jejuni wild-type and feoB mutant 
grown in iron-replete conditions. A) The wild-type and feoB mutant strains were grown 
separately in MEMα containing 20 mM sodium pyruvate + 0.036 µM  55Fe(II) final 
concentration, over a period of 24 hours. The accumulation of iron by the two strains was 
measured at 0, 8, 12 and 24 hours, similar to the 55Fe(II) uptake assays described 
previously. The data represents the mean of two experiments ± standard error. B) The 
wild-type and feoB mutant strains were grown separately in MEMα containing 20 mM 
sodium pyruvate + 0.036 µM 55Fe(II) final concentration, over a period of 24 hours. The 
accumulation of iron by the two strains was measured at mid-log-phase (12 hours) similar 
to the 55Fe(II) uptake assays described previously, to determine the levels in spheroplastic 
and periplasmic fractions post uptake. The data represents the mean of two experiments ± 
standard error. * indicates significant difference at a 5% level of significance. 
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Figure 7 A) Intracellular survival, binding and invasion efficiencies of C. jejuni 81-176 
wild-type strain and the feoB mutant within INT-407 epithelial cells. B) Intracellular 
survival, binding and invasion effiecies of C. jejuni 81-176  
wild-type strain and the feoB mutant within IPEC-1 epithelial cells. Epithelial cells were 
infected with the wild type strain and ∆feoB mutant at a multiplicity of infection 10:1 
(number of bacteria per eukayotic cell) and survival kinetics were analyzed over a 72 
hour period. “b” represents the binding efficiency and was obtained by subtracting the 
number of invaded bacteria from the total number of bacteria recovered without 
gentamicin treatment. “i”  represents the invasion efficiency and was calculated as the 
percentage of inoculum recovered after gentamicin treatment. The experiment was 
repeated thrice and the data represents the mean ± standard error. * indicates statistically 
significant difference at a 5 % level of significance, by Student t test, for the 72 hour time 
point. 
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Figure 8: Non competitive chick colonization assay. Comparative colonization properties 
were tested in wild-type and feoB mutant strains of C. jejuni NCTC 11168, C. jejuni TGH 
9011 and C. jejuni 81-176. Five birds per group were orally challenged with 104-105 cfu. 
The columns represent the means and the error bars indicate the standard errors. Non 
parametric Mann-Whitney Rank Sum test was used for statistical analysis. * indicates 
statistically significant difference at a 5 % level of significance. 
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Figure 8: 
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Figure 9: Competitive colonization ability of feoB mutants of C. jejuni NCTC 11168 and 
C. jejuni TGH 9011. A 1:1 mixed inocula of the wild-type and feoB mutant strains were 
orally inoculated into five birds. The in vivo competitive index is the ratio of the output 
mutant to the wild-type recovery divided by the ratio of the input mutant to wild type 
strain. The data represents the mean ± standard errors. * indicates statistical significance 
(p<0.0001). 
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Figure 9: 
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Figure 10: Colostrum-deprived neonatal piglet competitive colonization assay. 
A) The competitive colonization ability of the C. jejuni NCTC 11168 wild-type strain 
and its feoB mutant was assessed. Three piglets were orally challenged with a 1:1 mixed 
inocula of the wild-type and mutant strain. Seventy-two hours post inoculation, the pigs 
were euthanized and the intestinal segments- duodenum, jejunum, ileum, cecum and 
colon were collected. The intestinal contents were checked for the wild-type and feoB 
mutant titers. The CI was calculated as the ratio of the output mutant to the wild-type 
strain recovered divided by the ratio of the input mutant to the wild-type strain 
inoculated. The data represents the mean ± standard errors. * indicates statistical 
significance (p<0.0001). B) The competitive colonization ability of C. jejuni TGH 9011 
wild-type strain and its feoB mutant was assessed in three piglets. The data represents the 
mean ± standard errors. * indicates statistical significance (p<0.0001). C) The 
competitive colonization ability of C. jejuni 81-176 wild-type strain and its feoB mutant 
was assessed in two piglets.  
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Figure 11: Rabbit in vivo competitive colonization and in vitro competitive growth 
assay. The in vivo phenotype of feoB mutant was assessed in a 1:1 competition assay. The 
feoB mutant was mixed with the wild-type strain and inoculated into four ileal loops. At 
48 hours post infection, the loop contents were checked for the wild-type strain and 
mutant titers. The CI was calculated as the ratio of the output mutant to the wild-type 
strain recovered divided by the ratio of the input mutant to the wild type strain inoculated.  
The in vitro competition growth index was performed in triplicate. The in vitro CI 
represents the ratio of the feoB mutant to the wild-type C. jejuni NCTC 11168 in MH at 
early stationary phase. The data represents the mean ± standard errors. * indicates 
statistical significance at a 5 % level of significance (p=0.0176).
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Figure 11: 
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Figure 12: Cj1397-Cj1398 operon mapping by RT-PCR. The template RNA was purified 
from mid-log-phase bacteria grown in iron-limited medium MEMα. Predicted RT-PCR 
fragments with gene names are shown at the bottom. The gel lanes match the RT-PCR 
fragment labels. Lanes 1 and 7 corresponded to the 1 Kb ladder, lane 9 was a 100 bp 
ladder. Lane 8 was no RNA template control. 
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Abstract 
We have characterized the TonB systems from three strains of C. jejuni, C. jejuni NCTC 
11168, C. jejuni ATCC 43431 (TGH 9011) and C. jejuni 81-176, by defined mutagenesis, 
and assessed their role in the gastrointestinal colonization of day-old chicks and 
colostrum-deprived neonatal piglets. Analysis of the sequenced isolate, C. jejuni NCTC 
11168 genome, revealed the presence of three tonB genes, tonB1, tonB2 and tonB3. We 
demonstrated that the three TonB systems performed specific as well as redundant 
functions. Bioassays indicated that TonB3 specifically mediated the utilization of the 
siderophores enterobactin and lysine CAM, in C. jejuni NCTC 11168. The tonB2 and 
tonB3 single mutants were not affected in hemin and hemoglobin utilization, whereas the 
tonB2tonB3 double mutant was found to be completely impaired in the utilization of the 
above mentioned sources. Interestingly, the single tonB3 mutant of C. jejuni TGH 9011 is 
unable to utilize enterobactin, hemin and hemoglobin, whereas the single tonB2 mutant is 
unaffected in utilization of these iron sources as compared to the wild-type strain. The 
tonB2 mutant of C. jejuni 81-176 is completely impaired in the utilization of hemin, 
hemoglobin and lysine CAM. The construction of a triple tonB mutant in C. jejuni NCTC 
11168 was not successful due to the paucity of alternative genetic tools available for C. 
jejuni. Interestingly, the 55Fe3+ - enterobactin uptake assays further corroborated that the 
single tonB mutant was significantly compromised as compared to the wild-type strain. 
As expected, the double tonB mutants, tonB1tonB3 and tonB2tonB3 were also 
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significantly affected in 55Fe3+ - enterobactin transport as compared to the wild-type 
strain. The TonB systems of C. jejuni were found to be not involved in the adhesion and 
invasion of the INT-407 human intestinal epithelial cells. We assessed the role of TonB 
systems in colonization of the gastrointestinal tract using the avian and piglet 
colonization models. All the single and double tonB mutants were significantly affected 
in their ability to colonize the gastrointestinal tract of both animal models. The 
tonB1tonB3 double mutant was the most significantly affected, of all the combinations of 
mutants studied. Interestingly, the tonB2tonB3 double mutants and the tonB1tonB2 
double mutants were more compromised than the single tonB1 or single tonB3 mutants in 
colonization, further suggestive of the additive role of tonB2 in iron acquisition. The 
above in vivo colonization phenotype was found to be the same when wild-type and 
mutants were assessed for competitive and non competitive colonization of the chicken 
ceca. Overall, these results indicate that TonB mediated iron acquisition in C. jejuni is an 
important colonization determinant and likely contributes towards the pathogenesis and 
establishment of infection.  
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Introduction 
Iron is an essential nutrient for almost all pathogenic bacteria. Although iron is one of the 
most abundant elements on earth, its availability within the host is extremely limited due 
to its poor solubility. The availability of free iron at physiological pH within the host is 
10-18 M, whereas, the requirements of all microbes is approximately 10-8 M (35). Within 
the host, iron is usually either bound to proteins such as lactoferrin, transferrin and 
ferritin, or iron is present in hemoglobin (28, 45). The pathogenic bacteria usually employ 
two major mechanisms to acquire iron from host sources, which include high-affinity 
iron chelator (siderophore) mediated iron uptake and the uptake from host iron binding 
protein (transferrin, lactoferrin) or heme uptake via specific receptors (1, 44). The 
transport of ferric-siderophores or heme compounds in several gram-negative bacteria has 
been demonstrated to require specific outer membrane receptors and is dependent upon 
the TonB ExbB ExbD complex (34). The TonB transduces the energy from the 
cytoplasmic membrane to the outer membrane receptors for the transport of iron 
compounds (5, 21). The TonB dependent iron transport system has been found to 
contribute in the virulence of several gram-negative pathogens such as Shigella 
dysenteriae, Vibrio cholerae, Vibrio anguillarium,  Pseudomonas aeruginosa, Salmonella 
enterica serovar typhimurium, Salmonella enterica serovar typhi and Haemophilus 
influenzae (12, 17, 18, 36, 39-41). The food-borne pathogen Campylobacter jejuni, is a 
major cause of bacterial enteritis in humans world-wide (42, 43). With the availability of 
the complete genome sequence of C. jejuni NCTC 11168 in 2000, it has led to newer 
opportunities in better understanding of the molecular mechanism of pathogenesis. Iron 
acquisition has been considered as a potential colonization and virulence determinant in 
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C. jejuni (30). Recently, the complex response of C. jejuni to the availability of iron in 
the environment was characterized (16, 29). The C. jejuni genome lacks the genes 
responsible for biosynthesis of siderophores (30). Although a few strains of C. jejuni 
were identified to synthesize siderophores, they have not been fully characterized (10). It 
is not known whether C. jejuni NCTC 11168 produces siderophores. Strikingly, the 
genome has genes responsible for enterobactin uptake (30, 43).  Besides, it has been 
recently reported that cfrA, the outer membrane receptor functions in the transport of 
ferric-enterobactin in C. jejuni NCTC 11168 (29). However, the cfrA gene is not present 
in all strains of C. jejuni (43). It has also been documented that the periplasmic protein 
complex, ceuBCDE, mediates the uptake of enterobactin in C. jejuni. The chuABCD 
system mediates the uptake of heme in C. jejuni (19, 42, 43). Analysis of the C. jejuni 
NCTC 11168 genome reveals the presence of three possible TonB systems. TonB1 is 248 
amino acids in length and is the largest of the three TonB systems (30). Both the TonB2 
and TonB3 are 227 amino acids in length and have 41% identity. Identity between TonB1 
and TonB3 is 19% and that between TonB1 and TonB2 is 23%. E. coli TonB and           
C. jejuni TonB1 have 22% identity, E. coli TonB and C. jejuni TonB2 have 26% identity, 
while E. coli TonB and C. jejuni TonB3 have 28% identity (30). 
It is likely that the transport of ferric enterobactin, hemin and other iron compounds is 
TonB dependent in C. jejuni. However, the role of tonB genes in iron transport of           
C. jejuni has not yet been experimentally demonstrated. To assess the role of these TonBs 
in iron uptake, we constructed a series of single and double tonB mutants in C. jejuni 
NCTC 11168. The effect of these mutations was tested by in vitro and in vivo assays 
using chick colonization model and colostrum-deprived neonatal piglet model. We also 
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characterized the TonB2 system from C. jejuni 81-176 and the TonB2 and TonB3 
systems from C. jejuni TGH 9011 by in vitro assays. 
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Materials and methods 
Bacterial strains, media and growth conditions 
The bacterial plasmids and strains used in this study are listed in Tables 1 and 2 
respectively. Luria-Bertani (LB) broth or LB agar plates were used to routinely culture  
E. coli DH5α at 37˚C, aerobically. Media supplemented with kanamycin (30 µg/ml) 
and/or chloramphenicol (20 µg/ml) were used to grow strains containing plasmids.   
C. jejuni 81176 and C. jejuni ATCC 43431 (TGH 9011) were obtained from Dr Pickett 
and the American Type Culture Collection, respectively. C. jejuni NCTC 11168 was 
obtained from the National Collection of Type Cultures. Routine culturing of these 
strains was done at 37˚C in a MACS-VA500 microaerophilic workstation (Don Whitley, 
West Yorkshire, England) under 83 % N2, 4 % H2, 8 % O2 and 5 % CO2 on Mueller 
Hinton (MH) agar plates, MH medium or minimum essential medium (MEMα, 
Invitrogen).  Kanamycin (30 µg/ml) or chloramphenicol (20 µg/ml) or both were added 
as required. The C. jejuni strains were tested for motility on 0.4 % MH agar plates before 
performing any in vitro cell culture studies or in vivo animal experiments. For the in vitro 
growth assays, the C. jejuni wild type and mutant strains were grown in MH biphasic 
medium or MEMα or MEMα supplemented with 40 µM FeSO4 at 37˚C in the 
microaerophilic workstation. 
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Cell Culture 
Human INT-407 embryonic intestinal cells (acquired from the American Type Culture 
Collection) were cultured in minimum essential medium α (MEM α, Invitrogen), 
supplemented with 10 % fetal bovine serum (Invitrogen). Cells were grown in an 
incubator at 37˚C under 5 % CO2. 
 
Binding and invasion assays 
These assays were performed as described previously (33). Briefly, the binding assay was 
carried out by co-incubating mid-log-phase C. jejuni cells grown in biphasic MH media 
with 24 hour grown, semi-confluent INT-407 cells (about 105 cells per well) at a 
multiplicity of infection (MOI) of 10:1 (10 bacteria per eukaryotic cell). Three hours post 
incubation at 37˚C, in the presence of 5 % CO2, the cell growth medium was removed, 
and the monolayer was washed thrice with Hanks balanced salt solution (HBBS). 
Subsequently, infected cells were lysed with 0.1 % Triton X-100, at room temperature, 
for 30 minutes. Then the cell lysates were serially diluted and plated on MH agar plates 
to enumerate the number of bacteria bound to the eukaryotic cells and internalized within 
the eukaryotic cells.  
The invasion assay was performed similar to the binding assay, except that the infected 
cells were further incubated for an additional one hour in fresh medium with 250 µg of 
gentamicin per ml, to kill the extracellular bacteria. Subsequently, the cells were washed 
thrice with Hanks balanced salt solution, and were then lysed using 0.1 % Triton X-100 
for 30 minutes at room temperature. Cell lysates were serially diluted and plated on MH 
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agar plates to enumerate the number of bacteria that invaded within the eukaryotic cells. 
The invasion efficiency was expressed as the percentage of inoculum recovered after 
gentamicin treatment, whereas the binding efficiency was expressed by subtracting the 
number of invaded bacteria from the number of bacteria recovered from cells not 
subjected to gentamicin treatment. The results shown for the binding and invasion assays 
represent the means of three independent experiments ± standard error. 
 
Construction of the C. jejuni tonB mutants 
Single tonB mutant construction 
Single tonB1, tonB2 and tonB3 mutants of C. jejuni NCTC 11168 were constructed using 
similar inactivation strategy. C. jejuni NCTC 11168 chromosomal DNA was prepared 
using the Wizard genomic kit (Invitrogen). The tonB1 gene was PCR amplified using the 
primers TonB11 and TonB12 (each primer containing a BglII site). The resulting 1623bp 
PCR product was digested with BglII, and ligated to the BamHI restricted suicidal vector 
pUC19, yielding pAS16. An inverse PCR was performed to delete 665bp within the 
tonB1 gene with TonB13 and TonB14 primers (each primer containing a BamHI 
restriction site). The PCR product was cut with BamHI, self ligated and introduced into 
E. coli DH5α, yielding the plasmid pAS20. A BamHI restricted 1.4 Kb Kmr cassette from 
pILL600 plasmid was then cloned into the previously BamHI restricted pAS20, yielding 
pAS23. The orientation of the Kmr cassette was confirmed by sequencing, to be in the 
same direction as the tonB1 gene and then transformed into C. jejuni NCTC 11168 by 
natural transformation to generate the tonB1 mutant by allelic exchange. The natural 
transformation was performed as follows: C. jejuni wild-type cells were grown in MH 
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biphasic medium to mid-log-phase. Lawns were made with 50 µl of the cultured             
C. jejuni cells on MH plates and allowed to grow at 37ºC in the microaerophilic 
workstation for 12 hours. Then 1-1.5 µg of final construct plasmid DNA was spotted on 
the lawns and were incubated for an additional 12 hours at 37ºC in the microaerophilic 
workstation to permit the natural transformation of the wild-type cells. Thereafter, the 
lawns were harvested with 200 µl of MH broth, resuspended and spread onto MH plates 
containing kanamycin (30µg/ml) for the selection of transformants. The plates were 
incubated for 3-5 days at 37ºC in the microaerophilic workstation to allow the growth of 
transformants. The transformants were further confirmed for antibiotic resistance by 
checking for growth on antibiotic containing plates. Subsequently, the chromosomal 
DNA was extracted from the mutant clones and checked by PCR for confirmation of 
homologous double recombination events using a combination of primers that amplified 
the Kmr and tonB genes. The tonB2 (AS240) and tonB3 (AS239) mutants were 
constructed following a similar strategy as the one that was used for constructing           
C. jejuni NCTC 11168 tonB1 mutant. Briefly, a 1668bp DNA fragment containing the 
tonB2 gene was amplified by PCR using primers TonB21 and TonB22 (each primer 
contains a BglII site). The PCR product was digested with BglII and subsequently cloned 
into BamHI restricted pUC19 to obtain the plasmid pAS17. A 510bp deletion was made 
within the tonB2 gene (yielding pAS24) by inverse PCR using the primers TonB23 and 
TonB24 (each primer contains a BamHI site). Subsequently the 0.8 Kb Cmr cassette from 
pRY111 was introduced into the created BamHI site of the tonB2 gene, yielding the final 
construction pAS176. The orientation of the Cmr cassette was confirmed by sequencing, 
to be in the same direction as the tonB2 gene and then transformed into C. jejuni NCTC 
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11168 by natural transformation to generate the tonB2 mutant by allelic exchange. The 
natural transformation was performed as described earlier and transformants were 
selected on MH plates containing chloramphenicol (20µg/ml). For the construction of the 
tonB3 mutant, a 1.6 Kb DNA fragment containing the tonB3 gene was obtained by PCR 
using the primers TonB31 and TonB32 (each primer contains a BglII site). This PCR 
product was digested with BglII and cloned into the BamHI restricted pUC19 vector, 
yielding pAS41. A 500bp deletion was created within the tonB3 gene by inverse PCR 
using the primers TonB33 and TonB34 (pAS42) (each primer contains a BamHI site). 
Finally, the 1.4 Kb Kmr cassette from pILL600 was introduced into the created BamHI 
site of the tonB3 gene, yielding the final construct pAS356. A similar strategy was 
adopted to make single mutants in the tonB genes from the non-sequenced clinical 
isolates of C. jejuni, C. jejuni ATCC 43431 (TGH 9011) and C. jejuni 81-176 using the 
final constructs described above. The single tonB2 mutants of C. jejuni TGH 9011 
(AS183) and C. jejuni 81-176 (AS252) were constructed using the final construct 
pAS176 and the single tonB3 mutant of C. jejuni TGH 9011 (AS235) was constructed  
using the final construct pAS356. The primers and plasmids used in these constructions 
are listed in Tables 1, 2 and 3. 
 
 
Double tonB mutant construction 
The double tonB mutants of C. jejuni NCTC 11168 ∆tonB1tonB2 (AS241), ∆tonB2tonB3 
(AS242) and ∆tonB1tonB3 (AS355) were constructed using the final constructs described 
above and pAS348. The pAS348 (pUC19 carrying ∆tonB1::Cmr) final construct was 
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created by cloning the BamHI restricted 0.8 Kb Cmr resistance gene into the previously 
BamHI restricted pAS20 (pUC19 carrying ∆tonB1).  The single tonB mutant strains were 
used as the recipient strains and were transformed using the final constructs by the similar 
allelic strategy. The double tonB mutant ∆tonB2tonB3 (AS356) of C. jejuni TGH 9011 
was constructed using the AS235 as the recipient strain and the pAS176 final construct 
by the same allelic exchange procedure. The primers and plasmids used in these 
constructions are listed in Tables 1, 2 and 3. 
 
55Fe3+-enterobactin uptake assay 
Mid-log-phase C. jejuni cells grown in iron-limited MEMα medium were pelleted and 
washed in 10 mM Tris buffer (pH 7.4). The cells were resuspended in the uptake buffer 
to an OD600= 0.6 (equivalent to 109 bacteria per ml) and kept on ice. The uptake buffer 
was composed of 5 g/L Na2HPO4, 5 g/L KH2PO4, 1.18 g/L NH4Cl, 0.089 g/L Na2SO4, 
0.042 g/L MgCl2.6H2O and 10 g/L casamino acids. Then, the resuspended cells were 
allowed to equilibrate at 37˚C for 10 minutes before performing the uptake assay. The 
55Fe3+-enterobactin complex used as the iron source was prepared as follows: 10 µl of    
10 mM enterobactin was added to 5 µl of 55FeCl3 (3.6 mM stock solution), followed by 
the addition of 182.18 µl water and 2.88 µl of FeCl3 (0.025 M) to form the complex. This 
complex was incubated at room temperature for 30 minutes, followed by the addition of 
100 µl of sodium phosphate buffer (0.5 M) and 700 µl of double distilled water to make 
the volume to 1000 µl. This final volume was centrifuged at 13000 rpm for 10 minutes 
and the supernatant was collected. 100 µl of the supernatant was taken and diluted with 
9.9 ml of the uptake buffer. This diluted 55Fe3+-enterobactin complex was filtered twice 
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using a 0.45 µm nitrocellulose millipore filter. One ml of the filtered diluted            
55Fe3+-enterobactin complex was added to 10 ml of C. jejuni cells (achieving final 
concentration of 0.018 µM). The uptake assay was performed using Millipore filtering 
assembly (Millipore Corporation, Ledford, MS). One ml aliquots were taken at  
0, 3, 6, 9 and 12 minutes after the addition of the ferric-enterobactin complex to the cells. 
The aliquots were passed through the 0.45 µm nitrocellulose millipore filter and vacuum 
filtered. Five ml of 0.1 M citric acid buffer was used to wash away the unlabeled complex 
and the filters were allowed to dry and were then immersed in 5 ml of the scintillation 
cocktail (Scintiverse, USA), vortexed and measured for the scintillation counts in the 
Beckmann LS5000 TD scintillation counter. Activity as counts per minute (CPM) were 
corrected for background. To demonstrate whether uptake was proton dependent, 33 µM 
of the protonophore carbonyl-cyanide-m-chlorphenyl hydrazone (CCCP) was added to 
the cells 3 minutes after uptake was initiated with another batch of cells.  
 
Bioassay 
The ability of the C. jejuni wild-type and mutant strains to utilize the different iron 
sources were tested on iron-limited assay plates as described previously (3, 10, 29). 
Briefly, the bacterial strains to be tested were grown to mid-log-phase in MH medium, 
harvested by centrifugation, and resuspended in MH medium to an OD of 1.0 at 600 nm. 
The cells (1 ml) were seeded into 25 ml of MH medium containing 20 µM DFO 
(desferriferrioxamine), poured into Petri plates and allowed to solidify. Sterile disc papers 
containing 10 µl of 10 mM enterobactin, hemin, hemoglobin and other iron siderophore 
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sources were laid on the surface of the plate and the zone of growth promotion was 
measured after 24 hours of incubation at 37˚C under microaerophilic conditions.  
 
Sequencing of tonB2 gene from C. jejuni 81-176 strains 
The tonB2 gene was PCR amplified from C. jejuni 81-176 strains using the primers 
TonB21 and TonB22 and high fidelity Pfx polymerase enzyme (Invitrogen). The PCR 
products were sequenced at the DNA core facility (Oklahoma State University) using 
primers TonB21 and TonB22. The sequences were compared to the tonB2 gene sequence 
from C. jejuni NCTC 11168 and were aligned using the Clustal W alignment software 
(Biology work bench, San Diego, CA).  
 
In vivo colonization studies 
Chick colonization assays 
The two kinds of chick colonization experiments were conducted: non-competitive and 
competitive colonization assays.  
 
Non-Competitive Chick colonization 
On arrival of the one day old specific pathogen free chicks (Tyson farms, Arkansas), 
cloacal swabs were taken to make sure that they were Campylobacter free. The chicks 
were housed at 25˚C, and a brooder maintained a temperature in the range of 33-35˚C. 
Commercial chicken starter diet and water were given ad libitum to the chicks. For 
challenge, C. jejuni wild-type and tonB mutant strains were grown under microaerophilic 
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conditions in an MH biphasic medium. Mid-log-phase bacteria were harvested and 
resuspended in PBS buffer. An inoculum of 0.25 ml of a bacterial suspension (which 
contained approximately 104 to 105 viable bacteria) was fed orally to each bird. The 
negative control was an uninoculated group of birds. Five birds per group were 
inoculated separately with the wild-type strain or mutant. The colonization potential was 
determined four days post challenge, as per standard procedures described previously 
(29). Following euthanasia, the ceca were collected; the contents were homogenized and 
examined for viable counts by plating on plates of Campylobacter agar base (Oxoid 
CM935) along with the Campylobacter selective Karmali antimicrobial supplements 
(Oxoid SR167E). Post incubation at 37˚C for 72 hours, the titer was determined and 
expressed as cfu per gram of ceca. Statistical analysis at 5% level of significance was 
done using the non-parametric Mann-Whitney Rank sum test.  
 
Competitive chick colonization 
The competitive colonization studies were done using five chicks per group. Each bird 
was inoculated with 0.5 ml of bacterial suspension containing a 1:1 mixture of wild-type 
and tonB mutant strains. Approximately 105 viable bacteria each, of the wild-type and of 
the mutant, were present in the mixed inoculum, which was confirmed by plating serial 
dilutions of the mixed culture on MH agar with and without kanamycin (30 µg/ml) and/or 
chloramphenicol (20 µg/ml). Four days post inoculation, the ceca were collected as 
described above. Homogenization of the cecal contents was followed by serial dilutions 
in PBS buffer, and plating on Campylobacter agar base (Oxoid CM935), enhanced with 
the Campylobacter selective Karmali supplement (Oxoid SR167E) and on Karmali agar 
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plate containing kanamycin (30 µg/ml) and/or chloramphenicol (20 µg/ml). The colonies 
were counted after the plates were incubated at 37˚C for 72 hours in a microaerophilic 
chamber. The mutant titer was obtained from the cfu recovered on Karmali agar based 
plates containing kanamycin and/or chloramphenicol, and the wild type bacterial titer was 
calculated by subtracting the number of mutants from the total number of bacteria 
recovered on Karmali agar plates without kanamycin and/or chloramphenicol. Finally, 
the in vivo competitive index, which corresponds to the ratio of output mutant to wild 
type bacteria recovered divided by the ratio of input mutant to wild type bacteria 
inoculated, was calculated for each bird. Statistical analysis of the data at a 5 % level of 
significance was done using a single sample Student t test.  
 
Piglet Colonization studies 
Colostrum-deprived neonatal piglets were acquired from the Oklahoma State University 
swine farm, Oklahoma. After farrowing, the piglets were wiped off with Betadine and 
transported to the Laboratory Animal Research facility, OSU, Oklahoma. The 
uninoculated control and the experimental piglets were housed in separate pens. 
Approximately 80-100 ml of protein-rich and antibody-free reconstituted commercial 
replacer milk ration (Sav-A-Calf, Wisconsin) was fed to the piglets, four times daily.  
Upon arrival, rectal swabs were taken to ensure that the piglets were Campylobacter free. 
Prior to challenge with the mixed inocula, milk feeding was withheld for 2 hours.           
C. jejuni wild-type NCTC 11168 strain and tonB mutants were grown in biphasic MH 
medium to mid-log-phase, after which, they were centrifuged and resuspended in Similac 
milk (commercial milk formula) to an OD600 of approximately 2.0 (corresponding to  
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~ 5 X 1010 CFU/ml). The mutant and wild-type strains were mixed in a 1:1 ratio (5 ml 
each). The mixed inocula were fed to two piglets orally. The bacterial counts in the 
mixed inocula was confirmed by plating serial dilutions on MH agar with and without 
kanamycin (30 µg/ml) or chloramphenicol (20 µg/ml) for single tonB mutants, and with 
and without kanamycin (30 µg/ml) and chloramphenicol (20 µg/ml) for double tonB 
mutants. Milk without any bacteria was fed to control piglets.  
 
Piglets were observed daily for clinical signs such as fecal consistency, diarrhea and 
general health. The presence of blood in the feces was determined by using EZ detection 
kit (Biomerica). Seventy two hours after inoculation, the piglets were anesthetized with 
0.25 ml/kg of ketamine (100 mg/ml) and 0.125 ml/kg of xylazine (20 mg/ml) 
(intramuscular), following which, they were euthanised with 0.25 ml/kg of Beuthenesia-
D (intracardiac). Following necropsy, the intestinal segments duodenum, jejunum, ileum, 
cecum and colon were recovered. Gross lesions were examined in the piglets inoculated 
with the wild type-strain alone. The contents and the mucous layer of the intestinal 
segments were collected and homogenized in 5 ml of PBS buffer. The bacteria recovered 
from each organ were serially diluted and plated on Campylobacter selective media with 
and without antibiotics as described previously in the chick competitive colonization 
assay.  The competitive index for each organ was computed as the ratio of the output 
mutant to the wild-type strain recovered divided by the ratio of the input mutant to the 
wild type-strain inoculated. A single sample Student t test was used to statistically 
analyze the data at a 5% level of significance. 
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Results and Discussion 
Construction of tonB mutants 
The genome sequence of C. jejuni NCTC 11168 reveals the presence of three tonB genes, 
tonB1, tonB2 and tonB3 (30). We hypothesize that the multiple TonB systems in C. jejuni 
have specific and redundant functions. Multiple TonB systems have been identified in 
other Gram-negative bacteria such as Vibrio cholerae, Vibrio anguillarium, 
Pseudomonas aeruginosa and Haemophilus influenzae (12, 24, 38, 39). 
In order to determine the role of the three TonB systems of C. jejuni in iron acquisition, 
we mutated the tonB1, tonB2, and tonB3 genes in C. jejuni NCTC 11168 by allelic 
exchange strategy. In order to study the role of TonB in cellular invasion and because the 
sequenced strain C. jejuni NCTC 11168 is poorly invasive (33), we attempted to mutate 
these genes in two other highly invasive clinical isolates, C. jejuni ATCC 43431 (TGH 
9011) and C. jejuni 81-176 (32, 33). Although these isolates have not been sequenced, 
they have been recently compared by genome-wide analysis with the C. jejuni NCTC 
11168 (9, 22, 33). Although all the three tonB genes were reported to be present in the  
C. jejuni TGH 9011 (which is also the Penner serotype 0:3 reference strain), we were 
unable to mutate tonB1 using the same suicide vector as the one constructed to knock-out 
the tonB1 gene of C. jejuni NCTC 11168. The C. jejuni 81-176 is a human isolate and has 
been documented to be a pathogenic, highly invasive strain (32, 33). We were successful 
in making a tonB2 mutant in C. jejuni 81-176. The inability to make tonB1 and tonB3 
mutants was in agreement with the findings of Leonard et al (22) who had demonstrated 
that in the C. jejuni 81-176 genome, the tonB1 and tonB3 genes were absent. In order to 
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elucidate the relative functions of these tonB genes in C. jejuni, we also constructed the 
double mutants of tonBs. Figure 1A and 1B are representative PCR confirmation of the 
mutant constructions. Attempts to construct a triple tonB mutant lacking all the three 
known TonB systems were not successful with the available genetic tools, thus impairing 
the complete characterization of the TonB systems. Nevertheless, the construction of all 
the possible series of single and double TonB knock-outs allowed the characterization of 
their roles in iron acquisition and colonization of the gastrointestinal tract of the host.  
 
Growth characteristics of tonB mutants in vitro 
In order to determine whether the C. jejuni tonB mutants were affected in their ability to 
grow in vitro, we assessed the growth of the wild-type C. jejuni strain and tonB mutants 
in MH medium and in MEMα with or without 40 µM FeSO4. Growth in MH medium 
was tested for all the three C. jejuni isolates and their corresponding tonB mutants. There 
was no statistically significant difference in the growth rate of the wild type and the tonB 
mutants of C. jejuni NCTC 11168 (Figure 2 A, B), C. jejuni TGH 9011 (Figure 3A) or  
C. jejuni 81-176 (Figure 3B). The MH medium is not an iron free medium and the exact 
amount of iron in MH medium is not known, so, the growth studies with MH medium 
represent the phenotype of the wild-type and tonB mutants in iron containing medium.  
Further, we examined the in vitro growth of C. jejuni NCTC 11168 wild-type strain and 
its tonB mutants in iron defined medium (Figure 4A, 4B). The growth rate of the  
wild-type and tonB mutants were compared in the absence and presence of iron. There 
was a significant increase (p< 0.05) in the growth rate in the presence of iron as 
compared to the growth rate in the absence of iron for the wild type strain as well as the 
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mutants. These results indicate that the tonB mutant and the wild type strains exhibited a 
slower growth rate in iron limited medium. Similar results were observed by Field et al 
(10). We further compared the difference in the growth rates of the wild-type strain with 
the tonB mutants in the presence and absence of iron. At a 5% level of significance, there 
was a significant difference (p<0.05) in the growth rate of the wild-type strain with its 
tonB mutants. Also as expected, there was a significant difference in the growth rates of 
the wild-type strain, the tonB2tonB3 double mutant (p<0.04) and the tonB1tonB3 double 
mutants (p<0.03). The tonB3 single mutant and the two double mutants, tonB2tonB3 and 
tonB1tonB3, grew at a significantly slower rate than the wild-type strain. This data 
indicates that the tonB3 mutants were significantly affected in the growth rates as 
compared to the wild type strain when grown in the iron limited medium. Therefore, this 
in vitro growth defect suggests that the presence and absence of iron in the growth 
medium influences the growth pattern of the C. jejuni strains and that the tonB genes are 
likely to be iron regulated.  
 
The tonB mutants are not affected in binding and invasion of INT-407 cells 
 In order to determine the effect of the tonB mutation on binding and invasion of the  
INT-407 eukaryotic cells, we performed binding and invasion assays with all three  
C. jejuni isolates, which have been well characterized for their invasion ability.  
C. jejuni NCTC 11168 is a poor invader of INT-407 cells, whereas C. jejuni TGH 9011 
and C. jejuni 81-176 are highly invasive isolates. The ability of C. jejuni  to invade and 
survive within the eukaryotic cell has been shown to be a virulence determinant (7, 31). 
The intracellular growth within epithelial cells has been shown to be essential for 
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virulence in the Gram-negative bacterium S. typhi (23). Table 4 shows that none of the 
tonB mutants were significantly affected (p>0.05) in their binding and invasion 
efficiencies. In this study, we did not determine if the TonBs played a role in intracellular 
survival. It has been shown in Salmonella enterica serovar typhi, that the growth of the 
tonB mutant in the human monocyte cells was significantly restricted compared to the 
wild-type strain (12). A similar study with Shigella dysenteriae tonB mutant had 
demonstrated that invasion efficiency of the mutant was not affected, however, the 
intracellular survival and spread was significantly affected (36). Therefore, intracellular 
survival experiments with C. jejuni tonB mutants might shed light on the role on TonBs 
in the survival within the host cells.  
 
The tonB mutants were affected in utilization of iron sources in growth 
promotion assays 
In order to determine whether tonB mutants were defective in their ability to utilize 
siderophores and other iron compounds, we performed growth promotion assays 
(bioassays) as described in the materials and methods section. C. jejuni is known to 
colonize the enteric environments of its hosts (19) and, to survive inside the epithelial 
cells (31) and the macrophages (7). This facultative intracellular pathogen therefore has 
access to different potential sources of iron, although the exact sources which C. jejuni 
utilizes in the different environments is not clearly known. Whole C. jejuni NCTC 11168 
genome does not contain any siderophore biosynthesis genes (30), however, it does 
possess the machinery for enterobactin uptake. Enterobactin is a powerful tris-catecholate 
siderophore synthesized by E. coli (8).  It has been demonstrated that C. jejuni can utilize 
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the ferric-enterobactin complex for its growth and iron transport (29). We have also 
tested the tonB mutants for their ability to utilize another catecholate, lysine 
catecholamide (lysine CAM). The lysine CAM is structurally related to enterobactin such 
that it is a tetradentate chelator while enterobactin is a hexadentate chelator. Therefore, 
the lysine CAM provides four chelating atoms to coordinate iron, whereas the 
enterobactin provides six chelating atoms to fully coordinate the iron. Lysine CAM has 
been reported to be synthesized by Azotabacter vinelandii (20). The probable intracellular 
iron sources, hemin and hemoglobin were also screened for utilization by the tonB 
mutants. Therefore, in order to identify whether the multiple TonB systems in C. jejuni 
have any substrate specificity and whether they exhibit any redundancy in iron utilization 
from different sources, we studied their growth promotion ability. As seen in Tables 5 
and 6, the single tonB3 mutant of C. jejuni NCTC 11168 was defective in utilization of 
enterobactin, whereas the single tonB1 and tonB2 mutants were not affected. As 
expected, the double mutants of tonB3, tonB2tonB3 and tonB1tonB3 mutants also 
exhibited the same phenotype as the tonB3 single mutant. Similar phenotype was 
observed with the lysine CAM siderophore utilization by C. jejuni NCTC 11168 tonB 
mutants.  
The C. jejuni TGH 9011 and C. jejuni 81-176 wild-type strains were unable to utilize 
enterobactin (Table 6). The C. jejuni 81-176 was able to utilize lysine CAM siderophore, 
whereas C. jejuni TGH 9011 was found to be deficient in the utilization of lysine CAM 
siderophore. The tonB2 mutant of C. jejuni 81-176 was significantly defective in the 
transport of lysine CAM. Earlier, Guerry et al had shown in Campylobacter coli that the 
hemoglobin and hemin uptake was TonB-dependent (13). The utilization of hemin and 
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hemoglobin by C. jejuni was suggested to be mediated through the chuABCD transport 
system (37). Pickett et al reported that C. jejuni 81-176 utilized hemin and hemoglobin 
(32). Based on our bioassay data, the single tonB2 and tonB3 mutants of C. jejuni NCTC 
11168 were unaffected in the utilization of hemoglobin and hemin, whereas a double 
tonB2tonB3 mutant was completely defective in hemin and hemoglobin transports. This 
is the first report in which the uptake of hemin and hemoglobin in C. jejuni has been 
experimentally demonstrated to be TonB dependent. The tonB2 mutant of C. jejuni 81-
176 was found to be defective in utilization of hemin and hemoglobin. Based on the 
Leonard et al study, the C. jejuni 81-176 genome has only a single tonB2 gene (22). 
Therefore, as expected, the tonB2 gene of C. jejuni 81-176 appears to mediate the 
transport of all the iron sources tested and is likely to be the only functional tonB gene in 
this isolate.  
These data indicate that TonBs in C. jejuni have specific and redundant functions. The 
tonB3 mutant, based on our bioassay result, is required specifically for enterobactin, 
whereas the TonB2 and TonB3 together transport hemin and hemoglobin. Specificity and 
redundancy in function of TonBs phenotypes has also been demonstrated in V. cholerae 
(38). In Vibrio cholerae, both the TonBs are involved in hemin transport whereas TonB2 
specifically mediates schizokinen siderophore transport.  
We had also tested the ability of the wild-type C. jejuni isolates to utilize siderophores 
and iron sources such as cepabactin, aerobactin, ferrichrome, rhodotuloric acid, 
transferrin and lactoferrin. None of these sources were utilized by any of the wild types of 
C. jejuni.  
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55Fe3+-enterobactin uptake assays 
Transport of ferric-siderophores through outer membrane is proton dependent 
The active transport of iron against its concentration gradient has been shown to be 
dependent on the proton motive force as well as ATP. This has been demonstrated in     
E. coli and other Gram-negative bacteria, but has not been experimentally proven in      
C. jejuni (1, 5, 6, 26). In order to test the proton dependency for ferric-siderophore uptake 
in C. jejuni, we used the protonophore carbonyl-cyanide-m-chlorphenyl hydrazone 
(CCCP). Enterobactin mediated iron uptake was monitored following treatment of the 
cells with CCCP. As shown in Figure 5A, in contrast to untreated cells, the CCCP treated 
cells were not able to transport ferric-enterobactin complex (0.018µM final 
concentration). 
 
The tonB mutants were significantly affected in ferric-enterobactin uptake 
In order to determine if the tonB mutants were defective in ferric-enterobactin uptake, we 
performed 55Fe3+-enterobactin uptake assay and compared the uptake efficiencies of the 
C. jejuni NCTC 11168 wild-type strain and its tonB mutants. Cells grown in iron limited 
medium (MEMα), approximately 108 cells/ml were assessed over a 12 minute time-
course following the addition of 55Fe3+-enterobactin complex (0.018 µM final 
concentration of radiolabeled ferric-enterobactin). The uptake of the wild-type cells was 
compared with the uptake measured in the tonB mutant cells and was statistically 
analyzed by Student t test at a 5% level of significance. As shown in the Figure 5B and 
5C, there was a statistically significant difference (p<0.05) in the ferric-enterobactin 
uptake for several of the single and double tonB mutants (except the tonB2 mutant). 
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These data suggests the contribution of mainly the TonB1 and TonB3 towards the uptake 
of ferric-enterobactin in a short time course experiment. Both the ferric-enterobactin 
assay and the bioassay revealed similar findings. It is evident that while tonB1 mutant is 
affected in its iron uptake kinetics, the expression of tonB3 gene will permit the 
utilization of enterobactin for growth in iron restricted medium. 
Notably, the bioassay and uptake assays confirmed the involvement of TonB3 in the 
utilization of enterobactin. The partial ferric-enterobactin uptake observed in the tonB3 
mutant corresponded to the uptake seen in CCCP treated cells (Figures 5A, 5B), which   
therefore represents the binding of enterobactin to the outer membrane receptor, and not 
actual transport. Binding of iron-free siderophores has been shown to be a common 
feature of siderophore outer membrane transporters of Pseudomonas aeruginosa and     
E. coli (15). As expected, in addition to the TonB1 and TonB3 single mutants being 
affected in uptake, the combination of double tonB mutants were more severely affected 
in the transport of enterobactin in both the experiments.  
 
TonB2 sequence analysis 
In order to determine whether the differential phenotype observed with tonB2 mutants 
amongst the C. jejuni isolates was due to any differences in the protein at the amino acid 
level we sequenced the tonB2 gene from C. jejuni 81-176. The multiple sequence 
alignment by Clustal W revealed that the amino acid sequences of C. jejuni NCTC 11168 
TonB2 and C. jejuni 81-176 TonB2 are almost identical and/or conserved except at three 
positions (Figure 6). Interestingly, two out of these three positions involved substitution 
of threonine (polar) residue at positions 93 and 224 by isoleucine (hydrophobic  
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non-polar) residue. The third change identified was the substitution of isoleucine at 
position 184 by serine (polar) residue. These substitutions might have an effect on the 
three-dimensional structure of the protein. We also observed that arginine residue at 
position 199 was conserved in TonB2 and TonB3 of C. jejuni NCTC, and TonB2 of                   
C. jejuni 81-176. This conservation of arginine residue might have implications on the 
interaction with the TonB dependent outer membrane receptors.  
 
Animal Models 
The tonB mutants are significantly affected in their ability to colonize the ceca of 
birds 
In order to determine the potential benefits that C. jejuni wild-type strains have by 
possessing the multiple TonB systems, we assessed their role by non-competitive and 
competitive colonization of the chicken ceca. The chick model is an established and well 
characterized model for the assessment of the colonization potential of C. jejuni (11, 27, 
29). C. jejuni colonizes the intestinal tract of chicks as a commensal (14).  
 
Non-competitive cecal colonization 
The colonization ability of the tonB mutants and the wild-type C. jejuni NCTC 11168 
strain were assessed by orally challenging five birds per group separately with 
approximately 104 viable bacteria. Four days post inoculation, the birds were sacrificed 
and the ceca were recovered. The cecal contents checked for the wild-type strain and the 
tonB mutants recovery titer as described in the materials and methods. At a 5% level of 
significance (Non-Parametric Mann-Whitney Rank Sum test), all the tonB mutants were 
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found to be significantly affected in colonization as compared to the wild-type strain 
except the tonB2 mutant (p=0.095), which was found to be not affected in colonization 
(Figure 7). The single tonB1 mutant and the single tonB3 mutant as well as all the double 
tonB mutants were significantly reduced in their colonization of the ceca. These results 
indicate that tonB1 and tonB3 are essential for cecal colonization of C. jejuni. The level 
of colonization indicated the double mutants to be severely affected than the single 
mutants. The recovery of tonB1tonB3 double mutant was below the detection limit of 100 
cfu/gram ceca. 
 
Competitive cecal colonization 
The ability of the tonB mutants to colonize the chicken ceca was further tested in 
competition with the wild-type C. jejuni NCTC 11168 strain. The birds were inoculated 
with a 1:1 mixture of the wild-type strain and the individual tonB mutants. Five birds per 
group were tested for the colonization potential of the mutant and the wild-type strain. 
The experiment was performed as described in materials and methods section. The 1:1 
ratio of the mixed inoculum was confirmed by the determination of cfu. Ninety-six hours 
post challenge, the ceca were recovered and the contents were then plated on selective 
media with and without kanamycin or chloramphenicol antibiotics. The bacterial titer of 
the wild-type and mutant strains was recorded and the competitive index for each bird 
was calculated as the ratio of the mutant to the wild-type recovered. The competitive 
indices of each mutant group were compared by Student t test at a 5% level of 
significance. As shown in Figure 8,  with the exception of the single tonB2 mutants, all 
the other single and double tonB mutants were significantly affected in their ability to 
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colonize the gastrointestinal tract of birds (p<0.0001). These results corroborated the 
findings of the non-competitive chick colonization assays. The double mutants were 
severely attenuated followed by the tonB3 and tonB1 single mutants.  
This in vivo phenotype of tonB mutants reflected the iron limited environment of the 
chicken ceca. The growth characteristics of the tonB mutants in vitro was observed to be 
not significantly different (p>0.05) than the wild-type strain (Figure 2). Therefore, the 
inability of the mutants to grow in vivo is indicative of a significant in vivo specific 
defect. 
 
Colostrum-deprived neonatal piglets colonization model 
To determine whether the tonB mutants were defective in their ability to colonize the 
intestine of colostrum-deprived neonatal piglets, competitive colonization assays were 
performed. The use of colostrum-deprived neonatal piglets has been documented to be a 
relevant in vivo model for human Campylobacteriosis (2).  Babakhani et.al reported the 
induction of diarrhea in experimentally infected piglets, which was characterized by the 
presence of mucus and blood mimicking the signs of human Campylobacter infection. 
Moreover, the gastrointestinal tract of piglets is very similar to the human gastrointestinal 
tract (27). Also, the neonatal piglet model has been established and used for the screening 
of other iron acquisition mutants of C. jejuni strains (Stintzi unpublished data).  
C. jejuni NCTC 11168 wild-type strain and its tonB mutants were tested for their ability 
to colonize the intestinal tract of colostrum-deprived neonatal piglets by competitive 
colonization assays as described in the materials and methods section. Two piglets were 
tested for competitive colonization of each tonB mutant and the wild-type strain. Each 
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piglet was orally challenged with 1:1 mixed inocula containing the wild-type strain and 
each tonB mutant. The mixed inocula ratio was confirmed to be 1:1 by cfu determination. 
Seventy-two hours post challenge, the piglets were euthanized and the intestinal segments 
were collected. The contents of the intestinal segments were plated on selective media 
and the bacterial titers of the wild-type strain and the tonB mutants were determined. 
Then the competitive index was calculated for each piglet. The competitive colonization 
potential was determined for all the single and double tonB mutants and analyzed at a 5% 
level of significance by Student t test. The competitive index was tested for each group, 
for each piglet and was also tested organ-wise. The bacterial recovery was checked in the 
duodenum, jejunum, ileum, cecum and colon and the competitive index was determined. 
All the three single tonB mutants were significantly affected (p<0.0001) in their 
colonization potential as compared to the wild type strain (Figure 9 A, B, C). Since the 
wild type strain was recovered from all the intestinal segments, this data suggests that    
C. jejuni colonizes all the intestinal segments. As expected, the double tonB mutants were 
more severely affected in their colonization levels than the single tonB mutants 
(p<0.00001) (Figure 9 D, E, F). Our study demonstrated that the colonization potential of 
the single tonB mutants was significantly (though not severely) attenuated, which is 
likely due to the functional compensation by the other TonBs. The mutations in the two 
TonBs of the same C. jejuni strain further decreased the iron acquisition ability as 
compared to the single tonB mutants and therefore severely affected the colonization 
potential.  
In contrast to the chick colonization data, the tonB2 mutant was found to be significantly 
defective in the colonization of the piglet model. This differential phenotype in the 
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colonization potentials of the tonB2 mutant in the two animal models studied highlights 
the importance of assessing the mutants in multiple relevant animal models for thorough 
characterization of the function of a gene or protein. The differential phenotype exhibited 
by the tonB2 mutant suggests the expression of the TonB systems to be likely a host 
specific effect. Furthermore, different TonBs might play a different role in the 
colonization of the gastrointestinal tract of the host.  
Our in vivo results are similar to the in vivo phenotypes observed with the 
characterization of TonB transport systems in several other Gram-negative bacteria. For 
instance, in V. cholerae each of the tonB mutants had a moderate reduction in the 
competitive colonization with the wild-type strain, indicative of a role of each TonB 
system in vivo (25, 38). In Salmonella enterica serovar typhimurium, its tonB mutant was 
significantly attenuated in the infection of mice by intragastric route, but not via 
intraperitoneal route of infection (41). Pseudomonas aeruginosa tonB mutant was 
defective in experimental infection of immunocompromised mice (40). In  
Haemophilus influenzae type b, the tonB mutant was defective in infection of rats by 
intraperitoneal and intanasal route of infection (18). These reports indicate that the role of 
TonB dependent bacterial infection varies depending on the site of infection. Recently, it 
has been shown in V. anguillarium that only one of the TonBs is essential for virulence 
(39).  Our data demonstrated the additive and functionally redundant roles of C. jejuni 
TonBs in iron acquisition within the gastrointestinal tract of the host. Nevertheless, 
complete loss of TonB function cannot be confirmed due to lack of a triple tonB mutant 
in this study.  
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Concluding remarks 
From this study we can conclude that the TonB proteins are essential for the utilization of 
siderophores, heme compounds and other iron sources by C. jejuni and that the transport 
of the compounds across the outer membrane is proton dependent. The multiple TonBs in 
C. jejuni served specific and redundant functions in the transport of various iron sources. 
The outcome of growth promotion assays and uptake experiments suggests that all   
C. jejuni isolates exhibit a characteristic pattern in the utilization of iron from different 
sources. This is likely related to the presence or absence of functional multiple TonB 
system(s). The in vivo colonization experiments with the commensal chicken model and 
pathogenicity testing neonatal piglet model clearly demonstrated the significant 
contribution of TonBs in the colonization of the gastrointestinal tract by C. jejuni. 
Reduced colonization of the tonB mutants due to the inactivation of tonB genes might 
also affect other mechanisms besides iron acquisition pertaining to growth and infectivity 
of C. jejuni in vivo. It is evident in E. coli that TonB functions for Vitamin B12 uptake in 
addition to ferric iron acquisition (4). Exploring the possible functions of TonBs in        
C. jejuni might further contribute in better understanding of the role of TonBs in 
colonization and pathogenesis. 
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Table 1: Bacterial plasmids used in this study 
 
Strain Relevant characteristic(s)  a Source or reference 
pUC19 cloning and suicidal vector, Biolabs 
pAS16 pUC19 carrying tonB1 This study 
pAS20 pUC19 carrying ∆tonB1 This study 
pAS23 pUC19 carrying ∆tonB1:: Kmr This study 
pAS17 pUC19 carrying tonB2 This study 
pAS24 pUC19 carrying ∆tonB2 This study 
pAS176 pUC19 carrying ∆tonB2::Cmr This study 
pAS41 pUC19 carrying tonB3 This study 
pAS42 pUC19 carrying ∆tonB3 This study 
pAS356 pUC19 carrying ∆tonB3::Kmr This study 
pAS348 pUC19 carrying ∆tonB1:Cmr This study 
pRY111 Cmr resistance gene Guerry  
pILL600 Kmr resistance gene Labigne  
 
a
   Ampr , ampicillin resistant 
    Cmr , chloramphenicol resistance gene 
    Kmr , kanamycin resistance gene 
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Table 2: Bacterial strains used in this study 
Strain Relevant characteristic(s) Source or reference 
E. coli DH5α endA1 hsdR17(rK-m K-)supE44 Invitrogen 
C. jejuni strains   
AS144 C. jejuni NCTC 11168 NCTC 
AS27 AS144∆tonB1 This study 
AS240 AS144∆tonB2 This study 
AS239  AS144∆tonB3 This study 
AS241 AS144∆tonB1∆tonB2 This study 
AS242 AS144∆tonB2∆tonB3 This study 
AS355 AS144∆tonB1∆tonB3 This study 
AS53 C. jejuni ATCC 43431 (TGH ATCC 
AS183 AS53∆tonB2 This study 
AS235 AS53∆tonB3 This study 
AS356 AS53∆tonB2∆tonB3 This study 
AS275 C. jejuni 81-176 Pickett 
AS252 AS275∆tonB2 This study 
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Table 3: Primers used in this study 
Primer DNA sequence from 5’ to 3’ (restriction site) a 
TonB11 GGAAGATCTGCACCATTTAGATGAGCTTGC (BglII) 
TonB12 GGAAGATCTCACTTGCTGAATAATTTGGCT (BglII) 
TonB13 CGCGGATCCCAATATCAAACTTAACACAAACC 
TonB14 CGCGGATCCGTTATGCCTATTGATTACAAT (BamHI) 
TonB21 GGAAGATCTCGGGCAATATAGATGTCAAATC 
TonB22 GGAAGATCTTCTGATGATGCAAATATAGAAG 
TonB23 CGCGCATCCTATATAAGAAGCTTGGTATTTATG 
TonB24 CGCGGATCCCCACACTATAATGGAGATTTAG 
TonB31 GGAAGATCTTGACTTGCTAGCAGTTGAAGAT 
TonB32 GGCAGATCTCATTGATAGTAGCAGGAGCTTC 
TonB33 GCCGGATCCACTATACGCATAGCTTCTAAA 
TonB34 CGCGGATCCTCCACATTTTTGTTTATTTCACTA 
 
a
 The restriction sites used for cloning are underlined and correspondingly shown in 
parenthesis 
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Table 4: Binding and invasion assays with INT-407 cells 
 % Bindinga % Invasionb 
C. jejuni NCTC 11168 
  
Wild type 0.0067 ± 0.00083 0.00032 ± 0.000078 
∆tonB1 0.0043 ± 0.00062 0.00036 ± 0.00006 
∆tonB2 0.0053 ± 0.00082 0.00041 ± 0.000099 
∆tonB3 0.0048 ± 0.00085 0.00063 ± 0.00005 
∆tonB1B2 0.0057 ± 0.00092 0.0004 ± 0.000062 
∆tonB2B3 0.0059 ± 0.00075 0.00043 ± 0.000044 
∆tonB1B3 0.00553 ± 0.00064 0.0003 ± 0.000062 
C. jejuni TGH 9011   
Wild type 1.37 ± 0.087 0.37 ± 0.039 
∆tonB2 1.49 ± 0.11 0.36 ± 0.051 
∆tonB3 1.74 ± 0.61 0.63 ± 0.041 
∆tonB2B3 1.57 ± 0.075 0.57 ± 0.062 
C. jejuni 81-176   
Wild type 1.42 ± 0.061 0.61 ± 0.11 
∆tonB2 1.42 ± 0.1 0.47 ± 0.05 
a obtained by subtracting the number of invaded bacteria from the total number of 
bacteria recovered without gentamicin treatment 
b
 percentage of inoculum recovered after gentamicin treatment 
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Table 5: Bioassay for C. jejuni NCTC 11168 (zone of growth measured as diameter 
in mm) 
 FeSO4 Enterobactin Hemin Hemoglobin 
Wild type 14.75 ± 1.31 26 ± 1.91 25.25 ± 1.18 16 ± 1.68 
∆tonB1 15.25 ± 1.44 25.25 ± 1.65 21.75 ± 1.93 17.25 ± 1.80 
∆tonB2 15.25 ± 1.25 26 ± 1.35 21 ± 1 15.75 ± 1.75 
∆tonB3 15.25 ± 1.25 0 22.75 ± 1.11 16.25 ± 1.25 
∆tonB1B2 16 ± 1.63 24.25 ± 1.65 19.25 ± 1.11 13.5 ± 0.96 
∆tonB2B3 12.25 ± 0.63 0 0 0 
∆tonB1B3 16 ± 1.35 0 23 ± 1.47 16.25 ± 1.65 
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Table 6: C. jejuni bioassay results  
 FeSO4 Enterobactin Hemin Hemoglobin Lysine CAM 
C. jejuni NCTC 11168      
Wild type + + + + + 
∆tonB1 + + + + + 
∆tonB2 + + + + + 
∆tonB3 + _ + + _ 
∆tonB1B2 + + + + + 
∆tonB2B3 + _ _ _ _ 
∆tonB1B3 + _ + + _ 
C. jejuni TGH 9011      
Wild type + _ + + _ 
∆tonB2 + _ + + _ 
∆tonB3 + _ _ _ _ 
∆tonB2B3 + _ _ _ _ 
C. jejuni 81-176      
Wild type + _ + + + 
∆tonB2 + _ _ _ _ 
+, positive, forming a zone of growth around the iron source  
-, negative, no zone of growth around the iron source 
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Figure 1: Gel pictures of the wild type C. jejuni NCTC 11168 genes and the double 
tonB mutant. A) 0.9% agarose gel picture of PCR product obtained with the wild type 
C. jejuni NCTC 11168. tonB1 (lane 2), tonB2 (lane 3), tonB3 (lane 4) and standard     
1 Kb DNA ladder (lane 1). The approximate sizes of tonB1, tonB2 and tonB3 PCR 
products are 1623 bp, 1668 bp and 1600 bp respectively.  
B) 0.9% agarose gel picture of the PCR products obtained with the double 
tonB2tonB3 mutants of C. jejuni NCTC 11168. tonB1 (lane 2), ∆tonB2 (lane 3), 
∆tonB3 (lane 4) and the standard 1 Kb DNA ladder (lane 1).  
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A) 
 
 
 
B) 
 
1 2 3 4 
1 2 3 4 
 192 
Figure 2: Comparative growth of C. jejuni NCTC 11168 wild type and tonB mutants in 
MH biphasic medium. The data represents the mean of three independent experiments 
± standard error. A) Single tonB mutants. B) Double tonB mutants.
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Figure 3: Comparative growth of C. jejuni TGH 9011 and C. jejuni 81-176 wild type 
and tonB mutants in MH biphasic medium. The data represents the mean of three 
independent experiments ± standard error. A) C. jejuni TGH growth curves.                
B) C. jejuni 81-176 growth curves. 
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Figure 3: 
A) 
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Figure 4: Comparative growth of C. jejuni NCTC 11168 wild type and tonB mutants 
in MEMα medium. C. jejuni strains were grown overnight in MH biphasic medium, 
harvested, washed and resuspended in MEMα before inoculating into fresh iron 
restricted MEMα (A) or MEMα supplemented with 40 µM FeSO4 (B). The data 
represents the mean OD600 per ml measured at 24 hours (early stationary phase) 
from three independent experiments ± standard error. 
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Figure 4: 
A) 
 
 B) 
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Figure 5: Ferric-enterobactin uptake assay. C. jejuni NCTC 11168 strain was grown 
over night in iron limited MEMα medium, and harvested at mid-log phase for ferric-
enterobactin (final concentration 0.018 µM) uptake experiment. Uptake was monitored 
for 12 minutes following the addition of the 55Fe3+-enterobactin complex.                    
A) Enterobactin mediated iron transport in C. jejuni NCTC 11168 strain in presence or 
absence of the proton ionophore, CCCP at 33µM. B) Comparative uptake of the single 
tonB mutants and the wild type C. jejuni NCTC 11168 strain. C) Comparative uptake 
of the double tonB mutants and the wild type C. jejuni NCTC 11168 strain. 
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Figure 5: 
A) 
 
B) 
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Figure 6: Clustal W Alignment of TonB sequences of C. jejuni. Multiple sequence 
alignment of TonB1, TonB2 and TonB3 amino acid sequences from C. jejuni NCTC 
11168 and TonB2 from C. jejuni 81-176. Single, fully conserved residues are indicated 
by an asterisk, conservation of strong groups are indicated by a colon, conservation of 
weak groups are indicated by a dot and no markings below the alignment indicate non 
conserved residues. The numbers flanking the sequences refer to the last amino acids in 
the sequence. The arginine residue at position 199 is highlighted in red color and is 
underlined.  
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Figure 6: 
 
81176           MKTLFLNHKYQASYITFIVFIPLLFVIFHSNDFFKMEIK---NEDSFSLAIKQFTQTNP- 56 
tonB2NCTC       MKTLFLNHKYQASYITFIVFIPLLFVIFHSNDFFKMEIK---NEDSFSLAIKQFTQTNP- 56 
tonB3NCTC       MKTFISNHKNQSSFITLFVFTPLFFVFLYSKDFLHIQPNETIKENKFNMAIKHFVQNSSD 60 
tonB1NCTC       MKSSVIFGFVLSLILHTLVLMFFLFSFYTQEKSSGVDFKQGAEFTSIMMVSEFPIGELKE 60 
                **: .      :  :  :*:  ::* :  .:.   :: :   :  .: :. :         
 
81176           TNETKPTESIIEPIKPKPQPKVIKKTPEKIQKKVKKIPPHPIPN--KTPIAPTQEVKTFA 114 
tonB2NCTC       TNETKPTESIIEPIKPKPQPKVIKKTPEKMQKKIKKTPPHPIPN--KTPIAPTQEVKTFA 114 
tonB3NCTC       MKPTQPTQTIQEPSNVQP------KEPVQEIKKIKPRKEKPIAK--PKKIIPPANAKAIS 112 
tonB1NCTC       VSIDQKKSNSQDKNKKQDERISFNSQDKNAVLKVQKKIEKQDENQAQKEIANASENSKFK 120 
                 .  : ...  :  : :       .   :   *::    :   :   . *  . : . :  
 
81176           KTT-DTNVKPKITQLTQGK------DNHPVLKEIQKAIQQAQFYPRQAKKMRMQGTVKVE 167 
tonB2NCTC       KTT-DTNVKPKITQLTQGK------DNHPVLKEIQKAIQQAQFYPRQAKKMRMQGTVKVE 167 
tonB3NCTC       QPKKDTNMQQQTPQASSYQS-VSLTSNSELLKEIKSAIDEALIYPRQARKMRMSGEVLVE 171 
tonB1NCTC       NESLSAPLQSNKDKTQTIVSGNAKEQVKSYQALLMAHLTKFKKYPQEAIMQKQEGVVRIR 180 
                : . .: :: :  :           .       :   : :   **::*   : .* * :. 
 
81176           FLWKENKTLADLKIIESSGYDLLDKSALESIRKAS------LNFPHYNGDLRITLPIIYD 221 
tonB2NCTC       FLWKENKTLADLKIIEISGYDLLDKSALESIRKAS------LNFPHYNGDLRITLPIIYD 221 
tonB3NCTC       FTWTKEKKLENLKILKPSKYDFLNKSALETIRIAS------KKFPQYEKTFHIKIPLVYK 225 
tonB1NCTC       VSIDESGNVLSKELKKSCPYAALNDEALSLFKRASPLPKPPKEMLKNGDKISFVMPIDYN 240 
                .   :. .: . :: : . *  *:..**. :: **       :: :    : : :*: *. 
 
81176           FKILR--- 226 
tonB2NCTC       FKTLRG-- 227 
tonB3NCTC       LS------ 227 
tonB1NCTC       IKDYLGKK 248 
                :.       
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Figure 7: Non competitive chick colonization assay with tonB mutants of C. jejuni 
NCTC 11168. Comparative colonization properties were tested in the wild-type strain 
and the tonB mutants of C. jejuni NCTC 11168. Five birds per group were orally 
challenged with 104 cfu. The minimum detection limit of this assay was 100 cfu per gram 
of ceca. The columns represent the means and the error bars indicate the standard errors. 
Non parametric Mann-Whitney Rank Sum test was used for statistical analysis. * 
indicates statistically significant difference at p<0.0001 for the single mutants and 
p<0.00001 for the double mutants. 
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Figure 7: 
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Figure 8: Competitive chicken colonization studies with the tonB mutants of C. jejuni 
NCTC 11168. A 1:1 mixed inocula of the wild-type strain and ∆tonB strains were 
orally inoculated into five birds. The in vivo competitive index is the ratio of the output 
mutant to the wild-type strain recovered divided by the ratio of the input mutant to the 
wild-type strain inoculated. The minimum detection limit of this assay was 100 cfu per 
gram of ceca. The data represents the mean ± standard errors. * indicates a statistical 
significance of p<0.0001. 
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Figure 8: 
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Figure 9: Colostrum-deprived neonatal piglet competitive colonization assay. The 
competitive colonization ability of the wild-type C. jejuni NCTC 11168 strains and its 
tonB mutants were assessed. Two piglets were orally challenged with a 1:1 mixed 
inocula of the wild-type strain and the tonB mutant. 72 hours post inoculation, the pigs 
were euthanized and the intestinal segments, duodenum, jejunum, ileum, cecum and 
colon were collected. The intestinal contents were checked for the wild-type strain and 
the tonB mutant titers. The CI was calculated as the ratio of the output mutant to the 
wild-type strain recovered divided by the ratio of the input mutant to the wild-type 
strain inoculated. The minimum detection limit of this assay was 100 cfu per gram of 
intestine.  The data represents the mean ± the range of the values. This figure shows the 
CI for the mutants tonB1 (A), ∆tonB2 (B), ∆tonB3 (C), ∆tonB1B2 (D), ∆tonB2B3 (E) 
and ∆tonB1B3 (F). * indicates a statistical significance with a p<0.0001. 
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Figure 9: 
A) 
 
B) 
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C) 
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E) 
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Chapter V 
 
 
Conclusion 
 
The global aim of this project was to decipher the molecular mechanisms of iron 
acquisition in the food-borne pathogen, C. jejuni, since acquisition of iron has been 
demonstrated to be a key factor in the establishment of many bacterial infections. The 
complete genome sequence of C. jejuni NCTC 11168 suggested the presence of a 
putative ferrous iron transporter protein, FeoB and the presence of three putative TonB 
ExbB ExbD energy transduction complexes. We hypothesized that FeoB dependent 
ferrous iron transport and TonB mediated ferric iron transport systems were functional in 
C. jejuni and were important colonization determinants of C. jejuni infection. To test 
these hypotheses, we adopted a similar inactivation strategy by constructing knock-out 
mutants in feoB and tonB genes, and characterizing them in vitro and in vivo. We 
assessed the knock-out phenotypes for the poorly invasive and highly invasive C. jejuni 
isolates.  
For the first objective, to characterize the FeoB system in C. jejuni, the feoB gene was 
knocked out by insertional inactivation using antibiotic resistance cassette. A battery of in 
vitro experiments was conducted to characterize the feoB mutants in vitro. By in vitro 
growth assays, we demonstrated no difference in the growth pattern of the feoB mutants 
and the wild-type strain. Using 55Fe2+ uptake assays, we showed that ferrous iron uptake 
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was a proton dependent active process. The feoB mutant was significantly affected in iron 
uptake and was demonstrated to have decreased cellular iron accumulation. The role of 
FeoB in the intracellular survival of C. jejuni within human and porcine epithelial cells 
was found to be significant, highlighting the importance of high affinity transporters in 
iron acquisition. We further characterized the feoB mutants by microarray experiments, 
and demonstrated 110 genes to differentially express between the feoB mutant and the 
wild-type strain, with the up-regulation of oxidative stress defense gene katA and a non- 
heme iron protein Cj0012c. 
The presence of an extracellular ferric reductase activity was shown from both the  
wild-type and feoB mutant strain, highlighting the existence of a previously 
uncharacterized system in C. jejuni. The in vitro studies were supported with an extensive 
assessment of colonization potential of the feoB mutants in vivo using three diverse 
animal models. The feoB mutants were consistently affected in their ability to colonize 
the gastrointestinal tract of the commensal chick colonization model, the infection model 
rabbit ileal loop and colostrum-deprived neonatal piglets, indicating the phenotype to be 
an in vivo specific defect. This study is the first report of the use of neonatal piglets in the 
assessing of  C. jejuni mutants. This extensive characterization of feoB mutant suggests 
the significance of FeoB in iron acquisition and gastrointestinal colonization of animal 
hosts.  
 
The second objective of characterization of the TonB systems in C. jejuni was 
accomplished by constructing a series of tonB mutants. Three single tonB mutants and 
three double tonB mutants were constructed. The paucity of alternative tools that can 
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function in C. jejuni resulted in the failure of all our attempts in constructing a triple tonB 
mutant. The in vitro characterization of these tonB mutants demonstrated the TonBs to be 
iron regulated. Ferric iron uptake in C. jejuni was shown to be proton dependent. Growth 
promotion assays and 55Fe3+-enterobactin assays characterized the TonB systems and 
identified TonBs to perform specific and redundant functions. TonB3 was found to be 
specifically required for enterobactin utilization, whereas TonB2 and TonB3 were 
together required for the uptake of hemin and hemoglobin. The three C. jejuni isolates 
tested for their in vitro phenotype in our study demonstrated a characteristic pattern in the 
uptake of different iron sources. This could likely be related to the number of functional 
TonBs present in the different strains, and their substrate specificity, by virtue of 
conserved residues in the TonBs. The multiple TonB systems were screened for their role 
in the colonization of the gastrointestinal tract using the commensal chick model and the 
infection neonatal piglet colonization model. The tonB2 mutant was the only mutant to be 
not affected in chick colonization, whereas, all the other single and double tonB mutants 
were affected in chicks. All the tonB mutants were also attenuated in the colonization 
potential of the neonatal piglets, including the tonB2 mutant. These in vivo colonization 
data highlighted the importance of having multiple relevant animal models in the 
thorough characterization of a gene function in vivo. Overall, the TonBs were identified 
to significantly contribute in ferric iron uptake and in vivo colonization of the host. 
Thus, combining our in vitro and in vivo characterization of the FeoB and TonB systems, 
it is clear that both the systems contribute significantly in iron acquisition and 
colonization of the gastrointestinal tract.  
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Abstract 
Campylobacter jejuni is the most common bacterial cause of diarrhea worldwide. To 
colonize the gut and cause infection, C. jejuni must successfully compete with 
endogenous microbes for nutrients, resist host defenses, persist in the intestine, and 
ultimately infect the host. These challenges require the expression of a battery of 
colonization and virulence determinants. In this study, the intestinal lifestyle of C. jejuni 
was studied using whole genome microarray, mutagenesis, and a rabbit ileal loop model. 
Genes associated with a wide range of metabolic, morphological, and pathological 
processes were expressed in vivo. The in vivo transcriptome of C. jejuni reflected its 
oxygen-limited, nutrient-poor, and hyper-osmotic environment. Strikingly, the expression 
of several C. jejuni genes was found to be highly variable between individual rabbits. In 
particular, differential gene expression suggested that C. jejuni extensively remodels its 
envelope in vivo by differentially expressing its membrane proteins and by modifying its 
peptidoglycan, and glycosylation composition. Furthermore, mutational analysis of 7 
genes, hspR, hrcA, spoT, Cj0571, Cj0178, Cj0341, and fliD, revealed an important role 
for the stringent and heat shock response in gut colonization. Overall, this study provides 
new insights on the mechanisms of gut colonization, as well as possible strategies 
employed by Campylobacter to resist or evade the host immune responses.  
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Introduction 
Campylobacter is the most common non-viral etiological agent of infectious enteritis in 
humans and has been implicated in 14.2% of the 76-million food-borne illnesses reported 
annually in the United States (21). Campylobacter infections vary from mild diarrhea to 
severe abdominal pain (49). Rarely, they result in the development of Guillain-Barré 
syndrome, which is the primary cause of acute neuromuscular paralysis in the US (49). 
Because of the extremely high number of cases of food-borne infections reported yearly 
worldwide, the development of new strategies to fight these infections is urgently needed, 
and will depend on developing an understanding of host-pathogen interactions.  The 
complete genomic sequence of C. jejuni NCTC 11168 was released in 2000 (27) 
providing new opportunities for the investigation of Campylobacter pathogenesis.   
 Despite the high incidence of Campylobacter-mediated diarrhea, the microbial 
factors that govern gut colonization and pathogenesis are poorly understood in 
comparison with other enteric pathogens. In a complete infection cycle, Campylobacter 
cells are transferred from contaminated foods to the stomach, the intestinal tract and, 
finally, to the feces, allowing their transmission to a new host (6, 13). During this 
stressful journey through the gastrointestinal tract, Campylobacter encounters and must 
adapt to life-threatening environmental conditions, such as the acidic pH of the stomach, 
the high osmolarity of the gastrointestinal tract, intestinal gases, reactive oxygen and 
nitrogen compounds, changes in nutrient availability, and low inorganic ion 
concentrations (13). For successful colonization, Campylobacter cells must survive in the 
intestinal tract, either as free living microorganisms in the mucus layer, attached to the 
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epithelium, or intracellularly in epithelial cells (6). Campylobacter determinants involved 
in colonization and pathogenesis include flagella, host cell adherence and invasion, and 
toxin production (6).  Non-motile and aflagellated Campylobacter were shown to be 
affected in their ability to colonize the gastrointestinal tract as well as to invade the 
epithelial cells (25, 56). Many suspected adhesins have been identified, such as lipo-
oligosaccharide (20), flagella (56), or surface exposed proteins (CadF, PEB1) (23, 29). 
Host cell invasion has been extensively studied and is thought to be an important step in 
Campylobacter infection (6). Indeed, biopsies of humans diagnosed with C. jejuni 
enteritis revealed the presence of intra-cellular Campylobacter cells (47). Interestingly, 
toxin production has recently been proposed to modulate the host immune response, 
allowing the bacteria to escape the immune surveillance (9).  
To identify new potential virulence factors, we analyzed C. jejuni lifestyle in the gut 
using microarray technology.  The C. jejuni NCTC 11168 genome-wide expression 
profile was assessed during host colonization and pathogenic development, using a 
mammalian model of gastroenteritis, the rabbit ileal loop model. In addition, mutants 
were constructed by deleting genes of interest identified by our microarray analysis, and 
assessed for their ability to survive in the gastrointestinal tract of rabbits. 
 219 
Materials and Methods 
Bacterial strains, plasmids, and preparation of inocula.  
The bacterial strains and plasmids used in this work are listed in Table 1. The 
Campylobacter jejuni NCTC 11168 strain was acquired from the National Collection of 
Type Culture (NCTC, England) in the spring 2000. Campylobacter strains were cultured 
in Mueller-Hinton (MH) medium or on MH agar plates at 37°C in a microaerophilic 
chamber (Don Whiteley, West Yorkshire, England). Chloramphenicol resistant mutants 
were maintained on MH medium supplemented with 20 µg/ml of chloramphenicol. 
C. jejuni inocula were prepared by microaerobic culture (84% N2, 5% O2 and 11% CO2) 
in MH medium at 37°C with agitation using a stirrer. The bacterial growth was monitored 
by measuring the optical density at 600 nm. At early mid-log phase (OD600 of 
approximately 0.3), the bacterial culture was split in two and one half was used to 
produce purified total RNA from C. jejuni grown in vitro, while the other half was used 
to inoculate the rabbit ileal loops. Bacteria were collected by centrifugation (10 min, 
6000 x g), washed once with sterile PBS buffer, and resuspended in PBS buffer at a 
concentration of approximately 6.6 x 1010 cfu/ml. 
For the in vitro growth experiments, the C. jejuni wild-type and mutant strains were 
grown in MH biphasic medium at 37°C under microaerophilic conditions (83% N2, 4% 
H2, 8% O2 and 5% CO2).  
Rabbit ileal loop model (RIL) and isolation of Campylobacter jejuni total RNA. Rabbits 
were checked upon arrival to see if they carried Campylobacter by taking cloacal swabs 
for culture. Ileal loops were prepared according to published methods (3, 8). Briefly, New 
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Zealand White rabbits (<2 kg, female) were anesthetized, a laparotomy was performed, 
and two 20-cm sections of ileum with intact mesenteric blood supply were ligated per 
animal. Each loop was inoculated with approximately 1011 mid-log phase Campylobacter 
jejuni in 1.5 ml PBS buffer. The size of the inoculum was confirmed by bacterial 
enumeration on MH agar plates. Loops of two rabbits were injected with sterile PBS 
buffer and served as control animals. After replacing the intestinal loops in their 
appropriate position in the abdominal cavity, the abdominal wall and skin were closed in 
standard fashion and the rabbits were allowed to recover from anesthesia.  The rabbits 
were anesthetized again 24 or 48 hours after the inoculation, the intestinal loops were 
excised intact, and the animals were then euthanized. 
RNA turnover in the samples was quickly stopped by submerging the entire loops into 10 
ml of RNAlater solution (Ambion, Austin, TX). The loops were first weighed in order to 
evaluate fluid accumulation and the contents of each loop as well as the mucus layer then 
were recovered into 20 ml of a 50% solution of RNAlater in PBS buffer and centrifuged 
at low speed to remove epithelial cells (5 min at 1,000 x g). Thereafter, Campylobacter 
bacteria were separated from the intestinal microflora by filtration through 0.8 µm filters. 
Campylobacter cells were pelleted by centrifugation and total RNA was isolated using a 
hot phenol-chloroform protocol, as previously described (40). Traces of genomic DNA 
were removed by two or three consecutive treatments with DnaseI Amp grade enzyme 
(Invitrogen, Carlsbad, CA). The absence of contaminating genomic DNA was confirmed 
by polymerase chain reaction (PCR). RNA was further purified 2 to 5 times using a 
Qiagen RNAeasy mini kit (Qiagen, Valencia, CA) and the concentration of RNA was 
determined using RiboGreen RNA quantitation reagent (Molecular Probes, Eugene, OR). 
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Microarray construction and hybridizations.  
DNA microarrays were prepared using PCR amplified fragments of each annotated open 
reading frame from C. jejuni NCTC 11168, as previously described (40, 41). Twenty µg 
of total RNA from each growth condition (in vitro and in vivo) were converted to cDNA 
using 2 pmol of C. jejuni 3’ specific primers (set of 1654 3’ primers used for the PCR 
amplification of C. jejuni ORFs) and coupled to monoreactive fluors (Cy3 and Cy5), 
according to previously described procedures (40).  
 
Data collection and analysis.  
Microarray slides were scanned at 532 nm (Cy3) and 635 nm (Cy5) wavelengths with a 
laser-activated confocal scanner (ScanArray 3000) at 10 µm resolution, generating two 
TIFF images. Fluorescence intensities of each spot were collected using the GenePix Pro 
3.0.5 software (Axon Instruments, Foster City, CA.) after manual optimization of spot 
registration, and exported to OriginPro 7 spreadsheets (OriginLab Corporation, 
Northampton, MA). The analysis of the fluorescence data was conducted as follows: (1) 
The spots were filtered and excluded based on slide abnormalities or low signal 
(corresponding to spots flagged bad or not found). (2) After background subtraction, all 
spots with fluorescent mean intensities below three times the standard deviation of the 
background in both channels were removed from the final data analysis. (3) The 
fluorescence intensity in each wavelength was log2 transformed and normalized using 
locally weighted linear regression (lowess) performed by the MIDAS software (available 
from TIGR; http://www.tigr.org/software/). 
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For the microarray analysis, Campylobacter RNA was isolated 48 hours post-infection 
from five RIL rabbits. Each cDNA sample was individually co-hybridized with cDNA 
obtained from in vitro growth (mid-log phase bacteria) on microarray slides. The 
microarray hybridization was repeated up to three times depending on the amount of 
RNA purified from each rabbit, yielding between 2 and 6 measurements per gene per 
rabbit (each gene was spotted in duplicate on each slide). The microarray data were 
statistically analyzed using the “Significant Analysis of Microarray (SAM)” algorithm, 
which was specifically developed for genomic expression data mining (the Microsoft 
Excel add-in software is available at http://www-stat.stanford.edu/~tibs/SAM/) (46). 
Briefly, SAM uses the standard deviation of repeated gene expression measurements to 
assign a score to each gene.  It then estimates, for a particular score, a false discovery rate 
by permutations of the data. This SAM analysis ascertains that genes identified as 
“differentially expressed” do not arise from a random fluctuation of the large quantity of 
data generated (46). To identify genes whose expression differed significantly between in 
vivo and in vitro growth, we performed a one class response analysis by considering the 
five rabbits as one class. We applied a false discovery rate of 0.11% and a delta value of 
0.9. To identify genes with variable expression between rabbits, we performed a multiple 
classes analysis by treating each rabbit as one class. We applied a false discovery rate 
threshold of 1.64% and a delta of 0.19.  The microarray data of SAM positive genes were 
extracted into a text output file using the Samster software (available at 
http://falkow.stanford.edu/whatwedo/software/software.html). Finally, the ratios of the 
fluorescence intensities of all replicate spots from the hybridization of RNA derived from 
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each rabbit were averaged and used for further analysis. The data generated by this study 
are available online at http://www.cvm.okstate.edu/research/Facilities/CampyLab.  
 
Campylobacter jejuni mutants construction.  
Knockout mutants of C. jejuni NCTC 11168 were constructed by independently mutating 
6 genes; hrcA, Cj0571, spoT, hspR, Cj0341 and fliD. The same inactivation strategy was 
used for the hrcA, Cj0571, spoT, and hspR mutants. Briefly, the gene to be mutated was 
amplified by PCR from C. jejuni NCTC 11168 chromosomal DNA, which was extracted 
using a standard protocol (35). The PCR product was cloned into pUC19, using a unique 
restriction site (Table 2), and deletions of 42 bp, 600 bp, 627 bp, and 72 bp were made by 
inverse PCR in hrcA, Cj0571, spoT, and hspR, respectively. The chloramphenicol 
resistance cassette (Camr) was PCR amplified from pRY111 (55) using primers with 
appropriate restriction sites and cloned into the deletion site. Specific primers used for the 
first PCR amplification and the following inverse PCR are listed in Table 2. Recombinant 
plasmids carrying the Camr gene in the same orientation as the genes of interest were 
selected by DNA sequencing and transformed into C. jejuni NCTC 11168 using standard 
protocols (55). Transformants were identified on MH agar plates containing 20 µg/ml of 
chloramphenicol. The identity of the mutants was confirmed by PCR analysis using a 
combination of primer sets annealing within the mutated gene and the Camr gene.  
The Cj0341 and fliD mutants were isolated from a library of random mutants generated 
using the EZ::TNTM pMODTM-3<R6Kγori/MCS> transposon (Epicentre), in which the 
Camr cassette from pRY111 has been cloned (Stintzi, unpublished data). The mutant 
library was constructed following the manufacturer’s recommendation, and the Cj0341 
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and fliD mutants were identified during the first trial to assess the randomness of the 
library. The insertion site of the transposon in the Cj0341 and fliD mutants was identified 
using a single primer PCR procedure and DNA sequencing of the resulting amplification 
product, as described by others (16). The Cj0341 and fliD mutations were confirmed by 
PCR amplification using a primer that anneals within the mutated gene and another 
primer that anneals within the Camr gene. 
 
In vivo survival assays using a pool of mutants.  
The ability of the C. jejuni mutants to survive within the rabbit ileal loops was assessed. 
Each mutant was grown individually in MH broth to mid-log phase, harvested by 
centrifugation (10 min, 6000 x g), washed and resuspended in PBS buffer. The mutants 
were mixed to constitute the input pool by combining 5 x 109 cfu of each mutant with 7.5 
x 1010 cfu of the wild-type strain, C. jejuni NCTC 11168, in 5 ml of PBS buffer. One ml 
of this suspension was used to prepare genomic DNA following standard protocols. The 
remaining bacterial suspension was used to equally inoculate 4 ileal loops from 2 rabbits 
(1 ml per loop). At 48 hours post-infection, loop contents were harvested in PBS buffer 
and centrifuged at low speed to remove debris and epithelial cells. The supernatant was 
immediately processed to prepare genomic DNA, constituting the recovered pool of 
genomic DNA. Each loop was processed individually.  
The difference in relative abundance of each mutant between the input and recovered 
pools was evaluated by quantitative PCR, which was performed using an ABI Prism 7700 
DNA analyzer (Applied Biosystems, Foster City, CA) and the QuantiTectTM SYBR® 
Green PCR kit (Qiagen, Valencia, CA), according to the following protocol: 500 ng of 
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genomic DNA was added to 25 µl of 2xQuantiTect SYBR Green PCR solution and 0.3 
µM of each specific primer in a 50 µl final volume. The HotStar Taq DNA polymerase 
was activated by heating the reaction at 95°C for 15 min. PCR amplification was 
performed by 40 cycles of denaturation at 94°C for 15 s, annealing at 56°C for 30 s, and 
extension at 72°C for 45 s. The specificity of the PCR reaction was confirmed by melting 
curve analysis of the PCR product following the manufacturer’s recommendations 
(Applied Biosystems, Foster City, CA). Genomic DNA of each mutant was specifically 
amplified from both pools by using a combination of two primers, with one of them 
annealing within the mutated gene and the other within the chloramphenicol resistant 
cassette. The sequences of the specific primer sets are available online at 
http://www.cvm.okstate.edu/research/Facilities/CampyLab. The relative abundance of 
each mutant was then normalized to the DNA pool by using the cydA or argD genes. The 
competitive ratio of the relative abundance of each mutant between the input and 
recovered pools was obtained using the comparative threshold cycle (∆∆CT) method, as 
recommended by Applied Biosystems. The abundance of each mutant was assessed twice 
per loop and the mean CT value for each ileal loop was used for further analysis. The CT 
value corresponds to the PCR threshold cycle at which the fluorescence detected is 
significantly higher than the baseline value. The ratio of the mutant in the input to the 
recovered pool was calculated as follows: ratio input/recovered = 2-∆∆CT, where ∆∆CT = 
∆CT, recovered - ∆CT, input, and ∆CT, recovered or input is obtained by subtracting the mean CT 
value of the specific gene from the mean CT value of the reference gene (cydA or argD) 
in the genomic DNA from the input or recovered pool. Given that the wild-type strain 
was inoculated at a higher level than the mutants, the population as a whole (the mutants 
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plus the wild-type strain) should have a growth similar to the wild-type strain alone. The 
same assumption is usually made for the analysis of data generated by signature tag 
mutagenesis (10). Consequently, the normalized competitive ratio input/recovered of C. 
jejuni NCTC 11168 should be approximately equal to 1. A competitive ratio 
input/recovered above 1 indicated that the mutant was attenuated in vivo, while a 
competitive ratio below 1 indicated that the mutant survived better in vivo than the wild-
type. The data was statistically analyzed using the Student t-test and a P value below 0.01 
was considered significant. 
 
In vitro and in vivo competition experiments.  
C. jejuni wild-type and mutant strains were grown in biphasic MH medium to mid-log 
phase, centrifuged and resuspended in PBS buffer to OD600 ≈ 1.8 (approximately 1010 
cfu/ml). Two milliliter (each) of the wild-type and the mutant strains were mixed at a 1 to 
1 ratio. Four ileal loops (from 2 rabbits) were injected (each) with 1 ml of this 
suspension. The initial 1:1 mixture of mutant and wild-type strains was confirmed by 
plating serial dilutions of this mixed culture on MH agar with and without 
chloramphenicol (20 µg/ml). At 48 hours post-infection, the loops were recovered as 
described above. Their content as well as the mucus layer were collected and 
homogenized in 10 ml of PBS buffer. Serial dilutions of bacteria recovered from each 
rabbit’s loop were plated on karmali-agar plates (Campylobacter agar base (Oxoid 
CM935) supplemented with the Campylobacter selective karmali supplements (Oxoid 
SR167E)) and karmali-agar plates containing chloramphenicol (20 µg/ml). Plates were 
incubated at 37°C for 3 days before the colonies were counted. The titer of the mutant 
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was obtained from the CFU recovered on karmali-agar plates containing 
chloramphenicol, and the titer of the wild-type bacteria was calculated by subtracting the 
number of mutants to the total number of bacteria recovered on karamali-agar plates 
without antibiotic.  Finally, the in vivo competitive index was calculated for each loop 
and corresponds to the ratio of the mutant to the wild-type strain.  
For the in vitro competition assays, overnight cultures of the wild-type and mutant strains 
were mixed in a 1:1 suspension into fresh MH medium. This suspension was used to 
inoculate three replicate biphasic MH cultures. The bacterial growth was monitored by 
measuring the OD600 over time. The titer of each strain was determined in the inoculum, 
and at early stationary phase, by plating on MH-agar and MH-agar containing 
chloramphenicol (20 µg/ml). The in vitro competitive index was calculated for three 
independent growth experiments and is defined as the ratio of mutant to wild-type.  
A Student’s t test was used to statistically analyze the data from the in vivo and in vitro 
competition assays.   
 
Real-time quantitative RT-PCR analysis.  
The relative expression of 9 genes (flgE2, Cj0178, katA, spoT, ahpC, fliD, Cj0571, cydA, 
and Cj0366) was confirmed by real-time quantitative RT-PCR, as previously described 
(40), using the QuantiTectTM SYBR Green RT-PCR kit (Qiagen, Valencia, CA), 
according to the manufacturer’s recommendations. The relative expression of each gene 
was normalized to either the 16S or 23S RNA, and the extent of its induction was 
obtained using the comparative threshold cycle (∆∆CT) method, as described above. The 
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primers used are available online at 
http://www.cvm.okstate.edu/research/Facilities/CampyLab. 
 
Necropsy and histopathology.  
Four rabbits were used to evaluate the pathological changes in the RIL model caused by 
C. jejuni NCTC 11168. The loops were prepared as described above for the 
transcriptional profiling experiments. The loops from two rabbits were inoculated with 1 
x 1011 cfu of mid-log phase C. jejuni NCTC 11168, while the loops of the two other 
rabbits were injected with sterile PBS buffer. At 48 hours post-infection, the rabbits were 
anesthetized, the loops were recovered, and the animals were then euthanized with an 
overdose of Beuthanasia D (>0.25 ml/kg of body weight). A 0.5 cm middle section of 
each loop was immediately excised, flushed with formalin, linearly opened, placed flat on 
a card, and fixed in buffered 10% formalin, embedded in paraffin, section at 5 µm and 
stained with hematoxylin and eosin. Specimens were examined for evidence of 
inflammation, villus epithelial cell attenuation and crypt dilatation or hyperplasia.  
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Results and Discussion 
 
The rabbit ileal loop (RIL) model for campylobacteriosis.  
This animal model was initially chosen because of its documented ability to accurately 
model the histopathological lesions associated with human Campylobacter gastroenteritis 
(8). In addition, Campylobacter cells can be collected in a number sufficient for the 
investigation of in vivo genome-wide transcripts abundance. The model was created by 
surgical ligation of 20 cm sections of ileum, resulting in the cessation of the normal 
peristaltic flux, thereby facilitating Campylobacter gut colonization. The strain of C. 
jejuni NCTC 11168 used in our study is helically shaped, fully motile, and colonizes the 
gastrointestinal tract of chicks (26). Therefore, this strain is phenotypically different from 
the sequenced C. jejuni NCTC 11168 strain recently described by Gaynor et al. (11), 
which was described to be straight rod-shaped, non-motile, and a poor colonizer of 
chicks. To explore the feasibility of this model to study Campylobacter lifestyle in the 
gut by transcriptome profiling, we undertook a pilot study involving 4 rabbits: Rabbit 
intestinal loops were sampled at 24 or 48 hours post-inoculation (using 2 rabbits per time 
point). To note, the C. jejuni strain was passaged three times in vitro before its 
inoculation in the ileal loops. C. jejuni NCTC 11168 colonized the rabbit gut at bacterial 
concentrations of 105 cfu/loop and 107 - 109 cfu/loop, at 24 and 48 hours post-inoculation, 
respectively. The initial decrease in bacterial population from 1011 to 105 cfu per loop 
during the first 24 hours after inoculation reflects the challenges of surviving in a hostile 
environment, while the subsequent bacterial growth from 105 to 109 cfu/loop at 48 hours 
suggests the successful adaptation and colonization of C.jejuni in the rabbit intestinal 
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tract. Considering that 105 cells would not generate sufficient amounts of RNA to 
perform microarray hybridization, we decided to harvest the bacterial cells at 48 hours 
post-infection in the present study.  
Intestinal distension resulting from accumulation of gas and fluid (the first signs of 
diarrhea) was qualitatively observed at 48 hours post-infection in all infected rabbits but 
not in the control animals injected with the PBS buffer. Two infected rabbits and two 
control animals were used to evaluate pathological changes. Fluid accumulation was 
quantitatively estimated by weighing the intestinal content of the 8 loops, which indicated 
an increase of 0.09 ± 0.05 g content/g of ileal tissue in the infected loops compared with 
control loops. This difference was found to be statistically significant (P < 0.05 using a 
paired t-test). In contrast to the observations of Everest et al. (8), histopathological 
analysis of the ileal tissues did not reveal any severe pathology. This lack of damages 
likely reflects the inability of C. jejuni NCTC 11168 to invade epithelial cells or to exert 
morphologically evident cytotoxic effects on intestinal epithelial cells. In fact, the strain 
of C. jejuni NCTC 11168 used in our study is poorly invasive into human epithelial 
INT407 cells (30). Consequently, the transcriptome profile presented in this work reflects 
non-invasive Campylobacter lifestyle in the intestine during survival, colonization and 
the initial stages of pathogenesis. 
 
In vivo expression profiling validation.  
While microarrays provide a powerful approach for the investigation of gene expression, 
the performance of these expression studies in vivo is technically challenging. To date, 
expression profiling experiments have been limited mainly to in vitro environments. In 
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the present study, in vivo colonization of the intestinal tract by C. jejuni was investigated 
by conducting transcriptional expression profiling experiments during growth and 
survival within the natural gut environment. We utilized microarrays containing spotted 
PCR products representing approximately 98% of the annotated open reading frames of 
C. jejuni NCTC 11168 (40). The challenge of recovering intact C. jejuni mRNA from the 
intestine to ensure acquisition of an accurate and specific transcriptome profile was 
addressed by excising the entire intestinal loops and immediately submerging them in 
RNA stabilization solution to block RNA turnover. In order to minimize RNA 
degradation and/or changes in the gene expression  level, loops were immediately 
processed for RNA extraction and quantitative histopathological traits were not recorded. 
The content of each loop, including the mucus layer, was recovered in RNA stabilization 
solution, and C. jejuni was purified by filtration through 0.8 µm filters. This physical 
separation removed most of the endogenous microflora; more than 80% of the bacterial 
population was estimated to be constituted of C. jejuni. The yield of RNA recovered was 
between 12 to 55 µg per loop. The total RNA extracted from each rabbit’s two loops 
were combined. Twenty µg of RNA was reverse transcribed using C. jejuni specific 3’ 
end primers and fluorescently labeled with the Cy5 dye which fluoresces red. The relative 
abundance of transcripts was monitored by competitive hybridization with RNA 
extracted from bacteria grown in vitro to mid-log phase and labeled with the green 
fluorescent Cy3 dye. To address any potential cross-hybridization with RNA extracted 
from the remaining natural intestinal microflora, RNA was also purified from ileal loops 
of rabbits which had been injected with PBS buffer only. The yield of total RNA purified 
from the uninfected loops was between 1 and 3 µg per loop. The total RNA harvested 
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from two uninfected loops were combined, reversed transcribed, labeled with Cy5 and 
hybridized to the C. jejuni microarray. As shown in Figure 1, this RNA did not cross-
hybridize with genes from C. jejuni. In addition to physical enrichment of C. jejuni by 
filtration, the use of 3’ specific primers to synthesize cDNA further enhanced the 
specificity of the assay. A similar approach was employed by Talaalt and coworkers to 
amplify mycobacterial RNA from a mixture containing mammalian RNA (43). 
 
Global gene expression analysis and validations  
C. jejuni NCTC 11168 was inoculated into 5 rabbits and colonized the loops of these 
rabbits at a bacterial concentration of 3.108 cfu/loop (rabbit 1), 2.108 cfu/loop (rabbit 2), 
5.108 cfu/loop (rabbit 3), 4.107 cfu (rabbit 4), and 4.108 cfu/loop (rabbit 5). 
Campylobacter RNA samples were extracted from each rabbit 48 hours post-infection 
and individually hybridized to the microarray slides up to three times, depending on the 
amount of RNA purified from each loop. Specifically, rabbits 1, 4 and 5 yielded two 
measurements per gene, rabbit 2 yielded six measurements per gene, and rabbit 3 yielded 
four measurements per gene. The data were quantified, normalized, and reported as the 
ratio of gene expression of C. jejuni grown in the rabbits to that of C. jejuni grown in 
vitro. To limit the number of genes falsely identified as differentially expressed, we 
performed a statistical procedure. This test consisted in applying the significance analysis 
of microarray (SAM) algorithm to our microarray data. This statistical method has been 
shown to be more reliable than a standard t test or the use of a fold change threshold, and 
is relatively conservative in declaring a significant change in gene expression (46). A one 
class response SAM analysis, using the five rabbits as one group, identified 348 genes as 
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being differentially expressed between in vivo and in vitro growth with a false discovery 
rate of 0.11%. All SAM selected genes exhibit expression ratios greater than 1.5. As 
demonstrated in our previous study using the same microarray platform, a 1.5 fold 
differential expression is technically and biologically significant (40). This 
Campylobacter microarray platform has previously been shown to generate data with a 
high level of concordance with quantitative RT-PCR (40). However, in order to address 
the reliability of the microarray data generated in this study, the change in transcript 
abundance in rabbit 4 between in vitro and in vivo growth was confirmed for 9 genes 
(flgE2, Cj0178, katA, spoT, ahpC, fliD, Cj0571, cydA, and Cj0366) by real-time 
quantitative RT-PCR. The flgE2 gene was found to be 4 fold up-regulated, Cj0178 was 
200 fold up-regulated, katA was 130 fold up-regulated, spoT was 61 fold up-regulated, 
ahpC was 4 fold up-regulated, fliD was 5 fold down-regulated, Cj0571 was 2.5 fold up-
regulated, cydA was 350 fold up-regulated and Cj0366 was 300 fold up-regulated. 
Similarly to our previous study, while the quantitative RT-PCR confirmed the trend in 
differential gene expression observed with the microarray analysis, a quantitative 
difference in the fold change was observed between these two technologies. This 
difference reflects a lower dynamic range for the microarray experiments as compared to 
quantitative real-time RT-PCR, as previously reported by others (53). Notably, very few 
genes were found to be differentially regulated more than 20 fold by the microarray 
analysis while the real-time RT-PCR found several genes up-regulated more than 100 
fold. This observation highlights the semi-quantitative nature of microarray experiments 
and the low dynamic range of this technology (4). Furthermore, this technical limitation 
appears to be amplified in situations where a gene exhibits a very low expression level 
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under only one of the growth condition, which is the case of in vivo genome-wide 
expression analysis. As a consequence, the fold change in gene expression presented in 
this study should be significantly underestimated. Nevertheless, differentially expressed 
genes were readily identified by statistical analysis. Overall, 185 genes were found to be 
induced in vivo in all five rabbits. Among them, 177 exhibited more than two-fold 
differential expression with 91 of them showing more than 4-fold differential expression.  
Of the 199 genes found to be repressed in vivo, the expression level of 153 genes was 
reduced 2 fold and the expression level of 32 genes was reduced more than 4 fold.  
Multiple class response SAM analysis (considering each rabbit as one group) as well as 
two class unpaired data SAM analysis (considering each rabbit as one group and 
comparing each rabbit with each other) revealed some gene expression variability 
between rabbits. Multiple class response SAM analysis identified 170 genes differentially 
expressed between rabbits with a false discovery rate of 1.64%. Importantly, very few 
genes were found to be antagonistically expressed between rabbits. Indeed, the trend of 
differential expression remained essentially the same, while only the amplitude of change 
in transcript abundance varied. To confirm the variability of gene expression between 
rabbits and to rule out the possibility of intrinsic noise, we compared the expression 
measurements of these 170 genes within each rabbit and between rabbits (using the 
microarray data from rabbits 2 and 3). A high level of concordance with a correlation 
coefficient higher than 0.9 was obtained between replicate microarray hybridizations of 
RNA isolated from the same rabbit (Figure 2, panels A and B), whereas a very weak 
correlation was observed between hybridizations of RNA samples originating from two 
different rabbits (Figure 2, panel C). The variability of gene expression between rabbits 
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was further confirmed by quantitative real-time RT-PCR for flgE2 and Cj0178, which 
encode for the flagellar hook subunit protein and a putative outer membrane ferric-
siderophore receptor, respectively. These were found to be differentially expressed 
between rabbits 3 and 4. The microarray analysis indicated that the flgE2 gene was over-
expressed in rabbit 4 and down-regulated in rabbit 3, while the expression of Cj0178 was 
essentially unaffected in rabbit 3 and up-regulated in rabbit 4. By using the same RNA 
preparation as the one used for the microarray hybridization, quantitative RT-PCR 
confirmed the differential expression of both genes. The expression of flgE2 was found to 
be down-regulated approximately 70-fold in rabbit 3, and up-regulated 4-fold in rabbit 4, 
compared with in vitro growth. Cj0178 was found to be equally expressed in rabbit 3 and 
over-expressed 200-fold in rabbit 4 relative to in vitro growth.  
The observed variability in gene expression patterns is unclear but likely reflects both 
physiological and intrinsic variations in the rabbits. This hypothesis is in agreement with 
the observed difference in colonization level (1 log) and the variation in the amount of 
fluid accumulation (±55%) between rabbits. Obviously, the gastrointestinal environment 
cannot be controlled and is likely to vary from one rabbit to another, leading to variations 
in C. jejuni colonization and gene expression profiles. In addition, it is unknown if the 
rabbits used in this study had previously encountered C. jejuni. If it was the case, an 
immune response would likely take effect by 48 hours post-infection and might also 
result in the observed gene expression variability. Recently, Boyce et al. reported the 
genome-wide expression profile of Pasteurella multocida recovered from blood of 
infected chickens 20 hours after inoculation (2). Although blood has questionable 
pathological relevance because it is not the site of infection of P. multocida, similarly to 
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our study the authors observed a variable bacterial gene expression profile between 
infected hosts (2). More recently, Xu et al. characterized the transcriptome of Vibrio 
cholerae during intestinal growth 8 hours post-infection using the rabbit ileal loop model 
(54). In contrast to our study, V. cholerae gene expression was similar in the three rabbits 
tested. All together, these data highlight the complexity of studying genome-wide gene 
expression in vivo.  
 
Campylobacter lifestyle in the gut.  
Overall, the expression of 482 genes was found to be significantly altered in vivo. Based 
on their expression profiles, genes can be grouped into two major categories: (1) genes 
exhibiting similar differential expression in all 5 rabbits tested (348 genes, Figure 3); and 
(2) genes with variable expression between rabbits (170 genes, Figure 4). It should be 
noticed that 36 genes belong to both categories. These genes exhibit similar expression 
alteration in vivo in all five rabbits but different fold change amplitudes between rabbits. 
To elucidate further the intestinal lifestyle of Campylobacter, we grouped genes by 
functional annotations and mapped their expression profiles to all known biological 
processes, thus allowing the investigation of the overall physiological status of C. jejuni 
grown in vivo. This approach revealed the involvement of a wide range of metabolic, 
morphological and pathological processes (Figures 3 and 4). Figures 3 and 4 list only the 
genes found to be significantly differentially expressed between in vivo and in vitro 
growth by SAM analysis.  However, a biological process was considered to play a role in 
Campylobacter physiology in the intestine when the constituting genes were found to be 
either up-regulated or equally expressed in vivo compared to in vitro growth.  
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Energy and central intermediary metabolism  
The in vivo transcriptome pattern of C. jejuni was consistent with the oxygen-limited 
environment found in the intestine. The expression of genes encoding for the key 
enzymes in the oxidative phosphorylation pathway was decreased dramatically in all 5 
rabbits. These genes encode for NADH dehydrogenase (nuoG, nuoL and nuoH), and 
succinate dehydrogenase (sdhABC). Recently, fumarate, nitrate, nitrite, and N- or O-
oxides have been shown to constitute alternative terminal electron acceptors, allowing C. 
jejuni to carry out respiration under oxygen-restricted conditions in vitro (36). However, 
the genes encoding for the reductases involved in this alternative respiratory pathway 
were all down-regulated in vivo. In contrast, the genes encoding for the cytochrome bd 
oxidase (cydAB) were expressed in vivo but not or only slightly expressed in vitro. The 
differential expression of the cydA gene was confirmed by quantitative real-time PCR. 
The expression of cydA was found to be 350 fold higher in vivo compared to in vitro 
growth. Although the CydAB oxidase catalyses the oxidation of menaquinone using 
oxygen as an electron acceptor, this enzymatic complex has been shown in E. coli to 
possess a high affinity for oxygen, allowing the bacterium to carry out respiration under 
limited oxygen tension (5). In addition, the expression of E. coli cydAB is known to be 
induced under limiting oxygen conditions (5). Similarly, the CydAB complex could 
facilitate C. jejuni respiration in the oxygen-limited environment of the intestine. 
Interestingly, formate dehydrogenase (encoded by fdhABCD) was the only enzyme 
identified by the microarray analysis to be over or equally expressed in vivo relative to in 
vitro and capable of transferring electrons to the menaquinone pool. Other genes 
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encoding enzymes with similar activity were found to be down-regulated in vivo. 
FdhABCD enzyme participates in the respiratory chain of many bacterial species, 
enabling these organisms to respire using formate as an alternative terminal electron 
donor under anaerobic conditions (33). In C. jejuni, the formate dehydrogenase, together 
with the CydAB complex, could allow the bacterium to carry on oxygen respiration even 
under extreme oxygen limited conditions.  
The expression of the genes encoding enzymes involved in gluconeogenesis, the citric 
acid cycle, and the pentose phosphate pathway, were all down-regulated in vivo, except 
for fructose bi-phosphate aldolase (fba). Down-regulation of these genes is consistent 
with the oxygen deprived intestinal environment and the up-regulation of the carbon 
storage regulator, csrA. In E. coli, CsrA has been shown to repress the expression of 
genes involved in glycogen catabolism, gluconeogenesis, glycolysis, and motility (34). 
This enzyme likely performs a similar function in C. jejuni. 
 
Macromolecular synthesis and processing  
Genes encoding proteins involved in the synthesis and modification of macromolecules, 
in particular the ribosomal proteins (with the exception of the rpsA gene) and aminoacyl 
tRNA synthetases, were among the most highly up-regulated in vivo. The significance of 
this contradictory expression of rpsA (which encodes the ribosomal protein S1) and other 
genes from the same functional group is puzzling and requires confirmation by an 
alternative method and further investigation. In E. coli, the ribosomal protein S1 has been 
shown to be essential for cell viability, to promote the efficiency of translation, and to act 
as a repressor for its own synthesis (37). Depletion of the protein S1 resulted in a 
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stringent response consistent with amino acid starvation and an increased production of 
ppGpp (37).  Therefore, the down-regulation of the rpsA expression would suggest the 
induction of a stringent response in C. jejuni during intestinal colonization.  
 
Biosynthesis of cofactors  
Another group of genes expressed in vivo encodes proteins involved in the biosynthesis 
of the cofactors, biotin (bioABCD), riboflavin (ribADFH), thiamine (thiCDEGHJL), 
pantothenate (panBC), coenzyme A (accB and acs) and folic acid (folCD). These genes 
were found to be either up-regulated or equally expressed in vivo relative to in vitro 
growth (with the exception of two genes, thiG and D, from the thiamine biosynthetic 
pathway, which were found to be down-regulated). The expression of these genes 
suggests that these cofactors are unavailable in the intestine. As a consequence, and 
because biotin, riboflavin, thiamine and pantothenate are produced only by microbes and 
higher plants, these biosynthetic pathways could constitute an ideal target for drug 
development. This evidence that biotin is unavailable in the intestine is corroborated by 
the up-regulation of V. cholerae biotin biosynthetic genes during intra-intestinal growth 
(54), and by the inability of a V. cholerae biotin biosynthesis mutant to colonize the 
gastrointestinal tract of mice (22).  
 
Virulence and colonization determinants  
Suspected virulence and colonization factors of Campylobacter include motility and 
chemotaxis, host cell adherence and invasion, toxin production, lipo-oligosaccharide and 
surface structure biosynthesis, oxidative stress defense, iron acquisition and heat shock 
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response (49).  In contrast to genes encoding proteins involved in general metabolism or 
bacterial physiology, the expression of many genes related to virulence and/or 
colonization factors were highly variable among infected rabbits. The most notable 
among genes with flexible expression were those coding for proteins involved in 
flagellum biosynthesis. Motility is known to be an essential requirement for C. jejuni to 
colonize the host gut and ultimately cause disease (49). Considering that the flagellin 
subunit is the immunodominant antigen recognized during human or animal infection, it 
is assumed that the gene encoding this protein is expressed in vivo (28).  However, our 
microarray data suggest that there is considerable inter-animal expression variability 
among genes belonging to the flagellum locus. Most of the genes belonging to the 
flagellum locus were found to be down-regulated in 4 rabbits (and at a different level), 
while they were slightly up-regulated in one rabbit. This variability may allow the 
bacterium to evade the host immune system by shutting down flagellum production once 
colonization is accomplished. In support of this hypothesis, C. jejuni flagella have 
recently been proposed to be necessary for passage through the gastrointestinal tract of 
chickens, but not for persistence in the chicken’s ceacum (51). A similar effect on the 
expression of flagellar genes was also recently demonstrated in Salmonella enterica 
during macrophage intracellular growth (7).  
Another functional category of genes expressed in vivo relates to iron-responsive genes 
which encode proteins involved in iron metabolism and oxidative stress defense. Several 
of the genes encoding iron acquisition systems were found to be either up-regulated or 
equally expressed between in vivo and in vitro growth. These genes code for a putative 
ferric-siderophore transporter system (Cj0178 and Cj0173c-Cj0175c), a putative iron 
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transporter (p19 and Cj1658), and the three TonB-ExbB-ExbD energy transducing 
complexes. The genes encoding a putative heme outer-membrane transporter 
(ChuABCD) were found to be only slightly expressed in vivo, suggesting that heme does 
not constitute the main iron source in the gut. The genes encoding the components of the 
ferric-enterobactin uptake permease (ceuBCDE) were found to be up-regulated in vivo, 
however the cfrA gene encoding the ferric-enterobactin receptor appeared to not be 
expressed. As a microaerophilic bacterium, C. jejuni must deal with free oxygen radicals 
and other reactive molecules generated by normal aerobic metabolism and host defenses 
against microbial attack (49). The expression of most genes known to be associated with 
C. jejuni oxidative stress response was found to be increased during gastrointestinal 
growth (49). To note, the up-regulation of these genes is in agreement with an iron 
limited environment. Theses genes include sodB (superoxide dismutase), ahpC (alkyl 
hydroperoxide reductase), tpx (probable thiol peroxidase) and katA (catalase).  Consistent 
with the expression of these genes in vivo, a mutation of C. coli sodB has been reported 
to impede colonization of chick gut (31).  Furthermore, a mutation in katA sensitizes C. 
jejuni to hydrogen peroxide and reduces its intracellular survival in macrophages (49). In 
H. pylori, the catalase KatA has been shown to be required for persistent colonization in 
the mouse model (14). These results highlight the iron-restricted conditions in the rabbit 
intestine. The importance of iron metabolism for successful host colonization has been 
established for most pathogens (32), and should also be an essential factor for C. jejuni 
colonization in the intestine. Indeed, a fur mutant of C. jejuni, as well as a cfrA, ceuE and 
Cj0178 mutants, were recently shown to be significantly affected in their ability to 
colonize the gastrointestinal tract of chicks (26).  
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Interestingly, C. jejuni possesses a system of general protein glycosylation, which has 
been proposed recently to play an important role in C. jejuni pathogenesis (42). Indeed, 
mutation of genes encoding the glycosyltransferases, pglB (also named wlaF) and pglE 
(also named wlaK), affected their ability to adhere to and invade human intestinal cells, 
as well as to colonize the gastrointestinal tract of mice (42). In our study, the expression 
of three genes, pglB, pglE and pglG, which belong to this functional category, was found 
to varied between growth conditions. The expression of pglB and pglG was highly 
induced in vivo (in 4 rabbits) while the pglE expression was either similar or repressed in 
vivo compared with in vitro growth. The expression of the other genes from the 
glycosylation cluster (pglH, pglA, wlaJ, and pglF) was found to be similar in both growth 
conditions. It is not clear why expression of the genes belonging to the same biological 
pathway varied. However, a similar difference in expression between the pgl genes was 
observed previously in Campylobacter in response to temperature up-shift (40) and iron 
starvation  (26). Considering the absence of data on the functional role of each pgl gene 
in protein glycosylation, the significance of their expression profiles is difficult to assess.  
The genes encoding the recently discovered multidrug efflux pump in C. jejuni, cmeABC, 
were found to be highly up-regulated in vivo. Expression of cmeB was confirmed by real 
time RT-PCR to be up-regulated by approximately 300-fold in vivo compared with in 
vitro growth. This tripartite multidrug efflux transporter is composed of an outer 
membrane protein, CmeC (Cj0367c), a periplasmic fusion protein, CmeA (Cj0365c), and 
an inner membrane efflux transporter, CmeB (Cj0366c) (18). Interestingly, this efflux 
system has been shown to contribute greatly to bile resistance  and to be required for the 
colonization of the chick’s gastrointestinal tract (18, 19). Given the presence of a high 
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concentration of bile salts in the gut, the up-regulation of these genes could contribute 
significantly to the survival of Campylobacter in the host by allowing the bacterium to 
resist the harmful effects of these salts. 
Another important functional set of genes with variable expression between rabbits 
encodes for proteins involved in peptidoglycan biosynthesis. Specifically, murB ( a 
putative UDP-N-acetylenolpyruvoylglucosaminereductase), murC (UDP-N-
acetylmuramate-alanine ligase), and pbpC (penicillin-binding protein) were among the 
genes from this category that were the most differentially regulated. The differential 
expression of this category of genes suggests that there may be a modification of the 
murein sacculus in vivo, probably in response to the high osmolarity of the intestinal 
environment. Likewise, Staphylococcus aureus modifies its peptidoglycan layer under 
conditions of high osmolarity (50). While the activation of genes involved in 
peptidoglycan synthesis may constitute a repair mechanism necessary for the bacterial 
adaptation to environmental stress, the modification of the peptidoglycan structure may 
have broad implications for the stiffness and elasticity of the cell surface, thereby 
conditioning the bacterium to its ecological niche. 
Among the other genes annotated or previously characterized as virulence- or 
colonization-associated factors, Cj1279c (putative fibronectin domain-containing 
lipoprotein) and several genes involved in the heat shock response were found to be 
significantly up-regulated in vivo. Heat shock proteins are induced in response to various 
stresses and act by repairing and preventing damage caused by the accumulation of 
unfolded proteins. The importance of the heat shock response for Campylobacter 
intestinal tract colonization has previously been demonstrated (49). Genes identified as 
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heat shock proteins (40) and induced in vivo include clpB (ATP-dependent CLP protease 
ATP-binding subunit), dnaK (heat shock protein), grpE (heat shock protein), hrcA 
(putative heat shock regulator), and htpG (hsp90 family heat shock protein). The up-
regulation of these genes, together with the previous identification of ClpB as a B-cell 
antigen in human disease (45), suggests that these proteins play an important role in 
bacterial growth within the gastrointestinal tract. 
 
Mutational analysis.  
In order to study further the C. jejuni lifestyle in the intestinal tract of rabbits, we 
constructed knockout mutations of genes identified by our microarray analysis and 
investigated the ability of these mutants to survive in the rabbit intestinal loop by 
comparison with the parent strain, C. jejuni NCTC 11168. Seven genes were selected and 
individually mutated.  The main goal of this mutational analysis was to disrupt 
physiological functions that appeared to be important for the colonization of the ileal 
loop. In particular, the microarray data suggested an important role for the genes involved 
in the heat shock response, the stringent response, the iron metabolism, and the 
biogenesis of the flagellum in the intestinal lifestyle of C. jejuni. Therefore, the heat 
shock response was disrupted by mutagenesis of its two transcriptional regulators hrcA 
and hspR. The stringent response was disrupted by mutagenesis of the spoT gene which 
encodes the guanosine-3',5'-bis(diphosphate)3'-pyrophosphohydrolase. The iron 
metabolism was disrupted by mutagenesis of the Cj0178 gene which encodes a ferric-
siderophore outer-membrane receptor. This gene has been previously shown to be 
induced under iron restriction and is highly up-regulated in vivo. The flagellum 
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biogenesis was disrupted by mutagenesis of the fliD gene which encodes for the flagellar 
hook-associated protein. A mutant in the fliD gene has been shown to be non-motile (12). 
The fliD gene was found to be down-regulated in all 5 rabbits. Interestingly, among the 
genes encoding transcriptional regulators, Cj0571 was the only one from this category 
found to be significantly up-regulated in all 5 rabbits by the microarray analysis, 
suggesting an important role for this protein in vivo. Consequently, this gene was also 
mutated. Finally, a mutant into Cj0341 was chosen to be tested in the ileal model as an 
experimental control. The expression of this gene was found to be off under in vivo and 
in vitro growth conditions. Therefore, this mutant should not be affected in its ability to 
colonize the ileal loop.  
The 7 mutants and the parent strain were pooled together and inoculated into 4 ileal loops 
constructed in 2 different rabbits. After 48 hours post-inoculation, the ileal contents were 
recovered and directly processed for chromosomal DNA purification. Then, the relative 
amount of each mutant was evaluated by quantitative real-time PCR, as described in the 
Materials and Methods section. The competitive ratio of the number of cells at the time of 
the inoculation (in the input pool) to the number of cells recovered 48 hours post-
inoculation was normalized to the entire bacterial population in the pool for each mutant 
(Figure 5) so that the competitive ratio of the whole population is equal to 1. Considering 
that the wild-type strain was present in excess, compared with each mutant in the input 
pool, and assuming that it represents the major proportion of the population in the 
recovered pool, it should have a competitive ratio input/recovered equal to approximately 
1. Therefore, any deviation of the competitive ratio from a value of 1 would indicate an 
effect of the mutation on the survival ability of C. jejuni in the rabbit ileal loop. As 
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expected, the competitive ratio of the Cj0341 mutant was 0.9, indicating that this strain 
colonizes the ileal loop as well as the wild type. Of the 6 other mutants, 1 was unaffected 
(Cj0571), 1 had an advantage over the others with respect to survival in and colonization 
of the rabbit ileal loop (fliD; P<0.003), and 4 were significantly attenuated (hrcA, 
Cj0178, spoT and hspR; P≤0.002). The spoT and hspR mutated strains were the most 
affected mutants, while the hrcA and Cj0178 mutants were only slightly attenuated. 
Because mutants are out-competed by many other strains during a mixed infection, the in 
vivo phenotype of the affected mutants was confirmed in a 1 to 1 competition assay. Each 
mutant was independently mixed with the wild-type strain in equal numbers and injected 
into 4 ileal loops (constructed in two rabbits). The 1 to 1 ratio of the inocula was 
confirmed by cfu determination. Forty-eight hours post-infection, the loop contents were 
plated on selective medium for bacterial enumeration. Then, the competitive index was 
calculated as the ratio of the mutant to the wild type strain recovered from each ileal loop. 
As shown in Figure 6 (panel A), 3 out of the 5 mutants were confirmed to be statistically 
affected in their colonization ability (with a p ≤ 10-4). In order to determine whether the 
colonization phenotype of these mutants was specific for in vivo growth, an in vitro 
competition assay was performed. An equal amount of each mutant and wild-type strain 
was mixed in MH broth. The cultures were incubated at 37°C until late log phase (~30 
hours), after which serial dilutions were plated on MH-agar with or without 
chloramphenicol. These experiments were performed in triplicate. The in vitro 
competitive index was determined as described for the in vivo competition assay (Figure 
6, panel B). Four of the 5 mutants were found to be statistically affected in their ability to 
out-compete the wild-type strain during in vitro growth. Finally, in order to determine 
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whether the in vitro growth defect was caused by the competition with the wild-type 
strain, the growth kinetic of each mutant was independently determined (Figure 7). All 
five mutants were found to have a growth defect in vitro, with the spoT, hspR, and fliD 
mutants being the most affected.  
The competitive index of the hspR mutant in vitro and in vivo was 1.5.10-2 and 7.10-5 
respectively. While this mutant is affected in vitro, the 200 fold difference between the in 
vitro and in vivo competitive indexes indicates a significant in vivo specific growth 
defect. The attenuation of the hspR mutant in vivo suggests a role for the heat shock 
regulatory network in Campylobacter gut colonization. In contrast, the hrcA mutant was 
not significantly affected in its in vitro growth neither in its ability to colonize the ileal 
loop. While the function of hspR and hrcA  in C. jejuni is essentially unknown, the 
products of these genes were recently demonstrated to repress the transcription of the 
major heat shock proteins in H. pylori (groESL, hrcA, grpE, and dnaK) (38, 39). In 
addition, the HrcA-mediated repression was shown to be dependent on the binding of 
HspR to the promoter region (38). Interestingly, the transcription of the cbpA-hspR-orf 
operon was found to be exclusively regulated by HspR (38). Consequently, it is tempting 
to propose that the loss of HspR induces an increase in the abundance of heat shock 
proteins. Given that heat shock proteins are major immuno-dominant antigens, the over-
expression of these proteins would likely contribute to host resistance (52) . As a result, 
the hspR mutants should be less capable of colonization and survival in the host. In 
addition, given the absence of colonization defect for the hrcA mutant, the amount of 
these proteins would not be increased at a sufficient level in this mutant to induce host 
resistance. In support of this hypothesis, H. pylori hspR and hspR-hrcA double mutants 
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were reported to have attenuated colonization efficiency in wild-type mice, while they 
were unaffected in IL-12-deficient mice (15). Furthermore, C. jejuni infected patients 
have been shown to develop humoral response against the heat shock protein DnaK (44).  
In E. coli, spoT codes for a bi-functional enzyme able to catalyze the biosynthesis and the 
degradation of hyperphosphorylated guanine (p)ppGpp (1). In most eubacteria, (p)ppGpp 
has been shown to accumulate in response to stringent conditions, such as amino acid 
starvation, triggering the down-regulation of genes encoding the transcription and 
translation apparatus (1). As shown in Figure 6, the spoT mutant exhibits a competitive 
index of 9.10-6 in vivo. In contrast to this in vivo result, the in vitro competitive index 
was only 0.06, suggesting a significant in vivo specific defect. The decreased ability of 
the C. jejuni spoT mutant to colonize the host gut suggests an important role for the 
stringent response in vivo, likely allowing Campylobacter to deal with periods of nutrient 
starvation or other environmental stresses in the intestinal tract.  
While the function of Cj0178 has not been characterized, this protein exhibits high 
homology with ferric-siderophore outer-membrane receptors. In addition, the expression 
of Cj0178 is Fur regulated and induced in response to iron starvation (26). Consequently, 
Cj0178 is probably required for the acquisition of iron from an uncharacterized 
siderophore. The Cj0178 mutant exhibits a competitive index of 0.05 in vivo and 0.37 in 
vitro.  Given that C. jejuni NCTC 11168 does not seem to produce any siderophore (48), 
the growth defect of this mutant in vitro is unclear. The significant attenuation of the 
Cj0178 mutant in vivo is in agreement with its over-expression in our microarray 
experiment and might suggest an important role for this iron acquisition system in gut 
colonization.  
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Interestingly, while the fliD has a significant growth defect in vitro (exhibiting a a 
competitive index of 0.1), it colonizes the ileal loop as well as the wild-type strain  
(exhibiting a competitive index of 1.3). The fliD gene encodes a putative flagellar hook-
associated protein. In H. pylori, fliD is an essential component in the assembly of a 
functional flagellum and is required for colonization of the gastric mucosa of mice (17). 
Similarly to H. pylori, the C. jejuni fliD mutant is non-motile and aflagellated (12). While 
the survival of the fliD mutant in the gut is in disagreement with the essential role of the 
flagellum in the colonization of the gastrointestinal tract, it is consistent with the 
characteristics of the RIL animal model. Indeed, the physical ligation of the rabbit 
intestinal tract likely favors the survival of mutants affected in their ability to adhere to 
the mucus or the intestinal epithelial cells. In addition, considering that flagellin is the 
major immunodominant antigen during infection (24), the loss of the flagellum structure 
should promote evasion of the immune system. Consequently, a fliD mutant will have an 
advantage over the wild-type in vivo and thus compete better during in vivo than in vitro 
growth.  
  
Concluding remarks.  
This genome-wide expression profiling study revealed important elements of the 
Campylobacter lifestyle during host intestinal tract colonization. In addition to the genes 
discussed above that have known or potential functions, many other genes of unknown 
function were also found to be differentially expressed between in vivo and in vitro 
growth, and therefore constitute many new directions for future investigations. The 
transcriptome pattern of C. jejuni in vivo was consistent with that expected in an 
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environment that is oxygen-limited, hyper-osmotic, nutrient restricted, and containing 
reactive oxygen compounds. Interestingly, the comparison of the C. jejuni transcriptomes 
between different rabbits revealed gene expression variability during the course of an 
infection. This flexibility in gene expression is probably essential for Campylobacter to 
adapt to the changing environment of the gut. Furthermore, the genes encoding proteins 
involved in flagellum biogenesis were found to be differentially expressed between 
rabbits. They were up-regulated in one rabbit and down-regulated (at a different level) in 
all others. While the up-regulation of these genes is in agreement with the role of the 
flagellum in gut colonization, the decreased expression of these genes probably reflects a 
bacterial strategy to evade the host response. Finally, regulation of both the heat shock 
response and the stringent response were found to be necessary for efficient colonization 
of the host gastrointestinal tract.  
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Table 1: Bacterial strains and plasmids 
Strain or 
plasmid 
Relevant characteristicsa Source or 
reference 
E. coli    
DH5α endA1 hsdR17 (rk-mk-) supE44 thi-
1 recA1 gyrA relA1 ∆(lacZYAargF 
U169deoR [f80dlac∆(lacZ0 M15] 
Invitrogen 
   
C. jejuni   
NCTC11168 C. jejuni NCTC 11168 NCTC 
AS 283 NCTC11168∆Cj0571 This study 
AS 287 NCTC11168∆spoT This study 
AS272 NCTC11168∆hspR This study 
AS277 NCTC11168∆hrcA This study 
AS211 NCTC11168∆Cj0178 (26) 
AS317 NCTC11168∆Cj0341 This study 
AS318 NCTC11168∆fliD This study 
   
Plasmids   
pUC19 Cloning and suicide vector, Ampr Biolabs 
pRY111 cam resistance gene (55) 
pAS282 pUC19 carrying ∆Cj0571::cam This study 
pAS271 pUC19 carrying ∆hspR::cam This study 
pAS315 pUC19 carrying ∆hrcA::cam This study 
pAS286 pUC19 carrying ∆spoT::cam This study 
   
 
acam, chloramphenicol resistance gene;  
Ampr, ampicillin resistant 
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Table 2: Primers used in this study.  
Primer DNA sequence from 5’ to 3’ (restriction site)a 
Primers used for gene 
cloning 
 
spoT-01  ATGCGAATTCGAGATTTTAACCTATCCTTGACAC (EcoRI) 
spoT-02   ATGCCTGCAGCCATGATGCCATTCTTGAAA (PstI) 
Cj0571-01  ATGCGAATTCATGCAAGAAAATTTCATACGC (EcoRI) 
Cj0571-02   ATGCCTGCAGTCCCGTTGTAGCATCTTTTG (PstI) 
hrcA-01 ACGTGGTACCAATAGAGTGCTAGATATGAAGGAA (KpnI) 
hrcA-02 ACGTGGTACCGATGGTTTTCACTATCTACATGAA (KpnI) 
hspR-01 ACGTGGTACCGGAAAACAAAGCAGAAATGGAGC (KpnI) 
hspR-02 ACGTGGTACCGCACCACTGCGGTTGAAGAAA (KpnI) 
  
Primers used for 
inverse PCR 
 
spoT-03   ATGCGGATCCAAAACAGGAAAAGCAAAAGCA (BamHI) 
spoT-04   ATGCGGATCCAATGCCTTTTCTTTGCAT (BamHI) 
Cj0571-03   ATGCGGATCCGCTTAATTTTCCCAAAGCAAA (BamHI) 
Cj0571-04   ATGCGGATCCAGAACTGAAAATACGGCTAGAAGA (BamHI) 
hrcA-03 ACGTCCATGGATTGCTTCTATAGCAAATCAA (NcoI) 
hrcA-04 ACGTGCGGCCGCAAGCTCTTAGATTGTCAAATTCAC (NotI) 
hspR-03 ACGTCCATGGTTGCCATCGGTTCTACTTGG (NcoI) 
hspR-04 ACGTGCGGCCGCGAATCAATCTTGCTGGAGTA (NotI) 
  
 
aThe restriction sites used for cloning are highlighted in bold and indicated in parenthesis.  
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Figure 1  
Detection of C. jejuni transcriptome in vivo. Panels A and B show the rabbit ileal loops 
48 hours post-inoculation with C. jejuni or PBS buffer, respectively. The arrows indicate 
intestine distended with gas and fluid accumulation. Total RNA was extracted from the 
intestinal contents, reverse transcribed using C. jejuni specific 3’ primer, and labeled with 
the Cy5 dye. This labeled cDNA was co-hybridized to the microarray with Cy3 labeled 
cDNA, obtained from in vitro grown bacterial RNA.   
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A) B) 
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Figure 2  
Scatter plots showing the relationship between the log2 value of the gene expression ratio 
obtained from hybridization experiments with bacterial cDNA derived from the same 
rabbit (Panels A and B) or from two different rabbits (Panel C). The solid lines represent 
the linear regression fit of the data.  
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Figure 3  
Global view of genes with similar expression pattern between rabbits grouped by 
functional categories according to the Sanger Center C. jejuni genome database. Each 
row represents one gene and each column represents the expression profile in one rabbit 
(the mean of the fold change expression ratio of the technical replicates). The column 
label corresponds to the rabbit numbering. An increasing red intensity denotes genes that 
have their expression significantly increased in vivo compared to in vitro growth and an 
increasing green intensity indicates genes that have their expression significantly 
decreased in vivo compared to in vitro growth. A gray color indicates missing data. 
Genes with unknown functions are not represented.  
 
 268 
 
<0.33         1                   >3 
Energy and 
central 
intermediary 
metabolism 
Amino acid 
biosynthesis 
Purines, 
pyrimidines 
biosynthesis 
Cofactors 
biosynthesis 
Regulatory 
functions 
Ribosomal 
protein 
synthesis 
and 
modification 
Synthesis and 
modification of 
macromolecules 
Cell 
envelope 
Cell processes: 
transport and 
binding 
proteins 
Cell processes 
(others) 
Drug/analogue 
resistance 
1 2 3 4 5 1 2 3 4 5 1 2 3 4 5 
 269 
Figure 4  
Global view of genes with a variable expression pattern between rabbits. Each row 
represents one gene. Columns 1, 2, 3, 4, and 5 represent the expression profile in rabbit 1, 
2, 3, 4, and 5 respectively. For each rabbit, the microarray data correspond to the mean of 
the fold change expression ratio of the technical replicates. Red and green denotes 
transcripts that have their abundance increased or decreased in vivo compared to in vitro 
growth, respectively. The red and green intensities are proportional to the fold increase or 
decrease with maximal fold changes in transcript abundance of 3 and 0.33, respectively. 
A gray color denotes missing data. 
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Figure 5   
Competitive colonization ability of 7 mutants (hrcA, Cj0178, Cj0571, spoT, Cj0341, 
hspR, and fliD). The strains were pooled with the parent strain C. jejuni NCTCCC 11168 
(constituting the input pool) and inoculated into 4 rabbit ileal loops. Forty-eight hours 
post-inoculation, the intestinal content was recovered and processed for chromosomal 
DNA extraction. The number of bacteria was estimated by quantitative real-time PCR for 
each mutant as described in the Materials and Methods section. The normalized 
competitive ratio corresponds to the ratio of the number of mutant cells to the total 
number of bacterial cells in the input pool divided by the ratio of the number of mutants 
to the total number of bacteria in the recovered pool. The data is the mean of eight 
determinations (four biological replicates with two technical replicates each), and the 
error bars represent the standard deviations.  
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Figure 6  
In vivo (panel A) and in vitro (panel B) competition assays. The in vivo competitive 
index is the ratio of the mutant to the wild-type strain recovered in the ileal loop 48 hours 
post-infection. Four loops were infected with a mixture of each mutant and the wild-type 
strain at a ratio of 1 to 1. The in vitro competitive index is the ratio of the mutant to the 
wild-type strain in MH broth at late log phase. The in vitro competition assay was 
performed in triplicate. The error bars indicate the standard deviations. The symbol * 
indicates a statistical significance (P value <0.001).  
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Figure 7  
Growth kinetics of C. jejuni NCTC 11168 and 5 mutants, ∆hrcA (panel A), ∆hspR (panel 
B), ∆spoT (panel C), ∆Cj0178 (panel D), and ∆fliD (panel E). Biphasic MH cultures were 
incubated at 37°C under microaerophilic conditions. The growth kinetics were performed 
in triplicate and the error bars represent the standard deviations.  
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Scope and Method of study: Identification of colonization and virulence determinants that 
contribute to C. jejuni infection and survival in the gastrointestinal tract of the animal 
host would be an important tool in designing intervention strategies to combat the 
infection. Availability of iron in the host is a key environmental factor for controlling the 
establishment of many bacterial infections. The global aim of this project was to decipher 
the molecular mechanisms of iron acquisition in C. jejuni. We report the characterization 
of FeoB mediated ferrous iron and TonB mediated ferric iron acquisition in C. jejuni. We 
used directed mutagenesis to functionally disrupt the feoB and tonB genes. By performing 
a series of in vitro experiments such as 55Fe2+ uptake assays, cell culture based assays and 
microarrays; we have studied the role of FeoB in iron transport, iron accumulation and 
intracellular survival within human and porcine intestinal epithelial cells. TonB systems 
were characterized in vitro using growth promotion assays, ferric-enterobactin assays and 
cell culture. The FeoB and TonB systems were extensively assessed for their role in the 
in vivo colonization of the gastrointestinal tract of the chicken, rabbit ileal loop and the 
colostrums-deprived neonatal piglet models. 
 
Findings and Conclusions: The feoB mutant was significantly impaired in iron uptake 
and was demonstrated to have decreased cellular iron accumulation. FeoB was found to 
play significant role in the intracellular survival of C. jejuni within human and porcine 
epithelial cells. The feoB mutant was significantly affected in its ability to colonize the 
gastrointestinal tract of chicks, rabbits and neonatal piglets thus highlighting its 
importance in the gut colonization. Growth promotion assays and ferric-enterobactin 
assays revealed that TonBs played specific and redundant roles in acquisition of iron 
from different sources. TonB3 was found to be specifically required for enterobactin 
utilization, whereas TonB2 and TonB3 were together required for the uptake of hemin 
and hemoglobin.  All the tonB mutants were significantly affected in their ability to 
colonize the gastrointestinal tract of neonatal piglets. With the exception of tonb2 mutant, 
all the other series of single and double tonB mutants were affected in their ability to 
colonize the chicken ceca. Thus, combining our in vitro and in vivo characterization of 
the FeoB and TonB systems, it is clear that both the systems contribute significantly in 
iron transport and gastrointestinal colonization of the animal models. 
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